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Summary: 
Regulation of a gene transcription by RNA Polymerase III in Saccharomyces 
cerevisiae. The role of evolutionary conserved domains of the Maf1 protein, 
RNA Polymerase III repressor. 
Yeast cell encounters numerous environmental situations that require a rapid 
and efficient adaptation of the cellular metabolism to changing life conditions. One 
of the first responses, is the inhibition of RNA polymerase III (Pol III) transcription. 
The Maf1 protein, the unique negative regulator of the Pol III apparatus in 
Saccharomyces cerevisiae (Sc), is conserved through evolution. The family of 
eukaryotic Maf1 share highly conserved amino acid sequence with two easily 
recognizable regions called A and BC domains. The work performed during this PhD 
thesis concerns the role of these evolutionary conserved domains in the activity of 
ScMaf1. I have constructed a library of Maf1, identified and localized the mutations 
of corresponding Maf1 proteins and studied the phenotype. Using yeast two-hybrid 
system, I have found the A and BC domains interact physically and defined the 
minimal 34 aa fragment of the A domain involved in this interaction. Using genetic 
screen for internal suppressor mutations, I have identified that mutations localized 
in the BC domain (D250E, V260D-N344I) recovered the activity of Maf1 mutated in 
the A domain (K35E), as deduced from no defected growth, efficient Pol III 
repression, phosphorylation and cellular localization of identified suppressors. The 
identified K35E mutation disrupted physical interaction between Maf1 domains, 
unless the presence of additional D250E or V260D-N344I suppressor mutations 
occurred. The Take Home message from the results obtained during my PhD thesis 
is that: “Full repression of Pol III requires the physical interaction between Maf1 
domains”. 
 
Résumé : 
 
Etude de la régulation de la transcription par l’ARN polymérase III chez 
Saccharomyces cerevisiae. Rôle des domaines conservés au cours de 
l’évolution de la protéine Maf1, un répresseur de l’ARN polymérase III. 
Dans l’environnement, la levure doit faire face à des conditions variées qui 
nécessitent une adaptation rapide du métabolisme cellulaire. Une des premières 
réponses est l’inhibition de la transcription par l’ARN polymérase III (Pol III). La 
protéine Maf1, le seul régulateur de la machinerie de la Pol III chez Saccharomyces 
cerevisiae (Sc), est conservée au cours de l’évolution. Les protéines Maf1 des 
Eucaryotes contiennent deux domaines A et BC phylogénétiquement conservés. Ce 
travail de thèse a cherché à identifier le rôle de ces domaines dans la fonction de la 
protéine ScMaf1. J’ai construit une banque de mutants de Maf1, identifié les 
changements dans leurs séquences ainsi que leurs phénotypes. En utilisant la 
technique du double-hybride, j’ai montré que les domaines A et BC interagissent 
physiquement et que l’extrémité N-terminale de 34 acides aminés du domaine A est 
le fragment minimal nécessaire à cette interaction. Grâce à un crible génétique, j’ai 
mis en évidence que les mutations du domaine BC (D250E et V260D-N344I) 
permettent de restaurer l’activité de Maf1 mutée dans le domaine A (K35E). Cette 
restauration est observable pour le phénotype, la répression efficace de la 
transcription par la Pol III, le niveau de phosphorylation et la localisation cellulaire 
de Maf1. La technique du double-hybride m’a permis aussi de montrer que la 
mutation K35E inactive partiellement l’interaction entre les domaines de Maf1 qui 
est restaurée par les mutations suppresseurs D250E et V260D-N344I. Les résultats 
permettent de conclure que : « la répression de la transcription par la Pol III requiert 
l’interaction physique des domaines de Maf1  
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I. INTRODUCTION 
 
In eukaryotic cells, RNA polymerases (Pol) I and III are responsible for the 
synthesis of RNA species involved in ribosome biogenesis and the translation 
process. RNA synthesis by Pol I and Pol III represents more than 80% of all  
S. cerevisiae nuclear transcription activity and is controlled in a coordinated way in 
response to various cellular and environmental conditions (Willis et al., 2004; 
Warner et al., 2001; Warner, 1999). 
Pol III is responsible for the transcription of ~400 genes in S. cerevisiae (class III 
genes), mostly tRNA genes and 5S rRNA genes (Harismendy et al., 2003; Roberts et 
al., 2003; Moqtaderi et al., 2004). Analyses of the Pol III transcription system in  
S. cerevisiae have revealed a series of protein-DNA and protein-protein interactions 
leading to the recruitment of Pol III to its target tRNA genes: binding of the six-
subunit TFIIIC factor to the intragenic promoter, TFIIIC-directed recruitment and 
assembly of the three components of TFIIIB (TBP, Brf1 and Bdp1), and subsequent 
recruitment of the seventeen-subunit Pol III enzyme (Geiduschek and Kassavetis, 
2001) (Fig. 1).  
The Pol III machinery is remarkably conserved between yeast and human cells.  
The most conserved components are those involved in assembly of the transcription 
complex: the τ131 subunit of TFIIIC and two components of TFIIIB (TBP, Brf1). The 
five Pol III-specific subunits in S. cerevisiae (C31, C34, C37, C53 and C82, Fig. 2) 
all have structural and functional homologs in human cells (Schramm and 
 
Figure 1. Assembly of the transcription complex on S. cerevisiae tRNA gene. The scheme depicts 
the multistep pathway of transcription complex formation: (1, 2) promoter recognition by TFIIIC, (3) 
TFIIIC-directed assembly of the initiation factor TFIIIB, (4) recruitment of Pol III and (5) termination of 
transcription. Adapted from Harismendy et al., 2003. 
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Hernandez, 2002; Canella et al., 2010). These Pol III-specific subunits form two 
subcomplexes (Fig. 2). The C53/37 subcomplex is involved in promoter opening, 
elongation, termination and reinitiation (Cramer et al., 2008; Carter and Drouin, 
2009; Kassaventis et al., 2010; Landrieux et al., 2006), whereas the C82/34/31 
subcomplex is involved in promoter recognition and initiation. C34 interacts with 
TFIIIB, which recruits Pol III to promoters (Thuillier et al., 1995; Werner et al., 
1993) and is involved in open complex formation (Brun et al., 1997). 
Also Maf1, the general Pol III repressor, is conserved across eukaryotic 
organisms from yeast to man (Pluta et al., 2001). This conservation is of particular 
interest considering that misregulation of Pol III in human cells has been linked to 
malignant transformation. Excessive activation of Pol III-directed transcription can 
lead to tumorgenesis (Marshall et al., 2008; Marshall et al., 2008; Johnson et al., 
2008). In line with this observation, two mammalian tumor suppressors, Rb and 
p53, have been shown to act as global repressors of Pol III transcription (White, 
2008). Recent results of several groups report Maf1-mediated repression of Pol III 
transcription in human cells implicating H. sapiens Maf1 ortholog as a new class of 
mammalian Pol III regulators (Goodfellow et al., 2008; Reina et al., 2006; Johnson 
et al., 2007; Rollins et al., 2007). The involvement of H. sapiens Maf1 in the 
aberrant control of Pol III transcription in cancer cells remains to be elucidated. In 
the light of the high evolutionarily conservation of the Pol III machinery including 
Maf1, insights into Pol III (mis)regulation by Maf1 attained by studying model 
organisms, such as yeast, should provide some insight into the role of H. sapiens 
Maf1 in cancer development.  
 
Figure 2. A model of the Pol III transcription initiation complex. A model of the Pol III 
transcription initiation complex. Protein–protein contacts observed by the two-hybrid system are 
indicated by red dots. Green dots indicate the interaction between AC40, AC19, ABC10α and ABC10β 
with A190 and A135 Pol I subunits homologous to C160 and C128. Genetic interactions observed by 
using multicopy suppression experiments of full-length mutations are indicated by arrows. The 
arrowhead points toward the subunit harboring the suppressed mutation. For the sake of simplicity, 
only the τ131 subunit of TFIIIC is represented. Adapted from Flores et al., 1999.  
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1. Maf1-mediated repression of RNA polymerase III-
dependent transcription. 
 
The Maf1 protein was identified originally in Saccharomyces cerevisiae in a 
genome-wide screen for mutations that decrease the nonsense suppressor efficiency 
of SUP11 (tRNA-Tyr(UAA)) (Fig. 3). The isolated mutation (maf1-1) conferred 
temperature-sensitivity in medium containing glycerol (a nonfermentable carbon 
source) (Murawski et al., 1994). The identified maf1-1 mutation besides inactivating 
the MAF1 gene (maf1∆) lead also to the increase of tRNA level, suggesting a 
deregulation of Pol III transcription (Pluta et al., 2001; Kwapisz et al., 2002; 
Upadhya et al., 2002). The disturbance of S. cerevisiae cell growth in respiratory 
conditions at high temperatures was explained by the toxic effect of tRNA 
accumulation (Ciesla et al., 2007). Performed investigations placed Maf1 as a main 
repressor of Pol III, involved in transduction of signals from diverse signaling 
pathways to the Pol III apparatus (Upadhya et al., 2002).  
Maf1 represses Pol III transcription in response to unfavorable growth 
conditions (various drug treatment, oxidative stress), secretory pathway defects and 
during stationary phase and respiratory growth. Inactivation of MAF1 gene (maf1∆) 
blocks repression of Pol III transcription under all these conditions (Upadhya et al., 
2002). Moreover, it was shown that under conditions of carbon source starvation, 
endoplasmic 
 
Figure 3. The maf1∆ mutation results in increased tRNA level and antisuppressor phenotype. 
The presence of ade2-1 nonsense mutation leads to an accumulation of red pigment and can be 
overcome by a functional tRNA-Tyr (UAA) suppressor, SUP11. S. cerevisiae strain SUP11 ade2-1 
(MB159-4D) is white, while SUP11 ade2-1 maf1∆ (MB159-4D∆) is red, indicating that the deletion of 
the chromosomal MAF1 counteracts the effect of SUP11 and acts as an antisuppressor. Moreover, the 
maf1∆ mutation results in temperature-sensitive growth on glycerol-containing medium (YPGly), and 
an increase of tRNA to a level 3-4-fold higher than the level in parental isogenic SUP11 ade2-1 cells. 
Adapted from Kwapisz et al., 2002. 
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reticulum stress (induced by DTT, 1,4-dithiothretiol) and during oxidative stress 
(induced by hydrogen peroxide) S. cerevisiae cells also lack Pol III repression in the 
absence of MAF1 (Desai et al., 2005, Boisnard et al., 2009). Maf1 was also shown to 
be essential for the regulation of Pol III transcription during the transition of  
S. cerevisiae cells from medium with fermentable to a nonfermentable carbon 
source inducing respiratory growth conditions (Fig. 4, Ciesla et al., 2007).  
Recent data on Maf1 suggested possible connection between replication and 
transcription processes (Nguyen et al., 2010). In S. cerevisiae, active tRNA genes act 
as “replication fork barriers” during cell proliferation as Pol III with concomitant 
TFIIIB/TFIIIC transcription factors interfere with the elongation process carried out 
by processive DNA polymerases (Deshpande et al., 1996) in a way that might 
promote chromosome breakage. Checkpoint repression occurs in co-directional 
tRNA genes, which are replicated in the same direction as they are transcribed. The 
sensor kinase (Mec1), the signaling adaptor (Mrc1) and the transducer kinase 
(Rad53), involved in replication checkpoint, relay signals, which globally repress 
tRNA gene transcription in noneffected growth conditions and under replication 
stress (HU, hydroxyurea). Maf1 was shown to mediate replication stress signaling 
and pre-tRNA synthesis as shown by Rad53-dependent dephosphorylation of Maf1 
in HU-treated 
 
 
Figure 4. Inactivation of MAF1 leads to tRNA accumulation that is increased during cell growth 
on nonfermentable carbon sources. Cells with inactivated Maf1 grown in glycerol medium (YPGly) at 
37°C have markedly higher levels of each type of tRNA tested, compared to WT cells, although this 
increase is different for the individual tRNA species. Northern blotting analysis. RNA from WT and 
maf1∆ cells (YPH500 S. cerevisiae strain) were separated on polyacrylamide gels, followed by 
hybridization using labeled oligonucleotide probes complementary to various tRNAs, 5S rRNA and U3 
snoRNA. Numbers below represent quantification of the relative levels of each RNA present in WT and 
maf1∆ cells grown in glucose (YPD) and glycerol-containing medium (YPGly). Adapted from Ciesla et 
al., 2007. 
 - 5 - 
cells (Nguyen et al., 2010). Cells lacking Maf1 exhibit elevated tRNA synthesis and 
are more sensitive to HU-directed replication stress.  
These results have shown that S. cerevisiae cells require Maf1 to achieve Pol III 
repression and that Maf1 mediates multiple signals for Pol III regulation. 
In human cells, Maf1 seems to play a similar role as in S. cerevisiae, mediating  
Pol III repression. At least Reina et al. (2006) show that in response to MMS and 
rapamycin, knock-down of Maf1 diminishes repression of Pol III.  
Moreover, novel unpublished data on D. melanogaster Maf1 ortholog show an 
important global Maf1 effect on cellular growth and cell maintainance. Similarly to 
mammalian and S. cerevisiae cells, in D. melanogaster cells inhibition of tRNA 
synthesis occurs in response to nutrient deprivation in correlation with TOR (Target 
of rapamycin) signaling pathway inhibition. Moreover, in D. melanogaster, Maf1 was 
shown to regulate the development of larvae in response to nutrient availability. 
Diminished expression of Maf1 by RNA silencing (siRNA) caused increased tRNA 
levels, in spite of TOR inhibition induced by starvation. This correlated not only 
with faster larvae development, but also with their increased sensitivity and lower 
survival in response to starvation (Rideout and Grewal, 2010 – data unpublished). 
 
The mechanism of Pol III regulation by Maf1 affects several components of Pol III 
transcription apparatus. One of the phenomena occurring during regulation of  
Pol III activity is a physical interaction of Maf1 with Pol III largest subunit, C160. 
This was initially demonstrated by overexpression of the C160 N-terminal fragment, 
which led to suppression of maf1-1 temperature-sensitivity on a nonfermentable 
carbon source (Boguta et al., 1997). Further investigations provided some more 
evidences for the observed genetic interaction. Mutations in RPC160 (gene encoding 
C160) were obtained and described as spontaneous suppressors of maf1-1 and 
maf1∆ (Pluta et al., 2001). Also, co-immunopurification experiments revealed that  
S. cerevisiae Maf1 in cell extracts associates, directly or indirectly, with C160.  
Pull-down experiments have revealed that S. cerevisiae Maf1 interacts, most 
probably directly, with the N-terminal domain of C160 (235 residues) (Oficjalska-
Pham et al., 2006) and weakly but specifically with Brf1 (TFIIIB – related factor), a 
subunit of Pol III transcription initiation factor TFIIIB (Desai et al., 2005) involved in 
recruitment of Pol III to promoters. Desai et al. (2005) postulated that repression of 
Pol III by Maf1 occurs as a two step process: by blocking the assembly of the 
TFIIIB–DNA complex and subsequently by recruitment of Pol III to pre-existing 
TFIIIB–DNA complexes. 
 - 6 - 
Similar results supporting the hypothesis of interaction with components of  
Pol III, were obtained for human Maf1. Co-immunoprecipitation experiments 
indicated that human Maf1 interacts with Rpc1 (the largest subunit of Pol III – 
reported as C160 in S. cerevisiae cells), Brf1 (S. cerevisiae Brf1 homologue) and Brf2 
(a subunit of the TFIIIB complex required for transcription of U6 snRNA, 7SK and 
H1 genes) (Reina et al., 2006; Rollins et al., 2007; Goodfellow et al., 2008).  
 
In yeast S. cerevisiae, inhibition of Pol III activity by Maf1 was studied also in 
conditions involving the nutrient-sensing signal transduction pathway and during 
stationary growth phase.  
Inhibition of Pol III occurs during stationary growth phase or under rapamycin 
treatment, which mimics nutrient deprivation. It was estimated that the level of  
Pol III-dependent transcription decreases up to 10-20% after a 25-min. induction by 
rapamycin (Harismendy et al., 2003; Roberts et al., 2003). In the stationary growth 
phase, down-regulation of Pol III transcription occurs by decrease in Pol III, Brf1 
and Bdp1 (subunits of Pol III transcription factor - TFIIIB) recruitment to class III 
genes as shown by ChIP on chip analysis (Harismendy et al., 2003; Oficjalska-Pham 
et al., 2006). In the absence of Maf1, Pol III occupancy on class III genes strongly 
increases compared with the exponential phase of growth, Brf1 is present at similar 
levels while the presence of Bdp1 is slightly affected with very vivid  
Pol III-dependent transcription to (Oficjalska-Pham et al., 2006). Under rapamycin 
treatment, Pol III and TFIIIB (Brf1 and Bdp1) occupancy on class III genes 
decreases in control cells, while in cells lacking Maf1 the occupancy decreases 
slightly or does not change. Moreover, Maf1 occupancy on class III genes is 
increased during cell starvation (rapamycin treatment, nutrient deprivation) as 
shown by Oficjalska-Pham et al. (2006) and Roberts et al. (2006). In addition, 
interaction of Pol III with Maf1 is increased after treatment with rapamycin or in the 
stationary phase of growth (Oficjalska-Pham et al., 2006).  
All these results show that independently from the pathway inducing the  
down-regulation of Pol III transcription, Maf1 acts in a similar way by affecting 
directly the assembly of TFIIIB onto class III genes promoters and recruitment of  
Pol III to the transcription initiation complex.  
The activity of Maf1 is regulated at posttranslational level by phosphorylation 
that occurs in favorable conditions (Oficjalska-Pham et al., 2006; Moir et al., 2006; 
Willis and Moir, 2007). Furthermore S. cerevisiae Maf1 was shown to serve as a 
target for either PKA or Sch9 kinases (Lee et al., 2009; Huber et al., 2009). Huber et 
 - 7 - 
al. (2010) have demonstrated predominant role of the Sch9 kinase in Maf1 
phosphorylation in normally growing S. cerevisiae cells and Maf1-dependent Pol III 
down-regulation via Sch9 inhibition. Maf1 contains six motifs fitting the R(R/K)xS 
consensus, which is often attributed to AGC family kinases (S90, S101, S177, 
S178, S209 and S210) Huber et al. (2010) in an in vitro assay indicated these sites, 
and additionally S179, as a targets for the Sch9 kinase.  
In exponentially growing S. cerevisiae cells, Maf1 is phosphorylated and 
migrates as several bands corresponding to different phosphorylation states on 
modified SDS/PAGE polyacrylamide gels (Oficjalska-Pham et al., 2006). Different 
stress conditions, like rapamycin, stationary phase, chlorpromazine (CPZ), methyl 
methane sulfonate (MMS) or nutrient depletion that induce down-regulation of  
Pol III transcription, causes dephosphorylation of Maf1 and its migration as a single 
band, which is interpreted as a fast-migrating dephosphorylated form (Oficjalska-
Pham et al., 2006; Roberts et al., 2006; Moir et al., 2006). Maf1 interacts with Pol III 
in its dephosphorylated form (Fig. 5, Oficjalska-Pham et al., 2006; Roberts et al., 
2006, Huber et al., 2009), which indicates phosphorylation as a form of regulating 
Maf1 activity.  
Similarly to S. cerevisiae Maf1, human Maf1 also exhibits phosphorylation-
dependent activity. It was shown that, the inactive form of human Maf1 remains 
phosphorylated (Reina et al., 2006; Rollins et al., 2007; Goodfellow et al., 2008; 
Michels et al., 2010). The human Maf1 is phosphorylated on serines: S60, S68 and 
S75 (nota bene: amino acids positions in human Maf1 are not the same for  
S. cerevisiae Maf1), by mTORC1 kinase (Michels et al., 2010; Shor et al., 2010; 
Kantidakis et al., 2010). After treatment of human cells with rapamycin, Torin1 or 
MMS, Maf1 is dephosphorylated and migrates as a single fast-migrating form, in 
contrast, to unaffected cells presenting additional slow-migrating bands.  
 
Figure 5. Pol III-Maf1 interaction increases in stress conditions. Maf1 is phosphorylated, but 
only the dephosphorylated form of Maf1 interacts with Pol III. Western blot analysis using a 
modified acrylamide:bisacrylamide ratio SDS-PAGE of Maf1-myc immunopurified from exponential 
phase (Exp.), stationary phase (Stat.), or rapamycin-treated (Rap.) cells (IP Maf1, lanes 1–3) and of 
Maf1-myc co-immunopurified with C160 from the same cells (IP Pol III, lanes 4–6). Adapted from 
Oficjalska-Pham et al., 2006. 
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The dephosphorylated form of human Maf1 like S. cerevisiae Maf1 interacts with 
Pol III (Reina et al., 2006).  
S. cerevisiae Maf1 is also dephosphorylated under respiratory growth conditions, 
which are induced by the change from fermentable (glucose) to nonfermentable 
(glycerol) carbon source. Transfer from glucose to glycerol medium results in Maf1 
dephosphorylation (Ciesla et al., 2007). Re-transition of S. cerevisiae cells to glucose 
medium, is followed by Maf1 re-phosphorylation (Fig. 6, Towpik et al., 2008).  
The phosphorylation state of Maf1 is correlated with its cellular localization.  
In exponentially growing S. cerevisiae cells, Maf1 is phosphorylated and is present 
at the same concentration in the cytoplasm and the nucleus, as observed by 
immunofluorescent microscopy. Different stress conditions, treatment of cells with 
rapamycin, nutrient deprivation, stationary phase or respiratory growth conditions 
lead to dephosphorylation and nuclear concentration of Maf1, which is associated 
with repression of Pol III-dependent transcription (Oficjalska-Pham et al., 2006; 
Roberts et al., 2006; Moir et al., 2006; Towpik et al., 2008). Dephosphorylation of 
PKA/Sch9 sites that occurs under rapamycin treatment, correlates with Maf1 
relocation into the nucleus (Moir et al., 2006; Huber et al., 2009). However, it is not 
known whether dephosphorylation precedes, follows or is simultaneous with import 
of Maf1 into the nucleus (Moir et al., 2006). 
 
 
Figure 6. Maf1 is re-phosphorylated and exported out of the nucleus after transferring cells 
from respiratory conditions (glycerol medium, YPGly) to glucose medium (YPD). Maf1 becomes 
dephosphorylated upon transition from glucose to glycerol medium (compare YPD and YPGly lanes), 
the opposite transition results in gradual Maf1 phosphorylation (compare YPGly and YPD lanes; 5 min 
to 1 h). Relocation of Maf1 to the cytoplasm in response to glucose appeared to be concomitant with 
Maf1 hyperphosphorylation. Localization of Maf1 was analyzed by immunofluorescence microscopy 
using polyclonal anti-Maf1 antibodies. Nuclei were stained with 4,6-diamidino-2-phenylindole (DAPI) 
(top panel). Crude extracts prepared from the same cells by trichloroacetic acid precipitation were 
analyzed using SDS-PAGE with a modified acrylamide:bisacrylamide ratio, followed by immunoblotting 
with polyclonal anti-Maf1 antibodies (bottom panel). The slower-migrating diffuse band corresponds to 
phosphorylated forms of Maf1. Adapted from Towpik et al., 2008. 
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Nuclear import of S. cerevisiae Maf1 is directed by two nuclear localization 
sequences (NLS1 and NLS2). Activity of the N-terminal NLS (NLS1) was proposed to 
be regulated via phosphorylation, while the C-terminal NLS is regulated 
independently of the phosphorylation state (Moir et al., 2006). The accumulation of 
Maf1 in nucleus due to the lack of the Msn5 exportin protein is not sufficient to 
cause Pol III repression in the absence of additional factors that are triggered by 
cellular signaling pathways. Moreover, Maf1 was dephosphorylated and 
phosphorylated normally in the msn5∆ mutant and Pol III was under proper 
regulation (Fig. 7, Towpik et al., 2008). 
Recent investigations point that Maf1 localization does not depend only on 
shuffling between the nucleus and the cytoplasm, but also its presence in the 
nucleolus is detectable and has a crucial role for Maf1 activity in pathway involving 
TOR (Target of rapamycin) (Wei et al., 2009). TOR is an evolutionarily conserved 
P13K-related kinase and a central regulator of cell growth found originally in  
S. cerevisiae (Heitman et al., 1991). TOR proteins form two functional complexes: 
TOR complex 1 (TORC1) and TOR complex 2 (TORC2) (Loewith et al., 2002). The 
anticancer drug - rapamycin inhibits specifically TORC1. TORC1 regulates a broad 
spectrum of growth-related processes, including ribosome biogenesis and protein 
translation (Wullschleger et al., 2006). TORC1 is a major regulator of transcription 
in S. cerevisiae, counting all ribosomal genes transcribed by the three major RNA 
polymerases (Warner, 1999; Moss and Stefanovsky, 2002). Rapamycin (by 
 
Figure 7. Model of Maf1 regulation during transfer of S. cerevisiae cells from respiratory 
conditions to glucose. In response to the shift of respiratory growing culture to medium with glucose, 
nuclear Maf1 is phosphorylated (P) by an unknown kinase (X). Phosphorylation of Maf1 prevents its 
interaction with Pol III and enables binding to the Msn5 carrier and export out of the nucleus. In 
parallel, protein kinase A-directed phosphorylation at different sites prevents nuclear import of the 
cytosolic Maf1. Adapted from Towpik et al., 2008. 
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approaching TORC1) and nutrient starvation cause rapid repression of the TOR 
signaling pathway in correlation with ribosomal genes repression.  
Wei et al. (2009) showed that TORC1 (TOR complex 1) indirectly regulates 
synthesis of tRNA by Pol III through Maf1 phosphorylation. Moreover, TORC1 
regulates Maf1 translocation from the nucleoplasm to the nucleolus, a subnuclear 
compartment, in which, 5S rDNA is transcribed by Pol III. Maf1 is normally 
excluded from nucleolus. Inhibition of TORC1 by rapamycin promotes Maf1 
nucleolar localization and association with 5S rDNA, a Pol III transcribed 
chromatin.  
The scheme of Maf1-dependent Pol III transcription regulation in response to 
nutrient availability is presented on Figure 8. The graphic presentation shows also 
the simultaneous regulation of Pol I, which is coordinated at the same time by 
TORC1 effector, common for all eukaryotic RNA polymerases,. 
 
 
Figure 8. Model of Pol III transcription regulation mediated by Maf1 in response to nutrient 
depletion. TORC1 regulates simultaneously Pol I and Pol III according to nutrient availability. Sch9 
partially mediates TORC1 signaling to activate Pol I and Pol III transcription by the nutrients. In the 
presence of nutrients TORC1 promotes Pol I and Pol III transcription in the nucleolus and 
phosphorylates Maf1 preventing its negative effect on Pol III . Additionally, TORC1 activates Sch9 and 
uses Sch9 to phosphorylate Maf1 in the nucleus and promote its export to the cytoplasm. Bold lines, 
activation/repression; empty lines, changes in localization (from Boguta, 2009). 
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2. Search of evolutionarily conserved domains within the 
Maf1 sequence. 
 
The Saccharomyces cerevisiae MAF1 gene (Boguta et al., 1997) encodes a 
hydrophilic protein of 395 amino acids (aa) rich in serine and asparagine residues 
with a predicted molecular mass of 44.7 kDa. Comparison of the S. cerevisiae Maf1 
sequence with multiple databases using the BLAST server revealed more than a 
hundred orthologs in humans, animals (50), plants (28) and lower eukaryotes (27). 
No potential prokaryotic orthologs were identified. Although eukaryotic Maf1 differ 
in molecular mass, ranging from 26 kDa (S. pombe, H. sapiens) up to 45 kDa  
(S. cerevisiae) (Willis et al., 2004), they all share a common organization pattern.  
The family of Maf1 proteins contains three phylogenetically conserved sequence 
regions, labeled A, B and C (Pluta et al., 2001). The C-terminal acidic tail is present 
in most Maf1 orthologs. Similarity of Maf1 sequences is presented in Figure 9 
(Gajda et al., 2010). A short distance of approximately aa 10 between B and C 
segments is constant in evolution, with the exception of A. nidulans (showing 
insertion of aa 15), therefore this region could be considered as a single domain and 
is referred hereafter as the BC domain. In contrast, the space between A and B 
regions is different between species. A and BC domains are fused in E. cuniculi, 
whereas yeast S. cerevisiae and C. glabrata Maf1 orthologs have long linkers of aa 
182 and aa 174, respectively. Within the BC domain, signature sequences 
indicative of the Maf1 protein family can be identified (PDYDFS and 
LWSFnYFFYNKklKR, Fig. 9) (Pluta et al., 2001). Interestingly, in the majority of 
Maf1 orthologs, the second motif includes a nuclear targeting signal, proven to be 
functional in S. cerevisiae Maf1 (Moir et al., 2006). The PSORT program found in  
S. cerevisiae Maf1 two possible nuclear targeting signals: KRRK (position 204, 
NLS1) and a double signal RKRK-KRKR (positions 327 and 328, NLS2) (Pluta et al., 
2001).  
Despite numerous data on Maf1, no functional information has been obtained 
from its amino acid sequence due to lack of significant homology with protein 
domains of known function. 
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Figure 9. Alignment of Maf1 sequences. Schematic representation of Maf1 protein sequences from 
different species: Encephalitozoon cuniculi (gi|19069247|, size: 161 aa), Caenorhabditis elegans 
(gi|17506011|, size: 245 aa), Arabidopsis thaliana (gi|22326767|, size: 224 aa), Dictyostelium 
discoideum (gi|66816633|, size: 278 aa), Ciona intestinalis gi|198415188|, size: 233 aa), Drosophila 
melanogaster (gi|46409204|, size: 226 aa), Danio rerio ( gi|47087413|, size: 247 aa), Homo sapiens 
(gi|49065352|, size: 256 aa), Aspergillus nidulans (gi|67901388|, size: 314 aa), Schizosaccharomyces 
pombe (gi|254745531|, size: 238 aa), Candida glabrata (gi|49529111|, size: 391 aa) and 
Saccharomyces cerevisiae (gi|1170854|, size: 395 aa). Protein sequences have been aligned with 
MUSCLE multiple alignment software (41) and the figure created with Geneious Pro 4.5.4 software. 
Conserved domains are boxed and labeled by letters: A, B and C on the upper panel. Sequence 
alignments of each conserved domain (A, B and C) are shown in the lower panel. Histograms above the 
alignments indicate the percentage of identity among the sequences. Consensus sequences are shown 
above the alignments. Positions of K35E, D250E and V260D mutations are indicated by a star below 
the alignments (N344I mutation is located 6 aa after the end of the BC domain and therefore is not 
represented). 
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Classical methods of analyzing protein sequences focus on the detection of the 
highest amino acids identity.  
If the sequence of a protein with unknown structure is similar to one with 
known architecture, it is assumed, that the fold of the main polypeptide chain will 
share the same conformation. If the similarity between two sequences is statistically 
high this method may be very efficient. Yet in case of sequences with low similarity 
this method is not valuable, although differences between the investigated 
sequences may not imply any important differences in the three-dimensional (3D) 
folding of the proteins. This can be explained by the fact that sequence alignments 
compare whole amino acid sequences but do not take into account neither the 
formation of regular secondary structures by some sets of sequences and the 
concomitant spacial architecture of the protein imposed by the solvent, nor the 
biochemical properties of amino acids composing the polypeptide chain (Gaboriaud 
et al., 1987). 
The HCA (Hydrophobic cluster analysis) is an unconventional, highly efficient 
and sensitive method of analyzing protein sequences. HCA serves as a powerful tool 
to investigate the three-dimensional (3D) structure of a protein. Furthermore, it 
provides data to understand features of protein stability and folding (Callebaut et 
al., 1997). The idea of HCA was firstly reported by Gaboriaud et al. (1987) and 
Lemesle-Varloot et al. (1990). It originates from a two-dimensional (2D) helical 
representation of protein sequence and focuses on the presence of possible 
hydrophobic clusters formed by internal hydrophobic residues in amino acid 
sequence.  
The principles of HCA analysis are based on simple biological phenomena of 
hydrophobic and hydrophilic molecular entities that behave in a regular manner. 
Mostly hydrophobic amino acids dominate the internal core, while mostly 
hydrophilic amino acids lie on the protein surface to protect the core from solvent 
(water, ions). This dichotomic behaviour of hydrophobic and hydrophilic residues is 
due to the fast escape of hydrophobic amino acids from water under the pressure of 
entropic and enthalpic forces. In consequence, the hydrophobic amino acids create 
stable and compact structures that are typical for a particular fold. These 
structures are called clusters (Callebaut et al., 1997). Clusters of hydrophobic 
amino acids are statistically found in close correspondence with the internal 
features of regular secondary structures (Woodcock et al., 1992). Hydrophobic 
amino acids are known to be favored within the internal faces of regular secondary 
structures (α-helices and β-strands) and disfavored within the main irregular 
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secondary structures (loops) (Eudes et al., 2007). The HCA analysis divides amino 
acids into two main classes: the hydrophobic ones and the others, which are 
hydrophilic and/or indifferent to their environment. 
The hydrophobic amino acids are devided into two groups: strong hydrophobic 
amino acids (valine (V), isoleucine (I), leucine (L), phenylalanine (F)), which have the 
major impact on creating hydrophobic internal features of secondary structures and 
moderately hydrophobic amino acids (methionine (M), tryptophan (W), tyrosine (Y)) 
that may be exposed or semi-exposed to the outer surface. Tryptophan and tyrosine 
are thought to mediate often intermolecular interactions and tyrosine often favors 
loop formation. In HCA strong and moderately hydrophobic amino acids are 
grouped together and are highlighted as a hydrophobic clusters. Proline (P) due to 
distinctive cyclic structure of its side chain, acts as a structural disruptor in the 
middle of regular secondary structure elements, such as α-helices and β-strands. 
However, proline is commonly found as the first residue of an α-helices as well as 
on the boundaries of β-strands. Proline is also commonly localized in turns, which 
may account for the curious fact that proline is usually solvent-exposed, despite 
having a completely aliphatic side chain. In HCA, proline is currently considered to 
be a cluster breaker. All the other amino acids are considered as a single class of 
residues that have a minor impact on the development of hydrophobic clusters. 
Although these amino acids are regarded as a neutral for the formation of 
hydrophobic cores, they share some specific properties. For example arginine (R) 
and lysine (K), both, are polar amino acids with a long aliphatic stems. Sometimes 
these amino acids substitute hydrophobic amino acids, in situation when, their 
heads reach a polar environment (solvent or ionic pairs). Asparagine (N) can adopt a 
left helical main chain conformation otherwise mainly occupied by glycine (G). 
Alanine (A) occupies both hydrophobic and hydrophilic areas although it favours 
forming α-helices. Cysteine (C) is regarded as a nonpolar, hydrophobic residue, 
which suggests its participation in group of hydrophobic cluster formers. However, 
its ability to form disulphide bonds is a factor that excludes cysteine from 
mentioned group and its presence in polypeptide chain is always worth detailed 
consideration when analyzing the possible 3D structure of a protein. Threonine (T), 
a branched amino acid, frequently replaces valine (V) or isoleucine (I) in β-strands 
and, like serine (S), may mask its polarity inside α-helices. Serine is thought to 
mimic proline rings. Glutamic acid (E) and aspartic acid (D) are polar amino acids 
occupying hydrophilic areas (Callebaut et al., 1997).  
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In summary, the main driving forces of regular secondary structures are strong 
hydrophobic amino acids (V, I, L, F) as well as moderately hydrophobic amino acids 
(M, Y, W), while the main driving forces of loops are P, G, D, N and S. 
To make the representation of protein structures more clear and understandable 
by avoiding too many one-letter code symbols, HCA uses four symbols for particular 
amino acids: a star for proline (P), which has the greatest influence on the 
polypeptide chain, a diamond for glycine (G), which, in contrast, does not have a 
great impact on the conformation of the chain, squares with or without a dot - for 
serine (S) and threonine (T) respectively, which despite sharing polar properties, 
may mask their polarity by creating H-bonds with the carbonyl groups of the main 
chain, particularly within helices. 
The main principles of HCA presentation are explained on the example of 
human α1-antitrypsin (Callebaut et al., 1997, Fig. 10). The G246-S283 fragment of 
human α1-antitrypsin is displayed as a α-helix (3,6 aa per turn) formed on a 
cylinder (Fig. 10a). Residues from G246 to E264 have similar positions, which are 
parallel to the axis of the cylinder. Subsequently the cylinder has been cut to its 
axis and unrolled (Fig. 10b). Unfolding of the cylinder separates some adjacent 
amino acids. In order to preserve the natural environment of all residues and give a 
better impression of the sequence, the representation has been duplicated (Fig. 
10c). Hydrophobic residues have been contoured (Fig.10d).  
Hydrophobic amino acids commonly form the previously mentioned clusters. 
These clusters correspond to regular secondary structures (Woodcock et al., 1992). 
The vertical clusters, as shown experimentally, are associated with β-strands 
whereas the horizontal ones are mostly α-helices. This points the connection 
between the general shape of the cluster that indicates particular secondary 
structure. Between recognizable group of clusters there may occur visible stretches 
of sequences that are revealing a presence of loops or unstructured regions between 
the protein’s domains. The 2D α-helical presentation of hydrophobic clusters 
matches best match the observed regular α or β secondary structures of globular 
proteins.  
The HCA analysis of S. cerevisiae Maf1 reveals the presence of two highly 
structured regions, corresponding to the A and BC domains, which are separated 
by unstructured region, matching to the linker region between Maf1 domains. This 
linker region is poor in hydrophobic residues suggesting that in vivo it might be 
exposed on the outer surface, during protein folding. Moreover, comparison of the 
HCA analysis for the S. cerevisiae and H. sapiens Maf1 proteins, reveals their 
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similar organization indicative of the high conservation of these folds through 
evolution (Fig. 11). 
 
 
Figure 10. The main principles of HCA 2D presentation. (Adapted from Callebaut et al., 1997). 
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Figure 11. Hydrophobic Cluster Analysis (HCA) of Maf1 sequences. Schematic representation of predicted 3D structure of the S. cerevisiae vs H. sapiens 
Maf1 proteins. Red star indicates proline, diamond – glycine, squares with or without a dot – serine and threonine, respectively. Acidic residues (E, Q, N) are in 
red, basic residues (K, R) are in blue. Hydrophobic amino acids form clusters shown as green contoured areas). Vertical clusters correspond to β-strands 
whereas horizontal clusters are associated with α-helical structures. For further information see Callebaut et al., 1997. Localization of the A and BC domains 
of Maf1 is indicated with black arrows.  
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If the crystal structure of a protein is unavailable as in the case of Maf1 there is 
still a possibility to presume its structural organization. The bioinformatic field 
provides a wide range of different software tools for predicting a variety of protein 
structural features, such as secondary structures (e.g. PSIPRED), a presence of 
natively disordered regions (e.g. DISOPRED2) as well as boundaries of protein 
domains (e.g. DomPred). One of the most popular servers, the PSIPRED server, has 
been developed in the Bioinformatics Unit at the University College London. It 
consists of several independent servers dedicated to characterizing the protein 
features mentioned above as well as predicting of protein folds (e.g. 
mGenTHREADER), transmembrane helix topology (e.g. MEMSAT2) and 3D models 
of tertiary structures (e.g. BioSerf) (Bryson et al., 2005). 
PSIPRED is a highly accurate secondary structure prediction method based on 
the PSI-BLAST (Position Specific Iterated BLAST) (Altschul et al., 1997) output. 
PSIPRED has been estimated to achieve an average accuracy of 76,5%, which 
places this method among the most accurate softwares for predicting the secondary 
structure of the proteins. The PSIPRED server, apart from, the pure data analysis 
provides also a graphical representation of the secondary structure prediction, 
which makes the output visible and clearl to understand by the user (McGuffin et 
al., 2000). Comparison of S. cerevisiae and H. sapiens Maf1 sequences, according to 
PSIPRED analysis, revealed highly similar organization of secondary structures. In 
the A domain, PSIPRED prediction indicated the presence of two α-helices 
separated by two adjacent β-strands, while for the BC domain - five α-helices and 
concomitant four β-strands are predicted (Fig. 12). No secondary structure 
elements were predicted for the linker region.  
The DISOPRED2 server is commonly used for prediction of unstructured regions 
called regions of native disorders (http://bioinf.cs.ucl.ac.uk/disopred/). In contrast 
to PSIPRED, it is devoted to analyzing protein regions, that do not posses any static 
structures, but are in a constant change between different structures (Bryson et al., 
2005). The DISOPRED method was estimated to be one of the best methods of false 
positive rates. The method has an accuracy of ~93% per residue when using the 5% 
false positive rate threshold (Ward et al., 2004). Analysis of S. cerevisiae Maf1 amino 
acid sequence showed the presence of two structured regions of approximate 
localization: aa 1-50 and aa 225-325 (Fig. 13B, lower panel). These regions 
correspond to the A and BC domains of S. cerevisiae Maf1 (aa 1- 49 and aa 231-338 
respectively), separated by an unstructured region (aa 50-225) corresponding to the 
linker region separating Maf1 A and BC domains (aa 49-231). 
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Figure 12. Secondary structure prediction of Maf1 protein. PSIPRED v 2.6 protein structure 
prediction server was used to identify the secondary structures of S. cerevisiae and H. sapiens Maf1 
proteins. Only A and BC domains are presented. Green tube (or H letter), yellow arrow (or E letter) and 
black line (or C letter) represent alpha helix, beta strand and coil, respectively. 
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There is also a visible second unstructured region (aa 340- 395) that is related 
to the acidic tail of Maf1. Similar analysis of the H. sapiens Maf1 sequence revealed 
its analogous organization to the S. cerevisiae Maf1 protein. According to 
DISOPRED2, H. sapiens Maf1 present two structured regions of approximate 
localization: aa 1-50 and aa 85-210 (Fig. 13A, upper panel). These regions correlate 
with the position of the A and BC domains of human Maf1 (aa 1-49 and aa 83-203 
respectively). The identified structured regions are separated by an unstructured 
region (aa 50-85), which corresponds to the linker in H. sapiens Maf1 localized 
between aa 49-83. The graphical representation of the protein, reveals also a 
second unstructured region between aa 210-240, which is related to the acidic tail 
of H. sapiens Maf1 (aa 203-256). 
The DomPred (Protein Domain Prediction Server) serves as a tool to predict 
domain boundaries while predicting the overall fold of the protein 
(http://bioinf.cs.ucl.ac.uk/dompred)(Marsden et al., 2002). Analysis of the  
S. cerevisiae Maf1 amino acid sequence showed, similarly to the DISOPRED 
prediction, the presence of 2 domains (Fig. 14B, lower panel). According to the 
computational analysis, the boundary between the identified domains ranges 
between aa 100-240. This fragment could in approximate relate to the linker region 
between the A and BC domains of S. cerevisiae Maf1, as indicated by the sequence 
alignment (Fig. 9). Similar analysis performed for the H. sapiens Maf1 revealed 
different organization of the protein. Indeed, the DomPred software detected the 
presence of only one obvious domain (Fig. 14A, upper panel), corresponding to the 
A domain of H. sapiens Maf1 (aa 1-49). The fragment ranging from ca. aa 60-100 
might be related to the linker region of H. sapiens Maf1 (aa 49-83), while the 
structured region located ca. between aa 100-160 that could correspond to the 
conserved B domain of H. sapiens Maf1. The DomPred software failed to detect the 
anticipated, conserved remaining C domain, indicating, a “boundary” region (aa 
160-190) in its place, instead.  
Discrepancies between the DISOPRED and DomPred analyses does not exclude 
each other, as bioinformatic tools serve mostly as a guide for further genetic or 
biochemical protein analysis. However, all together, the results of HCA, DISOPRED 
and DomPred analyses with PSI-BLAST alignments show that Maf1 is organized in 
two structured regions separated by an unstructured linker. 
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Figure 13. Prediction of unstructured regions in Maf1 sequences. Graphical representation of 
native disorders existing in the Maf1 protein predicted by DISOPRED2, Prediction of protein disorder 
server (http://bioinf.cs.ucl.ac.uk/disopred/). False positive threshold is 5%. Visible peacks 
correspond to the unstructured regions of Maf1. Underneath a schematic representation of Maf1 
organization. Upper panel. H. sapiens Maf1; the A domain (aa 1-49) is indicated in blue, the BC 
domain (aa 89-203) is indicated in green color. Lower panel. S. cerevisiae Maf1; the A domain (aa 1-
49), the BC domain (aa 231-338), indicated as described. 
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Figure 14. Prediction of domain boundaries in Maf1 sequence. Graphical representation of the 
domain boundaries existing in Maf1 protein as predicted by DomPred, Protein Domain Prediction 
Server (http://bioinf.cs.ucl.ac.uk/dompred). Visible peacks correspond to unstructured boundary 
regions of Maf1 domains. Underneath a schematic representation of Maf1 organization as described in 
the legend to Fig. 13. Upper panel; H. sapiens Maf1. Lower panel; S. cerevisiae Maf1. 
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Apart from bioinformatic analyses, some experimental prerequisites also allow to 
consider Maf1 as a structured protein, which activity depends on organization of its 
folds. 
First approaches to distinguish the impact of particular parts of Maf1 on its 
potential to inhibit Pol III activity were made by Desai et al. (2005). The group 
investigated recombinant forms of different orthologs of Maf1: SpMaf1 (full-length 
protein from S. pombe in bacteria) and ScMaf1(B+C) (truncated form of Maf1 from  
S. cerevisiae containing only B and C sequence blocks). Both recombinant forms of 
Maf1 were able to inhibit tRNA-Leu and U6 snRNA synthesis in vitro. In addition, 
binding of these Maf1 recombinant forms to Brf1 blocked the assembly of TFIIIB 
onto DNA (Desai et al., 2005). These results suggested that the roles of A, B and C 
blocks in the activity of Maf1 are not equal. A domain seemed to be unnecessary for 
inhibition of Pol III-dependent transcription (at least for the S. cerevisiae Pol III 
transcription machinery). Further studies on the functions of Maf1 parts in its 
activity were investigated in the human ortholog.  
Considering the remarkable conservation of the yeast and human Pol III 
machineries, it could be also imagined, that the regulatory mechanisms involving 
Maf1 may be similar in yeast and man. Indeed, recent results presented by several 
research groups show Maf1-mediated repression of Pol III transcription in human 
cells indicating Maf1 orthologs as a new class of mammalian Pol III regulators 
(Goodfellow et al., 2008; Reina et al., 2006; Johnson et al., 2007; Rollins et al., 
2007).  
For the human Maf1, Pol III subunits and Brf1 were shown to associate with 
different regions of Maf1 (Reina et al., 2006). Two truncated versions of human 
Maf1, containing only the conserved A domain sequence (Maf1 aa 1-81) or both, the 
A and B domains, sequences (Maf1 aa 1-142) were investigated for potential 
interaction with Pol III subunits. The GST pull-down experiment showed that Rpc1 
(corresponding to C160 in S. cerevisiae) and Rpac2 (corresponding to AC19 in S. 
cerevisiae) were associated with the Maf1 aa 1-81 truncated version. In conclusion, 
Reina et al. (2006) postulated that the first 81 amino acids of human Maf1 are 
sufficient for its association with Pol III subunits and that the B domain of Maf1 is 
required for association with Brf1. These results clearly show that there is a link 
between the structure and activity of the Maf1 protein and that particular Maf1 
folds might be involved in different aspects of Maf1 activity as a repressor.  
Furthermore, a detailed study over the H. sapiens Maf1 (HsMaf1) has been 
subjected in laboratory of Christoph Műller (Grenoble at that time) with 
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collaboration with the laboratory directed by Olivier Lefebvre (CEA/Saclay). To 
experimentally characterize the structural organization of human Maf1 (HsMaf1), 
they have carried out limited proteolysis experiments in combination with size-
exclusion chromatography (Detailed description in supplementary material – 
Appendix 1, Gajda et al., 2010). 
Proteolytically stable fragments are considered to be structurally well defined, 
whereas protease-sensitive sites often correlate with disordered protein regions. 
Using limited proteolysis with trypsin, HsMaf1 protein (aa 256) was digested into 
two major stable fragments that were identified as HsMaf1 aa 1-45 and Maf1 aa 75-
234 using a combination of N-terminal sequencing and mass spectrometry (Q-Tof). 
These fragments corresponded to the A and BC domains of HsMaf1. The HsMaf1 
linker region between those fragments (aa 46-74) and the C-terminal acidic tail  
(aa 235-256) were degraded and thus presumably unstructured. Both fragments 
were further analyzed by size-exclusion chromatography. Surprisingly, the two 
HsMaf1 fragments, although of substantially different molecular masses, co-eluted 
at an apparent 1:1 stoichiometry, suggesting an intramolecular interaction between 
them. Moreover, co-expression of these N-terminal and C-terminal fragments of 
HsMaf1 in bacterial cells and their subsequent purification revealed that the His-
Tag A fragment of HsMaf1 co-precipitates with the un-tagged BC protein fragment 
at an apparent 1:1 stoichiometry, suggesting a direct interaction between these 
fragments. These results were also confirmed by co-elution using size-exclusion 
chromatography supporting a direct interaction between the A and BC domains of 
HsMaf1 (Fig. 15, Gajda et al., 2010).  
The results obtained by Christoph Műller’s group on the H. sapiens Maf1 as well 
as the good sequence conservation of the A and BC domains along evolution were 
an indication to study the relation of the A and BC domains in S. cerevisiae, an 
organism more amenable to study structure-function relationships. 
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Figure 15. Domain structure of human Maf1. A. Limited proteolysis and resulting proteolytic 
fragments of HsMaf1. SDS-PAGE of full-length human HsMaf1 protein (1, black) that is digested into 
two stable fragments aa 1-45 and aa 75-234 using trypsin (2, red). Bacterially co-expressed and  
co-purified HsMaf1 domains aa 1-45 and aa 85-210 (4, green). HsMaf1 aa 82-236 (3, blue) lacking the  
N-terminal 45 residues was expressed as a control. B. Size-exclusion chromatography profiles. 
Samples presented in (A) were separated on single or tandem Superdex 200 10/300 size-exclusion 
columns (GE Healthcare). Only the HsMaf1 construct 82-236 eluates in the void volume of the 
Superdex 200 size-exclusion column, while all other samples are monodispersed and elute 
approximately at volumes corresponding to monomers. The elution profile of different molecular 
weight standards is shown as a dashed line. Peaks I, II, III and IV correspond to ovalbumin 
(Mr=44000), carbonic-anhydrase (Mr=29000), ribonuclease A (Mr=13700) and aprotinin (Mr=6500), 
respectively. Fractions corresponding to the red and green elution profiles were analyzed by 
denaturing gel electrophoresis and shown as insets. Fragment 1-45 co-elutes with proteolytic 
fragments - 75-234 and 75-262 (red profile) and with the recombinant fragment 85-210 (green profile). 
Adapted from Gajda et al., 2010. 
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II. AIM OF THE WORK 
 
The Maf1 protein was identified in the early ’90 in the laboratory directed by 
Prof. Boguta. Since then numerous studies concerning Maf1 function as a Pol III 
repressor have been directed. Currently, Maf1 is considered as the one and only Pol 
III repressor in S. cerevisiae cells that conveys signals from the diverse signaling 
pathways on Pol III apparatus.  
Maf1 is highly conserved through evolution. The common organization for  
S. cerevisiae Maf1, described as two structured regions of high similarity separated 
by an unstructured linker region, is typical for all eukaryotic Maf1 orthologs. These 
regions of high similarity, called the A and BC domains have no functional 
homology with the identified protein domains.  
Since Maf1 organization is conserved through evolution it must be of high 
importance for Maf1 activity as a Pol III repressor.  
This work addressed two main questions:  
Is there a structure-function relation between the A and BC domains of Maf1 
and the regulation of Pol III transcription? 
Are the A and BC Maf1 domains involved in phosphorylation or the cellular 
localization of the protein? 
To explore these matters and evaluate the significance of the A and BC domains 
of Maf1, libraries of maf1 mutants harboring mutations localized in sequence 
encoding each particular domain were constructed and the cellular behavior of 
chosenMaf1 mutant proteins was investigated.  
Supported by the biochemical analysis done by Christoph Műller’s group 
indicating direct interaction between the domains of human Maf1, also in this work 
the genetic suppressor approach and yeast-two-hybrid system were applied to 
explore the potential interaction between the A and BC domains of S. cerevisiae 
Maf1.  
Finally, to investigate how Maf1 affects the Pol III apparatus, a search for 
partner proteins of Maf1 using parts of Maf1 A and BC domains as a bait was 
performed.  
Altogether, the aim of this study was devoted to a deeper understanding of the 
structure-function relationship between Maf1 domains and its capacity to repress 
Pol III. 
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III. RESULTS 
1. Construction of S. cerevisiae Maf1 mutated in 
evolutionarily conserved regions - A and BC domains. 
 
The common approach in analyzing the relationship between the primary 
sequence of a protein and its activity is to construct several mutants in the gene 
encoding this protein and investigate their changed cellular behavior depending on 
the carried mutations. To gain a better understanding of Maf1 functions in  
S. cerevisiae yeast cell, the MAF1 gene was mutagenized in order to generate 
defined mutations localized in each particular domain. The obtained maf1 mutants 
have been initially characterized due to amino acid substitutions and the growth 
phenotype. 
1.1. Maf1 mutations in the A domain. 
 
To obtain library of Maf1 protein mutated in the evolutionarily conserved A 
domain, the rapid method of “Gap repair” for localized mutagenesis has been 
applied (Muhlrad et al., 1992). The strategy of constructing MAF1 mutants was 
based on low-fidelity PCR. Sequence encoding A domain and the linker (aa 1-180) 
has been amplified under conditions that predicted obtaining 1-2 mutations in this 
region. Co-transformation of the maf1∆ strain with the low fidelity PCR product and 
gapped plasmid containing regions of MAF1 flanking the A domain enabled in vivo 
recombination to repair the gap with mutagenized DNA encoding A domain (Fig. 
16). The phenotype of 10 000 transformants was screened. Preliminary analysis 
revealed that among screened transformants nearly 1 000 exhibited temperature-
sensitive growth on medium containing glycerol, a nonfermentable carbon source 
(characteristic phenotype for mutated maf1 strain, Boguta et al., 1997). Potential 
maf1 mutants were used to isolate plasmid DNA that was subsequently examined 
by PCR to confirm the presence of the mutagenized region of Maf1 A domain. 
Approximately 500 plasmids harboured the A domain encoding sequence. After PCR 
verification, selected plasmids were amplified in E. coli and analyzed with 
endonuclease EcoRI. Plasmids giving an appropriate restriction pattern (61) were 
retransformed to the maf1∆ S. cerevisiae strain (YPH500 maf1∆) to confirm that the 
observed phenotype results from mutations in maf1 allele. Sequencing revealed the 
type of mutation of the maf1 gene in each of the analyzed plasmids. Selected 
mutants were additionally examined by Western blotting to confirm the expression 
of the Maf1 protein. 
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Transformants were once more replica plated on medium containing glycerol 
and incubated for 3 days at 37ºC. The growth phenotype observed for the analyzed 
S. cerevisiae cells expressing mutated Maf1s ranged from: lack of growth (-) similar 
to the maf1∆ strain, moderate growth defect (+/-) up to no growth defect (WT). No 
correlation between the observed growth phenotype and the mutagenized region of 
Maf1 was noted. Moreover, the K→E mutations of the second amino acid obtained 
in this screen seemed not to change the predicted in vivo half-life of Maf1 protein as 
reported by the “N-end rule” (Varshavsky, 1997).  
Sixty-one isolated maf1 mutants were classified based on the type of identified 
mutations: missense, frameshift or STOP codon. Missense maf1 mutants (32) 
represented mutations in sequence encoding: the A domain alone (22), the A 
domain and the linker region between the A and BC domains (5) or only the linker 
region (5). 
 
 
 
Figure 16. Schematic representation of the experimental strategy applied to construct Maf1 
mutated in the A domain. The Maf1 A domain is indicated with blue color. The “gap-repair” system 
based on homologous recombination in vivo has been presented. Sequence, mutated by low-fidelity 
PCR encoding the A domain is designated with a blue star. Resulting plasmid harboring maf1 mutated 
in the sequence encoding A domain is presented on the right. 
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Among the identified missense maf1 mutants: 16 represented single amino acid 
substitution, 10 - double amino acid substitutions and 6 - triple amino acid 
substitutions. The description of plasmids harboring the identified mutations 
conveying temperature-sensitive growth phenotype is included in Table 1A.  
The remaining maf1 mutants (29) represented: mutations in the intron sequence 
(3), defective start codon (5) (included in Table 1A), premature stop codons (9) 
(Supplementary material - Table S1) and frameshift mutations (12) (Table S2). 
Plasmids harboring maf1 but that transmitted WT growth phenotype (15) are 
included in Table 1B. 
Noteworthy are maf1 mutants with mutations localized in the intron sequence 
(80 nt sequence localized in MAF1 between 7-86 nt ). Mutation A → T (54 nt) in the 
“pAG64” maf1 mutant confers lack of growth on glycerol-containing medium 
indicating a nonfunctional Maf1 (Table 1A). Moreover, R11S (pAG34), S28G-K35E 
(pAG48) and S131P (pAG72) maf1 mutants, which, apart from missense mutations 
localized in the sequence encoding A domain, retain an additional mutations 
localized in the intron sequence (Table 1A), also exhibit lack of growth on glycerol-
containing medium. In addition, preliminary Western blotting analysis with 
polyclonal anti-Maf1 antibodies did not reveal the presence of Maf1 in these 
mutants (Marlena Maciak 2008, data unpublished). Collectively, these data suggest 
impairement of the MAF1 mRNA maturing process and point to these maf1 mutants 
as a valuable objects for studying MAF1 mRNA splicing.  
Introns are composed of 3 sequences required for splicing. These consensus 
sequences are: 5’-GTATGT, bridge-TACTAAC and TGA-3’. In MAF1 they are located 
at 7-12 nt, 49-55 nt and 64-66 nt). Interestingly S28G-K35E (pAG48), “pAG64” and 
S131P (pAG72) maf1 mutants are mutated in these sequences responsible for 
appropriate splicing but not the R11S (pAG34) maf1 mutant (Table 1A).  
Worth noting is the growth phenotype observed of the Y84H (pAG16) maf1 
mutant, which exhibits superior growth on glycerol-containing medium comparing 
to the wild-type (WT) yeast cells (Table 1B). The Y84H (pAG16) maf1 mutant retain 
single amino acid substitution Y84→H, which is localized in the linker between the 
A and BC Maf1 domains. The linker region is not conserved through evolution and 
appears to be unstructured, which makes the observed growth phenomena 
surprising. Amino acid substitution at this residue (Y84), but of a different kind, 
was also observed in Y84C (pAG59) maf1 mutant, which exhibited lack of growth in 
the studied conditions. This may be explained by the fact that the Y84C (pAG59)  
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Table 1A. Plasmids carrying maf1 allele mutated in sequence encoding A domain and the linker. Table represents plasmids encoding Maf1 mutated in 
either A domain or linker between the A and BC domains or both regions, start codon or intron. Growth phenotype on glycerol-containing medium at 37ºC 
(YPGly) signed as a: lack of growth (-) or moderate growth defect (+/-). Protein expression in several cases confirmed by Western blotting analysis with 
polyclonal anti-Maf1 antibodies – marked (+) for expressed (-) for expression not detected or (NT) not tested. Plasmids organized according to the region 
mutagenized, growth phenotype resulting from mutated maf1 allele and number of missense mutations that occur (relative to translation start site). 
 
Plasmid Mutated 
region 
No. 
missense 
mutations 
Amino acid 
substitution 
Change in 
codon 
Silent mutations Mutations in 
promoter 
region 
Mutations in 
intron 
YPGly Protein 
expression 
pAG24 A single Y44 → F TAT → TTT N13 (AAT → AAC) none G → A (7 nt) 
T → C (58 nt) 
- NT 
pAG34 A single R11 → S AGA → AGT I31 (ATT → ATC) A → G (-6 nt) A → C (17 nt) 
A → G (85 nt) 
- - 
pAG40 A single K2 → E AAA → GAA none none T → C (57 nt ) - NT 
pAG53 A single K2 → E AAA → GAA none none none - NT 
pAG68 A single K2 → E AAA → GAA none none A → G (53 nt) - NT 
pAG48 A double S28 → G 
K35 → E 
AGT → GGT 
AAG → GAG 
K42 (AAA → AAG) none A → G (54 nt) - - 
pAG50 A double K2 → E 
H50 → R 
AAA → GAA 
CAT → CGT 
D30 (GAT → GAC) T → A (-83 nt) T → A (27 nt) - NT 
pAG58 A double R41 → G 
I47 → N 
AGA → GGA 
ATT → AAT 
none T → C (-153 nt) 
T → C (-75 nt) 
none - NT 
pAG8 A single F32 → I TTC → ATC none A → T (-180 nt) 
T → C (-140 nt) 
none +/- + 
pAG70 A single K35 → E AAG → GAG none none none +/- + 
pAG37 A double N17 → H 
L43 → S 
AAT → CAT 
TTA → TCA 
none A → G (-180 nt) 
A → X (-177 nt) 
T → X (39 nt) +/- + 
pAG49 A double N17 → H 
L43 → S 
AAT → CAT 
TTA → TCA 
none A → G (-180 nt) 
T → X (-177 nt) 
T → X (37 nt) 
T → X (38 nt) 
+/- + 
pAG66 A double F32 → V 
T33 → A 
TTC → GTC 
ACA → GCA 
Y44 (TAT → TAC) T → C (-142 nt) A → G (53 nt) +/- NT 
pAG27 A triple I25 → T 
S28 → G 
R41 → S 
ATC → ACC 
AGT → GGT 
AGA → AGT 
S39 (TCA → TCG) none T → C (37 nt ) +/- + 
pAG61 A 
linker 
double K2 → E 
N117 → I 
AAA → GAA 
AAT → ATT 
none none none - + 
pAG23 A 
linker 
triple F32 → S 
I54 → T 
N142 → D 
TTC → TCC 
ATT → ACT 
AAT → GAT 
none none none - + 
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Continued: 
Plasmid Mutated 
region 
No. 
missense 
mutations 
Amino acid 
substitution 
Change in 
codon 
Silent mutations Mutations in 
promoter 
region 
Mutations in 
intron 
YPGly Protein 
expression 
pAG67 A 
linker 
triple E10 → G 
S39 → P 
L149 → F 
GAG → GGG 
TCA → CCA 
TTA → TTT 
none none none +/- + 
pAG59 linker single Y84 → C TAT → TGT none none T → C (52 nt) - NT 
pAG72 linker single S131 → P TCT → CCT none T → C (-15 nt) A → G (50 nt) 
A → G (85 nt) 
- - 
pAG29 start 
codon 
double M1 → K 
K97 → R 
ATG → AAG 
AAG → AGG 
Q144 (CAA → CAG) none none - - 
pAG35 start 
codon 
single M1 → T ATG → ACG none T → C (-98 nt) 
A → G (-30 nt) 
A → G (53 nt) - NT 
pAG56 start 
codon 
single M1 → V ATG → GTG none none none - - 
pAG69 start 
codon 
multiple M1 → V 
K2 → E 
L16 → H 
N113 → S 
N115 → S 
N120 → I 
ATG → GTG 
AAA → GAA 
CTC → CAC 
AAC → AGC 
AAT → AGT 
AAT → ATT 
R11 (AGA → AGG) 
R89 (AGA → AGG) 
none none - - 
pAG9 start 
codon 
single K2 → X AAA → AA- S77 (TCA → TCG) none none - - 
pAG64 intron intron none none none none A → T (54 nt) - NT 
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Table 1B. Description of plasmids carrying maf1 allele conveying no defected growth on medium containing glycerol (YPGly) at 37ºC. Table 
represents plasmids encoding Maf1 mutated in the A domain, the A domain and linker between the A and BC domains, linker or intron. Plasmids organized 
according to the region mutagenized, and quantity of mutations that occur. 
 
Plasmid Mutated 
region 
No. 
missense 
mutations 
Amino acid 
substitution 
Change in 
codon 
Silent mutations Mutations in 
promoter 
region 
Mutations in 
intron 
YPGly 
pAG5 A single F32 → S  TTC → TCC F93 (TTT → TTC) none none WT 
pAG11 A single D40 → G  GAT → GGT none none none WT 
pAG47 A single F3 → S TTT → TCT none none none WT 
pAG51 A single K2 → R  AAA → AGA none none none WT 
pAG62 A single L43 → F TTA → TTT K2 (AAA → AAG) none A → G (24 nt) 
A → T (45 nt) 
WT 
pAG21 A double D30 → G  
Y44 → C  
GAT → GGT 
TAT → TGT 
I31 (ATT → ATC) none none WT 
pAG33 A double Q14 → R  
H50 → Q  
CAA → CGA 
CAT → CAA 
P132 (CCA → CCG) A → X (-198 nt) 
A → G (-183 nt) 
none WT 
pAG17 A triple N13 → S  
S39 → L  
D48 → V  
AAT → AGT 
TCA → TTA 
GAT → GTT 
none none none WT 
pAG10 A 
linker 
double D30 → V  
N58 → D  
GAT → GTT 
AAT → GAT 
none none none WT 
pAG19 A 
linker 
triple F32 → L  
N62 → D 
N106 → D  
TTC → CTC 
AAT → GAT 
AAT → GAT 
F135 (TTT → TTC) A → T (-2 nt) none WT 
pAG25 linker single C79 → S  TGC → AGC T15 (ACT → ACC) 
A38 (GCA → GCG) 
T → C (-185 nt) 
T → C (-141 nt) 
none WT 
pAG74 linker triple N112 → S  
N122 → S 
K137 → R  
AAC → AGC 
AAT → AGT 
AAA → AGA 
N128 (AAT → AAC) none none WT 
pAG16 linker single Y84 → H  TAT → CAT none A → G (-162 nt) none WT+ 
pAG22 intron intron none none none none A → G (23 nt) WT 
pAG30 intron intron none none none A → G (-30 nt) T → C (57 nt) WT 
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maf1 mutant retain additional mutations in the intron sequence (Table 1A), which 
impaires Maf1 maturation and is responsible for the observed growth defect. Such 
observation supports the importance of intron splicing in MAF1, which could play a 
part in the cellular regulation of Maf1 expression and mediate the regulation of  
Pol III by Maf1. 
• Analysis of potential regions exhibiting increased mutagenesis frequency 
localized within the A domain of mutated Maf1.  
The obtained maf1 mutants were subsequently analyzed to determine the 
specific region of the Maf1 protein important for disruption of its activity. 
Comparison of mutated amino acid residues and temperature sensitivity on 
glycerol-containing medium at 37ºC did not allow to specify the region of Maf1 
responsible for manifestation of the temperature-sensitive growth (Fig. 17).  
Nevertheless, analysis of maf1 mutants with amino acid substitutions leading to 
the appearance of premature STOP codons has shown that the A domain with the 
linker region seems not sufficient for Maf1 activity. This observation is supported by 
the N120S-S166STOP (pAG6) maf1 mutant, in which, maf1 translation is expected 
to be stopped after aa 166 residue. Although the full-length Maf1 A domain is 
hypothetically expressed (aa 1-49) with the concomitant linker region (aa 50 – 166), 
the N120S-S166STOP (pAG6) maf1 mutant exhibits temperature-sensitive growth 
on glycerol-containing medium (similar to maf1∆ strain), which indicates inactive 
form of Maf1. This observation suggest that the presence of the BC domain (that is 
absent in the N120S-S166STOP (pAG6) maf1 mutant) is necessary for Maf1 activity. 
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Figure 17. Schematic representation of Maf1 A domain and the linker amino acid sequence with marked regions of mutation incidence that 
occurred during global mutagenesis of the MAF1 gene. The A domain encompass region 1 – 49 aa (blue) while the linker region ranges from 50 – 150 aa 
(grey). In yellow highly conserved amino acid residues have been highlighted. Temperature-sensitive phenotype on glycerol-containing medium at 37ºC 
(YPGly), both: lack of growth (-) and moderate growth defect (+/-) caused by the identified mutations in maf1 are highlighted with light blue colour. Mutations 
in maf1 causing no growth defect in restricted conditions (WT) are also included. 
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1.2. Maf1 mutations in the BC domain. 
 
To obtain library of Maf1 mutated in the BC domain, a “Gap repair” strategy 
similar to that used to construct the A domain maf1 mutants has been applied 
(Muhlrad et al., 1992). Sequence encoding the BC domain (174-375 aa) was 
amplified by low-fidelity PCR and co-transformed to the YPH500 maf1∆ strain 
together with MAF1-harboring plasmid gapped within the BC region (Fig. 18). 
Resulting transformants have been screened for a temperature-sensitive growth 
phenotype on medium supplemented with glycerol. After retransformation of 
constructs to maf1∆ the S. cerevisiae strain (YPH500 maf1∆), 61 maf1 mutants were 
further analyzed. Sequencing revealed the type of mutation of the maf1 gene in 
each of the analyzed plasmids (Table 2). Selected mutants have been tested for 
Maf1 expression by Western blotting with polyclonal anti-Maf1 antibodies. 
 
 
 
Figure 18. Schematic representation of the experimental strategy applied to construct Maf1 
mutated in the BC domain. The Maf1 BC domain is indicated with green color. The “gap-repair” 
technique based on homologous recombination in vivo has been presented. Sequence, mutated by low-
fidelity PCR, encoding the BC domain is designated with a blue star. Resulting plasmid carrying maf1 
mutated in the sequence encoding the BC domain is shown on the right.  
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Among the 61 analyzed maf1 mutants: 3 represented single amino acid 
substitutions, 10 - double amino acid substitutions and 5 - triple amino acid 
substitutions (Tab. 2). Higher mutagenesis level was observed for the BC domain in 
comparison to the construction of A domain maf1 mutants. The remaining maf1 
mutants represented: multiple mutations (20), premature STOP codons (9) and 
frameshift mutations (14) (Data shown in supplementary material, Tables S3-5). 
Similarly to maf1 mutants in the A domain, the growth phenotype on a 
nonfermentable carbon source (glycerol medium - 37ºC) observed for the BC 
domain maf1 mutants ranged from: lack of growth (-) similar to the maf1∆ strain, 
moderate growth defect (+/-) up to no growth defect (WT). The description of 
mutations and correlated growth phenotypes are included in Table 2. Plasmids 
carrying the mutated maf1 allele that convey WT growth are listed in 
supplementary Table S3. 
• Analysis of potential regions exhibiting increased mutagenesis frequency 
localized within the BC domain of mutated Maf1. 
The obtained maf1 mutants were classified according to their growth phenotype. 
An attempt has been made to identify the specific region of the BC domain 
responsible for the disruption of Maf1activity resulting in temperature-sensitive 
growth on medium containing glycerol. Like in the case of mutations in the A 
domain, identification of mutations leading to the apparent growth defect of yeast 
cells did not allow to specify any particular region of the BC domain responsible for 
the impairment of Maf1 activity. High mutagenesis level within the BC domain 
(most mutants carried multiple mutations) was a problem in assigning a particular 
mutation to a specific phenotype. Nevertheless, the analyzed mutations having 
impact on yeast growth were determined to be predominantly localized in highly 
conserved amino acid residues of Maf1: L238, I239, L242, N243, S252, E272, 
M294, C299, F302, S305, E314 and in residues close to the nuclear localization 
signal (328-332 aa, RKRKR-NLS2) L325, Y326, N227, K329, R332 (Fig. 19). 
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Table 2. Plasmids carrying maf1 allele mutated in sequence encoding the BC domain. Growth 
phenotype on glycerol-containing medium at 37ºC (YPGly) signed as a: lack of growth (-) or moderate 
growth defect (+/-). Protein expression was confirmed by Western blotting with polyclonal anti-Maf1 
antibodies. Plasmids organized according to the growth phenotype resulting from mutated Maf1 and 
number of missense mutations that occur.  
 
Plasmid No. 
missense 
mutations 
Amino acid 
substitution 
Change in 
codon 
Silent mutations YPGly 
pAG107 single M294 → R ATG → AGG none - 
pML6 double I241 → F 
R332 → G 
ATC → TTC 
AGA → GGA 
K356 (AAA → AAG) 
K357 (AAA → AAG) 
G360 (GGA → GGG) 
- 
pAG110 double S252 → T 
R332 → G 
TCA → ACA 
AGA → GGA 
none - 
pAG132 double L242 → P 
K329 → I 
CTC → CCC 
AAA → ATA 
A334 (GCT → GCA) 
G348 (GGC → GGT) 
- 
pAG136 double M294 → R 
L354 → S 
ATG → AGG 
TTG → TCG 
S252 (TCA → TCT) 
D366 (GAT → GAC) 
- 
pAG147 double L242 → P 
H249 → Q 
CTC → CCC 
CAT → CAA 
none - 
pAG171 double I239 → F 
D258 → V 
ATT → TTC 
GAT → GTT 
S252 (TCA → TCG) 
P315 (CCT → CCC) 
- 
pMM2 triple E272 → L 
C299 → R 
Q359 → L 
GAA → AAA 
TGC → CGC 
CAG → CTG 
L301 (CTT → CTC) 
A355 (GCA→ GCT) 
- 
pAG113 triple I239 → V 
Y317 → F 
S341 → P 
ATT → GTT 
TAT → TTT 
TCG → CCG 
F310 (TTT → TTC) 
A334 (GCT → GCC) 
- 
pAG148 triple S305 → P 
N327 → D 
N344 → D 
TCA → CCA 
AAC → GAC 
AAT → GAT 
I339 (ATT → ATA) 
D352 (GAT → GAC) 
- 
pMM4 double F302 → S 
L311 → W 
TTT → TCT 
TTG → TGG 
A355 (GCA → GCT) +/- 
pAG139 double I241 → N 
N243 → T 
ATC → AAC 
AAC → ACC 
none +/- 
pAG167 double N243 → S 
F267 → S 
AAC → AGC 
TTT → TCT 
Q303 (CAA → CAG) 
P306 (CCT → CCC) 
+/- 
pAG116 triple L238 → P 
E314 → G 
K329 → I 
CTG → CCG 
GAG → GGG 
AAA → ATA 
G224 (GGT → GGA) 
I290 (ATT → ATA) 
+/- 
pAG127 triple N327 → Y 
I339 → T 
S341 → P 
AAC → TAC 
ATT → ACT 
TCG → CCG 
S309 (TCT → TCC) +/- 
pMM1 multiple 
(5) 
L242 → S 
L325 → P 
Y326 → F 
L354 → S 
L362 → Q 
TTG → TCG 
CTT → CCT 
TAC → TTC 
TTG → TCG 
CTT → CAG 
none +/- 
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Figure 19. Schematic representation of the Maf1 BC domain amino acid sequence with marked regions of mutation incidence that occurred during 
global mutagenesis of the MAF1 gene. The BC domain covers region 231 – 338 aa (green). Region outside the BC domain, including the acidic tail, ranges 
from 339 – 390 aa (grey). In yellow highly conserved amino acid residues have been highlighted. Temperature-sensitive phenotypes on glycerol-containing 
medium at 37ºC (YPGly), both: lack of growth (-) and moderate growth defect (+/-) caused by the identified maf1 mutations are highlighted with light blue 
color. Mutations in maf1 causing no growth defect in restricted conditions (WT) are also included. 
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Table 3. Classification of plasmids carrying maf1 allele. Table presents organization of plasmids according to the mutagenized region of Maf1 and growth 
phenotype on glycerol-containing medium at 37ºC (YPGly). Plasmids subjected to further analysis are bolded. Mutations are indicated below name of bolded 
plasmids. 
 
Region 
mutagenized 
A A + linker linker BC 
YPGly 
phenotype 
- +/- - +/- - - +/- 
pAG24 pAG8 
F32I-maf1 
- - pAG59 pAG107 - 
pAG34 pAG70 
K35E-maf1 
- - pAG72 - - 
pAG40 - - - - - - 
pAG53 - - - - - - 
pAG68 - - - - - - 
pAG48 pAG37 pAG61 
K2E-N117I-maf1 
- - pML6 
I241F-R332G-maf1 
pMM4 
F302S-L311W-maf1 
pAG50 pAG49 - - - pAG110 pAG139 
I241N-N243T-maf1 
pAG58 pAG66 - - - pAG132 
L242P-K329I-maf1 
pAG167 
N243S-F267S-maf1 
- - - - - pAG136 
M294R-L354S-maf1 
- 
- - - - - pAG147 
L242P-H249Q-maf1 
- 
- - - - - pAG171 
I239F-D258V-maf1 
- 
- pAG27 pAG23 
F32S-I54T-N142D-maf1 
pAG67 
E10G-S39P-L149F-
maf1 
- pMM2 
E272L-C299R-Q359L-
maf1 
pAG116 
L238P-E314G-K329I-
maf1 
- - - - - pAG113 pAG127 
N327Y-I339T-S341P-
maf1 
 
- - - - - pAG148 
S305P-N327D-N344D-
maf1 
- 
multiple - - - - - - pMM1 
L242S-L325P-Y326F-
L354S-L363Q-maf1 
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1.3. Preliminary characterisation of Maf1 mutants. 
 
By applying low-fidelity PCR and “Gap-repair” in vivo system a library of Maf1 
mutated in evolutionarily conserved regions - A and BC domains has been created. 
Obtained maf1 mutants exhibit thermosensitive growth phenotype on medium 
containing glycerol, a nonfermentable carbon source, which forces a change in the 
cellular metabolism from fermentation to respiratory growth – a phenotype typical 
for maf1∆ S. cerevisiae cells (Boguta et al., 1997). The presence of a thermosensitive 
growth phenotype is conncted either with the absence of Maf1 or a nonfunctional 
Maf1 unable to repress Pol III. Impairment of Maf1 function may correspond to 
defects in several steps of Maf1 activity: expression, phosphorylation state, 
transport from cytoplasm to nucleus or interaction with the Pol III apparatus.  
Several maf1 mutants carrying mutations in different regions of Maf1 and 
exhibiting different growth phenotype, were subjected to further investigation (Table 
3). More attention has been drawn to Maf1 mutated in the BC domain, which, due 
to its the higher evolutionary conservation in comparison to the A domain, seems 
more be crucial for Maf1 activity.  
1.3.1 Does mutations in the BC domain of Maf1 trigger destabilization 
of the protein? 
 
In first attempt, the expression profiles of mutated Maf1s have been studied in 
standard growth conditions (YPD, exponential phase). Investigated plasmids 
harbouring the maf1 allele were introduced to the YPH500 maf1∆ strain and the 
respective Maf1 mutant proteins have been examined by Western blotting with 
polyclonal anti-Maf1 antibodies. The analysis verified the lack of Maf1 expression 
for maf1 alleles mutated in the START codon sequence (Table 1A) harbored by 
pAG29, pAG56, pAG69 and pAG9 plasmids that conveyed previously observed 
growth defect of yeast cells on glycerol-containing medium at 37ºC (Fig. 20B). 
Differences in protein expression between Maf1 mutated in A domain and the 
linker (K2E-N117I (pAG61), F32S-I54T-N142D (pAG23), F32I (pAG8) and E10G-
S39P-L149F (pAG67) maf1 mutants) and the wild-type Maf1 (WT) were insignificant 
(Fig. 20A). Contrary to the effect of mutations localized in the A domain, several 
maf1 alleles mutated in the sequence encoding BC domain exhibited major 
disproportion in the Maf1 expression profile (Fig. 20A)  
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Figure 20. Analysis of the protein expression profile among Maf1 mutated in A domain and the 
linker region between the A and BC domains. The YPH500 maf1∆ strain harboring plasmids 
carrying mutated maf1 allele was grown to exponential phase (Exp.) in rich glucose medium. Cells 
were harvested and crude cell extracts prepared by trichloroacetic acid precipitation (TCA) were 
analysed using SDS-PAGE followed by immunoblotting with polyclonal anti-Maf1 antibodies. Growth 
phenotypes on glycerol-containing medium at 37ºC (YPGly) resulting from the analyzed mutated maf1 
allele are indicated below; (-) thermosensitivity, (+/-) moderate thermosensitivity. B. Plasmids carrying 
maf1 mutated in start codon.  
 
 
Figure 21. Maf1 is expressed to a different extent depending on localization of identified 
mutations. The YPH500 maf1∆ strain harboring plasmids carrying maf1 allele mutated in the 
sequence encoding BC domain was grown to exponential phase (Exp.), cells were harvested and 
subsequently analyzed by Western blotting with polyclonal anti-Maf1 antibodies as described in the 
legend to Fig. 20. Growth phenotype on glycerol-containing medium at 37ºC (YPGly) resulting from the 
analyzed mutated maf1 allele indicated below; (-) thermosensitivity, (+/-) moderate thermosensitivity. 
B. Decreasing expression of Maf1 in identified maf1 allele mutated in the sequence coding BC domain 
is symbolized.  
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Furthermore L242P-H249Q (pAG147), S305P-N327D-N344D (pAG148), N243S-
F267S (pAG167), N327Y-I339T-S341P (pAG127), M294R-L354S (pAG136), I241F-
R332G (pML6), E272L-C299R-Q359L (pMM2) and L242S-L325P-Y326F-L354S-
L363Q (pMM1) maf1 mutants demonstrated reduced Maf1 expression compared to 
nonmutated Maf1 (WT) and other Maf1s mutated in the BC domain. The decreased 
level of Maf1 among the analyzed maf1 allele is depicted on Fig. 21B. The 
disproportion of Maf1 expression did not correlate to the growth phenotype of 
relevant yeast cells (see Fig. 21A) suggesting that the observed growth phenotype 
does not reflect the amount of cellular Maf1 but rather its ability to inhibit Pol III. 
One might also suspect that other factors, like protein stability or degradation, 
might be responsible for noticeable differences in Maf1 expression profile.  
We might hypothesize that amino acid substitutions impose some conformational 
changes to the protein structure that do not affect its ability to interact with the Pol 
III apparatus and repress transcription, but physically destabilize the protein 
leading to its shortened life-time. On the other hand, it might be also possible also 
that amino acid substitutions cause conformational changes in a way that it makes 
the protein susceptible for accidental interactions with some other unspecific 
 
Figure 22. Identified mutations leading to decreased Maf1 cellular expression localize in the BC 
domain. The image is a schematic representation of Maf1 organization. The A domain is coloured with 
blue while the BC domain with green. The amino acid sequence of the Maf1 BC domain is presented in 
details. Evolutionarily conserved residues are marked with grey colour. Amino acid substitutions 
identified in S. cerevisiae cells expressing lower levels of Maf1 are indicated with a red type. Amino 
acid substitutions that occurred repeatedly are marked with grey squares. Studied plasmids harboring 
maf1 alleles with identified mutations are indicated on the bottom right. 
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environmental factors that ultimately direct it to degradation pathway. 
Localization of the identified mutations in maf1 alleles exhibiting decreased 
Maf1 expression indicated the BC domain of Maf1 to be important for protein 
stability (Fig. 22). 
 
1.3.2 Dephosphorylation of mutated Maf1 in terms of starvation 
induced by rapamycin. 
 
The rapamycin is a convenient drug agent that by inhibiting the TOR signalling 
pathway, induces a response in S. cerevisiae yeast cells similar to conditions of 
starvation. In terms of nutrient deprivation wild-type (WT) Maf1 is activated - 
undergoes dephosphorylation and is transported to nucleus leading to repression of 
Pol III transcription. The described maf1 mutants, previously analyzed for the Maf1 
expression profile in standard growth conditions were subsequently examined for 
their dephosphorylation ability under rapamycin treatment.  
To this aim, cells were grown in rich medium containing glucose until they 
reached the exponential growth phase, then treated by adding rapamycin to the 
medium at a final concentration of 0,2 µg/ml and incubated for 60 min. at 30ºC. 
Crude cell extracts isolated from the YPH500 maf1∆ S. cerevisiae strain expressing 
mutated maf1 alleles were subjected to electrophoresis in denaturating conditions 
(SDS-PAGE) with modified acrylamide:bisacrylamide ratio (Oficjalska-Pham et al., 
2006) that enabled discrimination between phosphorylated and dephosphorylated 
Maf1 forms. SDS-PAGE electrophoresis was followed by immunoblotting with 
polyclonal anti-Maf1 antibodies.  
During the exponential growth phase wild-type Maf1 (WT) migrates as several 
bands: a dephosphorylated corresponding to faster migrating band and slower 
migrating diffuse bands corresponding to phosphorylated Maf1 forms that 
disappear under rapamycin treatment (Fig. 23). Deviations from this rule will be 
called in further  parts of this work “affected dephosphorylation”.  
Presented analysis demonstrated that there is no correlation between region of 
Maf1 mutagenized and its capability to undergo dephosphorylation under 
rapamycin induction. Indeed, among maf1 alleles mutated in sequence encoding 
the A domain or the linker we observed either dephosphorylation comparable to 
wild-type Maf1 (WT) – K2E-N117I (pAG61), F32I (pAG8) and E10G-S39P-L149F 
(pAG67) maf1 mutants or affected dephosphorylation observed in F32S-I54T-N142D 
(pAG23) maf1 mutant (Fig. 23). Moreover, we can not conclude from the phenotype 
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of analyzed maf1 mutants on ability of mutated Maf1 to undergo dephosphorylation 
for the reason that respective yeast cells presented both: growth defect and 
moderate growth defect on glycerol-containing medium. 
Similarly, in case of maf1 alleles mutated in sequence encoding the BC domain 
we observed Maf1 dephosphorylation either comparable to nonmutated Maf1 (WT) 
e.g. I239F-D258V (pAG171) maf1 mutant exhibiting growth defect on glycerol-
containing medium (Fig. 24) and F302S-L311W (pMM4), I241N-N243T (pAG139) 
maf1 mutants exhibiting moderate growth defect (Fig. 25) or affected 
dephosphorylation of Maf1 in mutants exhibiting both: thermosensitive phenotype –  
I241F-R332G (pML6), E272L-C299R-Q359L (pMM2), M294R-L354S (pAG136), 
L242P-H249Q (pAG147), L242P-K329I (pAG132) and S305P-N327D-N344D 
(pAG148) maf1 mutants (Fig. 24) and moderate thermosensitive phenotype – 
N243S-F267S (pAG167), N327Y-I339T-S341P (pAG127), L242S-L325P-Y326F-
L354S-L363Q (pMM1) and L238P-E314G-K329I (pAG116) maf1 mutants (Fig. 25). 
Nevertheless, there is an evident link between the Maf1 expression profile and 
its capability to undergo dephosphorylation in terms of rapamycin induced cellular 
starvation. Each of mutated maf1 allele that formerly were reported to convey 
diminished expression level now demonstrated disordered phosphorylated form in 
exponential growth phase and then affected dephosphorylation under examined 
conditions. Compare Fig. 24 with Fig. 21 (both panels) - I241F-R332G (pML6), 
L242P-K329I (pAG132), M294R-L354S (pAG136), L242P-H249Q (pAG147), E272L-
C299R-Q359L (pMM2), S305P-N327D-N344D (pAG148) and compare Fig. 25 with 
Fig. 21 (both panels) - N243S-F267S (pAG167), (L238P-E314G-K329I) pAG116, 
N327Y-I339T-S341P (pAG127), L242S-L325P-Y326F-L354S-L363Q (pMM1). This 
apparent correlation might support the hypothesis that the improperly folded Maf1 
mutant forms are unstable and possibly degraded. Perturbations of 
phosphorylation and dephosphorylation phenomena of Maf1 mutant forms might 
reflect this inappropriate protein folding preventing from regular phosphorylation. 
However, one of the isolated maf1 mutants, demonstrated no alterations in the 
Maf1 expression profile (thereby no expected destabilization or degradation) but was 
shown to be affected in phosphorylation and dephosphorylation process (F32S-
I54T-N142D (pAG23) maf1 mutant). This indicates that the observed disorder in 
Maf1 phospho-forms is a direct consequence of mutations within the Maf1 encoding 
sequence. 
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Figure 23. Analysis of dephosphorylation of Maf1 mutated in the A domain and the linker 
region upon conditions of starvation induced by rapamycin. The YPH500 maf1∆ strain harboring 
plasmids carrying mutated maf1 allele was grown to exponential phase (Exp.) in rich glucose medium, 
exposed to rapamycin at a final concentration of 0,2 µg/ml in the medium and further incubated at 
30ºC. Cells were harvested as described in the legend to Fig. 20 and subsequently analyzed by SDS-
PAGE with a modified acrylamide:bisacrylamide ratio followed by immunoblotting with polyclonal anti-
Maf1 antibodies. The slower migrating diffuse bands correspond to phosphorylated forms of Maf1. 
Growth phenotypes on glycerol-containing medium at 37ºC (YPGly) resulting from analyzed mutated 
maf1 allele and the identified mutations are indicated on the right; (-) thermosensitivity, (+/-) 
moderate thermosensitivity.  
 
 
 
Figure 24. Analysis of dephosphorylation of Maf1 mutated in the BC domain in terms of 
starvation induced by rapamycin. Figure presents the YPH500 maf1∆ strain harboring plasmids 
carrying mutated maf1 allele that influence thermosensitive growth on medium containing glycerol at 
37ºC (YPGly) (-). Identified mutations indicated on the right. Analysis performed as described in the 
legend to Fig. 23. 
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Figure 25. Analysis of dephosphorylation of Maf1 mutated in the BC domain in terms of 
starvation induced by rapamycin. Figure presents the YPH500 maf1∆ strain harboring plasmids 
carrying mutated maf1 allele that influence moderate thermosensitive growth on medium containing 
glycerol (+/-). The identified mutations are indicated on the right. Analysis performed as described in 
the legend to Fig. 23. 
 
Moreover, an interesting issue occurred under rapamycin treatment that is 
visible in all maf1 mutants independently from its phosphorylation and capability 
to undergo dephosphorylation in nonpermissive conditions. The repeatedly 
appearance of the increased quantity of Maf1 in S. cerevisiae cells while rapamycin 
treatment, independently of strain tested, which indicated, that observed effect is 
due to increased expression of Maf1 under starvation stress conditions (compare 
lane 15’ and 60’ after rapamycin treatment on Fig. 23-25). Similar increased level of 
Maf1 synthesis upon stress conditions was visible on Western blotting analyses 
presented in Oficjalska-Pham et al., 2006 (for rapamycin) and Roberts et al., 2006 
(for chlorpromazine, CPZ). 
One might suspect that apart from the phosphorylation state of Maf1 the level of 
Maf1 expression is an additional mode of Maf1 activity regulation. Thus it might be 
possible that in more harsh stress conditions, when rapid inhibition of Pol III 
transcription is required, an increased synthesis of Maf1 occurs, which leads to 
more efficient Pol III repression. This hypothesis is supported by the bioinformatic 
analysis of MAF1 promoter sequence (Graczyk, 2006 – master thesis, data 
unpublished). Comparative analysis of the MAF1promoter sequence of such yeast 
species as: S. cerevisiae, S. paradoxus, S. kudriavzev, S. mikatae, S. bayanus and  
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S. pombe revealed the presence of conserved consensus sequence for following 
transcription factors: Pho 4 (gnktgcac(-)), Abf1 (rTCAyTnnnnAc) and Msn4 
(mAGGGG). The used abbreviation correspond to: N – nonspecific nucleotide, R – 
purine, Y – pirymidine, M – adenine or cytosine, K – guanidine or tymidine, with the 
lower-case letters are signed for nucleotides of a minor impact on transcription 
factor binding.  
The increased quantity of Maf1 under rapamycin treatment might be due to the 
up-regulation by Msn4 transcription factor, which possibly binds to the MAF1 
promoter sequence. Msn4 is the transcription factor that regulate the general stress 
response of S. cerevisiae (Martinez-Pastor et al., 1996). Msn4 regulates the 
expression of ~200 genes in response to several stresses, including heat shock, 
osmotic shock, oxidative stress, low pH, glucose starvation, sorbic acid and high 
ethanol concentrations, by binding to the STRE element (stress response element),  
mAGGGG, located in the promoters of these genes (Gasch et al., 2000; Causton et 
al., 2001).  
Perturbations in phosphorylation and dephosphorylation phenomena observed 
among the selected maf1 mutants (Table 4) was cautiously analyzed by 
bioinformatic approach revealing detailed impact of identified amino acid 
substitutions on preservation of potential phosphorylation sites in mutated Maf1 
forms or possible manifestation of novel phosphorylation sites that appear due to 
introduction of amino acid substitutions into Maf1 sequence. To predict both: 
changed and novel phosphorylation sites in maf1 protein, NetPhos v 2.0 software 
has been applied (http://www.cbs.dtu.dk/services/NetPhos/) (Bloom et al., 1999). 
Potentially phosphorylated serine, threonine and tyrosine residues have been 
depicted in Table 5. Concomitant kinases targeting the indicated phosphorylation 
sites were allocated by NetPhosK v 1.0 software, a kinase-specific eukaryotic protein 
phosphorylation sites prediction tool (http://www.cbs.dtu.dk/services/NetPhosK/). 
(Bloom et al., 2004). Currently, NetPhosK covers the following kinases: PKA, PKC, 
PKG, CKII, Cdc2, CaM-II, ATM, DNA PK, Cdk5, p38 MAPK, GSK3, CKI, PKB, RSK, 
INSR, EGFR and Src.  
Indeed, performed analyses revealed major discrepancies between the already 
existing in Maf1 potential phosphorylation sites and both modification and 
emerging novel phosphorylation sites in maf1 proteins presenting disturbance in 
phosphorylation and dephosphorylation phenomena. (Table 5). Furthermore  
modifications of phosphorylation sites implied also alteration of set of kinases 
targeting indicated phosphorylation sites. E. g in many maf1 alleles substitution 
 - 48 - 
S245 was detected. This serine was depicted as a potential phosphorylation site, a 
target for kinases: DNAPK and cdc2. Alteration in sequence of context caused by 
adjacent mutations led to the abolition of cdc2 kinase activity in advantage of  the 
DNAPK kinase (L242P-K329I (pAG132), L242P-H249Q (pAG147), L242S-L325P-
Y326F-L354S-L363Q (pMM1) maf1 mutants) or the contrary - abolition of the 
DNAPK kinase activity in advantage of cdc2 (N243S-F267S (pAG167) maf1 mutant) 
or abolition of other kinases like PKA - also in (N243S-F267S (pAG167) maf1 
mutant).  
However, crucial alterations significantly affecting phosphorylation and 
dephosphorylation phenomena may be the effect of elimination of potential 
phosphorylation sites in maf1 proteins (in. pAG23, pAG136, pMM2, pAG148, 
pAG127 plasmids) or a manifestation of novel phosphorylation sites (in pAG23, 
pAG132, pAG136, pAG147, pAG167 and pMM1 plasmids).  
 
 WT dephosphorylation Affected dephosphorylation 
- +/- - +/- 
pAG61 
(K2E-N117I-maf1) 
pAG8 
(F32I-maf1) 
pAG23 
(F32S-I54T-N142D-
maf1) 
- 
A 
- pAG67 
(E10G-S39P-L149F-
maf1) 
- - 
pAG171 
(I239F-D258V-maf1) 
pMM4 
(F302S-L311W-maf1) 
pML6 
(I241F-R332G-maf1) 
pAG167  
(N243S-F267S-
maf1) 
- pAG139 
(I241N-N243T-maf1) 
pAG132 
(L242P-K329I-maf1) 
pAG116 
(L238P-E314G-
K329I-maf1) 
- - pAG136 
(M294R-L354S-maf1) 
pAG127 
(N327Y-I339T-
S341P-maf1) 
- - pAG147 
(L242P-H249Q-maf1) 
pMM1 
(L242S-L325P-
Y326F-L354S-
L363Q- maf1) 
- - pMM2 
(E272L-C299R-Q359L-
maf1) 
- 
BC 
- - pAG148 
(S305P-N327D-N344D-
maf1) 
- 
 
Table 4. Classification of analyzed plasmids carrying maf1 allele according to observed ability 
of mutated Maf1 to undergo dephosphorylation under conditions of starvation induced by 
rapamycin. Growth phenotype on glycerol-containing medium at 37ºC (YPGly) resulting from analyzed 
mutated maf1 allele is indicated above lanes: (-) thermosensitivity; (+/-) moderate thermosensitivity. 
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Table 5. Analysis of potential phosphorylation sites in Maf1 mutants, which disruption by concomitant mutations in sequence of context, may 
cause defect in phosphorylation and following dephosphorylation of mutated Maf1 under rapamycin treatment. Prediction of potentially 
phosphorylated serine, threonine and tyrosine residues performed by NetPhos v 2.0 software(http://www.cbs.dtu.dk/services/NetPhos/). Prediction of kinases 
involved in phosphorylation of indicated residues by NetPhosK v 1.0 software. (http://www.cbs.dtu.dk/services/NetPhosK/). Output score is a value in the 
range [0.000-1.000]. Only scores above the threshold of 0.500 are taken into account. Table presents both: changed or disrupted phosphorylation sites 
already existing in Maf1 sequence and novel phosphorylation sites appeared in according to amino acid substitutions identified in mutated Maf1 forms. 
 
Plasmid Amino acid 
substitution 
Predicted 
phosphorylation 
sites 
Context 
sequence 
Score 
(≥0.5) 
Predicted 
kinases 
Score 
(≥0.5) 
Novel 
phosphorylation 
sites 
T34 - lost 
S138 - changed 
DISTTKAVA 
TFPKSAKLD 
0.658 
0.983 
PKC 
not detected 
0.57 
- 
pAG23 F32S 
I54T 
N142D S32 – new 
T33 – new 
SCDISTTKA 
CDISTTKAV 
0.684  
0.574 
cdc2 
PKC 
0.54 
0.81 
yes 
pML6 I241F 
R332G 
S245 - changed FLNASYPDH 0.962 DNAPK / cdc2 0.51 / 0.51 none 
S245 - changed IPNASYPDH 0.989 DNAPK / cdc2 - lost 0.51 / - pAG132 L242P 
K329I Y246 - new PNASYPDHD 0.866 not detected - 
yes 
T295 - lost NSHMRLSDC 0.523 not detected - pAG136 M294R 
L354S S297 – new 
S354 - new 
HRTLSDCVL 
VEDASAKKP 
0.919 
0.947 
RSK / PKA 
PKC 
0.54 / 0.76 
0.69 
yes 
S245 - changed IPNASYPDQ 0.991 DNAPK / cdc2 - lost 0.51  pAG147 L242P 
H249Q Y246 – new 
S252 – new 
S253 - new 
PNASYPDQD 
DQDFSSVEP 
QDFSSVEPT 
0.640 
0.937 
0.994 
not detected 
CKII 
not detected 
- 
0.58 
- 
yes 
pMM2 E272L 
C299R 
Q359L 
S277 - lost 
T274 - lost 
Y276 - lost 
T295 - changed 
LNTLYSLGRQ 
KFLNTLYSL 
LNTLYSLGR 
NSHMTLSDR 
0.685 
0.786 
0.586 
0.658 
CKI / PKC 
DNAPK  
not detected 
not detected 
0.61 / 0.67 
0.50 
- 
- 
none 
pAG148 S305P 
N327D 
N344D 
S305 - lost  
S309 - changed 
S345 - changed 
S346 - changed 
LFQYPPSNS 
PPSNSFLED 
SRLDSSTGE 
RLDSSTGEV 
0.819 
0.663 
0.949 
0.989 
GSK3 
CKII 
RSK / PKA 
CKII 
0.50 
0.59 
0.53 / 0.61 
0.57 
none 
S245 - changed 
S263 - changed 
T262 - changed 
ILSASYPDH 
FVKTSLKTS 
DFVKTSLKTS 
0.992 
0.895 
0.753 
DNAPK - lost / cdc2 
CKI / PKC / PKA - lost 
PKC 
- / 0.55 
0.57 / 0.59 / - 
0.65 
pAG167 N243S 
F267S 
S267 – new 
S269 - new 
SLKTSISKF 
KTSISKFEN 
0.980 
0.842   
not detected 
not detected 
- 
- 
yes 
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Continued: 
Plasmid Amino acid 
substitution 
Predicted 
phosphorylation 
sites 
Context 
sequence 
Score 
(≥0.5) 
Predicted 
kinases 
Score 
(≥0.5) 
Novel 
phosphorylation 
sites 
pAG116 L238P 
E314G 
K329I 
S309 - changed 
Y317 - changed 
SPSNSFLEDG 
DGPGYLWNL 
0.651 
0.848 
CKII 
not detected 
0.55 
- 
none 
pAG127 N327Y 
I339T 
S341P 
S345 - lost 
S346 - changed 
PRLNSSTGE 
PRLNSSTGE 
0.824 
0.959 
RSK / PKA 
CKII 
0.52 / 0.67 
0.53 
none 
S245 - changed ISNASYPDH 0.994 DNAPK / cdc2 - lost 0.51 / - pMM1 L242S 
L325P 
Y326F 
L354S 
L362Q 
Y246 – new 
S354 - new 
SNASYPDHD 
VEDASAKKP 
0.950  
0.947 
not detected 
PKC 
- 
0.69 
yes 
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The described bioinformatic analysis could explain the detected disturbance in 
the ability of Maf1 mutant forms to undergo proper phosphorylation followed by 
dephosphorylation under rapamycin treatment. Nevertheless, an additional 
experiments are required to validate these bioinformatic models. 
1.3.3 Analysis of phosphorylation patterns of Maf1 mutatnt proteins. 
 
Since preceding survey highlighted the problem of defect in mutated Maf1 
phosphorylation forms an attempt to better discriminate between different 
alterations has been made. Using OdysseyTM Infrared Imaging System, I could more  
clearly analyze the phosphorylation pattern of wild-type Maf1 and its mutated 
derivatives. OdysseyTM Infrared Imaging System bases on Western blotting analysis 
but instead of HRP-conjugated secondary antibodies employs secondary antibodies 
labeled with IRDyeTM infrared dyes. This system provides higher sensitivity and 
enables to obtain sharper, more detailed bands and visualize subtle mobility shifts 
caused by protein modifications such as phosphorylation. Since then served as a 
valuable tool to study phosphorylation pattern among analyzed maf1 alleles.  
To this aim, cells were grown in rich medium containing glucose to exponential 
growth phase. Crude cell extracts isolated from YPH500 maf1∆ S. cerevisiae strain 
expressing mutated maf1 allele were subjected to SDS-PAGE with modified 
acrylamide:bisacrylamide ratio as described previously (Oficjalska-Pham et al., 
2006) and subjected to immunoblotting with polyclonal anti-Maf1 antibodies 
followed by incubation with secondary antibodies labeled with IRDyeTM infrared 
dyes in accord with protocol provided by LI-CORTM Biosciences.  
Preliminary study of Maf1 mutated forms shows diverse phosphorylation pattern 
among examined maf1 alleles. 
Studied maf1 alleles were partitioned into two groups: exhibiting not affected 
dephosphorylation under rapamycin induced conditions of starvation and that of 
observed affected dephosphorylation (Table 4). Comparative analysis of maf1 alleles 
by OdysseyTM Infrared Detection System revealed that maf1 alleles presenting in 
previous Western blotting analysis not affected dephosphorylation, similar to that 
observed in wild-type Maf1 (WT), have in exponential growth phase, as well, 
analogous phosphorylation pattern to that observed in WT Maf1 (Fig.26).  
The second group of maf1 alleles presented in previous Western blotting 
analysis affected phosphorylation and dephosphorylation under rapamycin  
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Figure 26. Phosphorylation patter of mutated Maf1s comparable to nonmutated Maf1. Mutated 
Maf1 that are regularly dephosphorylated under rapamycin treatment (see Table 4) exhibit, in 
exponential growth phase (Exp.), phosphorylation pattern comparable to nonmutated (WT) Maf1 
unspecific to region mutagenized and growth phenotype observed among examined yeast cells. The 
YPH500 maf1∆ strain harboring plasmids carrying mutated maf1 allele was grown to exponential 
phase (Exp.) in rich glucose medium. Cells were harvested as described in legend to Fig. 20 and 
subsequently analyzed by SDS-PAGE with a modified acrylamide:bisacrylamide ratio followed by 
immunoblotting with polyclonal anti-Maf1 antibodies. For visualization of Maf1 phospho forms 
OdysseyTM infrared fluorescence detection system involving secondary polyclonal antibodies labelled 
with IRDyeTM infrared dyes was used. Growth phenotype on glycerol-containing medium at 37ºC 
(YPGly) resulting from analyzed mutated maf1 allele indicated below; (-) thermosensitivity, (+/-) 
moderate thermosensitivity. 
 
 
Figure 27. Changed phosphorylation pattern of mutated Maf1. Mutated Maf1s that exhibit defect 
in dephosphorylation under rapamycin treatment (see Table 4) exhibit miscellaneous phosphorylation 
pattern even in exponential growth phase (Exp.), unspecific to region mutagenized and growth 
phenotype observed among examined yeast cells. Analysis performed as described in legend to  
Fig. 26.  
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treatment in comparison with WT. Even in absence of rapamycin, in exponential 
growth phase, this group presented diverse phosphorylation pattern (Fig. 27).  
Detected phosphorylation patterns did not correlate neither to the growth 
phenotype on glycerol-containing medium of relevant yeast cells nor to the region of 
Maf1 mutagenized (A domain or BC domain). However, investigated maf1 alleles 
visibly portrayed several “classes” of phosphorylation patterns indicating some 
universal changes in mutated Maf1 folding reflected by a different type of 
phosphorylation. Also this “classes” of phosphorylation patterns could not be 
simply elucidated by detailed analysis of potential phosphorylation sites that were 
altered or created de novo in Maf1 amino acid sequence (Table 5). 
Unfortunately, analyses of maf1 alleles by OdysseyTM Infrared Detection System 
in presence of rapamycin were not performed due to a lack of time.  
The appearance of particular “classes” of phosphorylation patterns (Fig. 27)  
(i- F32S-I54T-N142D (pAG23); ii – I241F-R332G (pML6), N243S-F267S (pAG167); iii 
– M294R-L354S (pAG136), N327Y-I339T-S341P (pAG127), L242S-L325P-Y326F-
L354S-L362Q (pMM1) and iv – L242P-H249Q (pAG147), L242P-K329I (pAG132), 
S305P-N327D-N344D (pAG148), L238P-E314G-K329I (pAG116) maf1 mutants) 
implies some typical for each “class” alteration of mutated Maf1 activity. Thus 
capability of these mutated Maf1 forms to approach nucleus was subsequently 
studied as a next phenomena characterizing Maf1.  
 
1.3.4 Cellular localization of Maf1 mutated proteins. 
 
To investigate cellular localization of mutated Maf1 forms particular 
representatives of maf1 allele were chosen from each of studied groups:  
maf1 mutants undergoing nonaffected dephosphorylation under rapamycin 
treatment mutated in A domain K2E-N117I (pAG61) and mutated in the BC domain 
(I239F-D258V (pAG171), F302S-L311W (pMM4)). 
maf1 mutants undergoing affected dephosphorylation under rapamycin treatment 
belonging to several “classes” of phosphorylation patterns described previously - 
mutated in A domain (i - F32S-I54T-N142D (pAG23) maf1 mutant) and mutated in 
the BC domain (ii – I241F-R332G (pML6), N243S-F267S (pAG167); iii - N327Y-
I339T-S341P (pAG127), L242S-L325P-Y326F-L354S-L362Q (pMM1) and iv – L238P-
E314G-K329I (pAG116) maf1 mutants).  
To this aim cells were grown in rich medium containing glucose to exponential 
growth phase, treated with rapamycin (final concentration 0,2 µg/ml) and 
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incubated for 60 min. at 30ºC. Localization of mutated Maf1s was analyzed by 
immunofluorescence microscopy using polyclonal anti-Maf1 antibodies. Nuclei were 
stained with 4’,6-diamidino-2-phenylindole (DAPI). 
The fluorescence signal of wild-type Maf1 (WT), during exponential phase of 
growth in glucose containing medium is dispersed through whole cell. After 
rapamycin treatment the concentration of Maf1 specific signal is observed in 
nucleus in accordance with published results (Oficjalska-Pham et al., 2006)  
(Fig. 28).  
Analysis of cellular localization of mutated Maf1 with preserved 
dephosphorylation capability showed that under rapamycin induction Maf1 might 
be present both: through all cell (K2E-N117I (pAG61) maf1 mutant) as well as 
concentrated in nucleus as for wild-type Maf1 (I239F-D258V (pAG171) and F302S-
L311W (pMM4) maf1 mutants). Both cellular localizations of these maf1 mutants 
indicate that the migration of mutated Maf1s from cytoplasm to nucleus is 
influenced by amino acid substitutions identified in these maf1 alleles and that 
migration is not connected to dephosphorylation of these Maf1s. 
Cellular localization of mutated Maf1 with disrupted dephosphorylation 
capability showed also diverse localization of mutated Maf1 forms (Fig. 28): 
i - F32S-I54T-N142D (pAG23) maf1 mutant is constantly present in cytoplasm.  
ii – I241F-R332G (pML6) maf1 mutant is constantly present in cytoplasm, which is 
not surprising since this maf1 allele harbors mutation in nuclear localization signal 
sequence (NLS2) – R332G that disrupts transport to nucleus. Belonging to the same 
“class” of phosphorylation pattern, N243S-F267S (pAG167) maf1 mutant presents 
nuclear localization under rapamycin induction.  
iii – N327Y-I339T-S341P (pAG127) maf1 mutant is constantly present in cytoplasm, 
while L242S-L325P-Y326F-L354S-L362Q (pMM1) maf1 mutant exhibits nuclear 
localization under rapamycin treatment. That implies that we cannot deduce the 
cellular localization of Maf1 from the phosphorylation pattern. However, noteworthy 
is fact that N327Y-I339T-S341P (pAG127) maf1 mutant harbors mutation N327Y, 
which is very close to NLS2 (328 – 332 aa) that raises possibility that cytoplasmatic 
localization is a result of disturbed NLS2 sequence. 
iv – L238P-E314G-K329I (pAG116) maf1 mutant is also constantly cytoplasmatic 
but as in case of I241F-R332G (pML6) maf1 mutant this maf1 allele harbors 
mutation in NLS2 sequence – K329I. 
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Figure 28. Cellular localization of mutated Maf1 is independent from its ability to 
dephosphorylate under rapamycin treatment and observed initial phosphorylation pattern. The 
YPH500 maf1∆ strain harboring plasmids carrying mutated maf1 allele was grown to exponential 
phase (Exp.) in rich glucose medium, exposed to rapamycin in final concentration of 0,2 µg/ml in 
medium and incubated further at 30ºC for 60’ (minutes). Cells were harvested as indicated. Maf1 
localization was analysed by immunofluorescence microscopy using polyclonal anti-Maf1 antibodies. 
Nuclei were stained with 4’,6-diamidino-2-phenylindole (DAPI); WT, wild-type. 
 
Taken together there is not enough data to state about correlation between 
cellular localization and phosphorylation pattern of mutated Maf1 forms. However, 
supported on the fact, that N243S-F267S (pAG167) and L242S-L325P-Y326F-
L354S-L362Q (pMM1) maf1 mutants are transported to nucleus although exhibit 
affected phosphorylation and dephosphorylation phenomena while K2E-N117I 
(pAG61) maf1 mutant is constantly cytoplasmatic although undergoes regular 
dephosphorylation under rapamycin treatment, one might deduce, that there is no 
correlation between capability of Maf1 to undergo dephosphorylation in terms of 
rapamycin treatment and its translocation to nucleus. 
1.4. Summary  
Dedicated study presented here, devoted to analysis of mutated Maf1 forms, 
revealed several important issues that are a promising field for further researches. 
Position analysis of identified among library of maf1 alleles mutations could not 
uncover the region of Maf1 responsible for abolition of Maf1 activity as a Pol III 
repressor – as deduced from thermosensitive phenotype of relevant yeast cells on 
glycerol-containing medium. The BC domain seems to be more significant for Maf1 
activity because with a higher evolutionarily conservation in comparison to A 
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domain. Moreover, mutations in the BC domain might lead to decreased synthesis 
of Maf1 or its degradation as assumed from diminishing expression profile of 
L242P-H249Q (pAG147), S305P-N327D-N344D (pAG148), N243S-F267S (pAG167), 
N327Y-I339T-S341P (pAG127), M294R-L354S (pAG136), I241F-R332G (pML6), 
E272L-C299R-Q359L (pMM2) and L242S-L325P-Y326F-L354S-L363Q (pMM1) maf1 
mutants. Furthermore these maf1 mutants presented multiple differences in 
phosphorylation pattern and potential ability to undergo dephosphorylation. 
However, cautious examination of maf1 mutants with altered phospho-forms 
showed that the disturbance in both: phosphorylation/dephosphorylation of Maf1 
is region independent since either Maf1 mutated in the A domain or Maf1 mutated 
in the BC domain may present nonaffected phosphorylation/ dephosphorylation as 
well as affected. This observation appointed involvement of identified in maf1 alleles 
amino acid substitutions in modification of potential phosphorylation sites present 
in Maf1. In addition detailed study over the maf1 alleles presenting defect in 
phosphorylation/dephosphorylation phenomena revealed that it is possible to 
discriminate between several “classes” of defective phosphorylation patterns in 
SDS-PAGE. That insight suggests some universal changes in folding of mutated 
Maf1 reflected by a different type of phosphorylation. The appearance of particular 
“classes” of phosphorylation patterns implies some common characteristic for the 
different Maf1 functions. Furthermore, no correlation between capability of Maf1 to 
undergo dephosphorylation and its translocation to nucleus could be detected since 
either maf1 alleles with preserved phosphorylation/dephosphorylation phenomena 
or affected dephosphorylation present both cellular localizations (nuclear or 
dispersed through all cell) under rapamycin treatment. The other functions of Maf1 
(interaction with the Pol III enzyme, inhibition of Pol III transcription, exit from the 
nucleus after removal of rapamycin, etc.) should be studied in the future to 
decipher if there are some relationship between a class of phosphorylation pattern 
and a modification of a function of Maf1.  
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2. Full repression of RNA polymerase III transcription 
requires interaction between two domains of its negative 
regulator Maf1. 
 
The results obtained by Christoph Műller’s group upon H. sapiens Maf1 
indicating interactions between the A and BC domains of Maf1 encouraged me to 
undertake a study upon the relation between evolutionarily conserved regions of  
Maf1 – A and BC domains. To investigate if the interaction between domains of 
Maf1 is conserved through evolution, the proposed hypothesis was analyzed in 
another organism, S. cerevisiae yeast, that is also more amenable to study 
structure-function relationships of Maf1. As a first raised problem, the potential 
genetic interaction between Maf1 domains has been studied and further predicted 
physical interaction between them. 
2.1. Genetic interaction between evolutionarily conserved regions – A 
and BC domains of S. cerevisiae Maf1. 
2.1.1 Screening for mutations localized in BC domain that suppress 
single point mutations identified in A domain. 
 
One approach to study the genetic interaction between protein domains is to 
identify second-site mutations that compensate for the initially observed defects. I 
looked therefore for second site suppressor mutations within the BC-encoding 
region of MAF1 that allowed thermosensitive S. cerevisiae cells harboring mutated 
A-encoding region of MAF1 to grow on glycerol-containing medium at 37ºC.  
To this aim, among the library of Maf1 mutated in A domain, K35E-maf1 
(pAG70) mutant was chosen as an initial maf1 allele. K35E-maf1 mutant carries 
single amino acid substitution in highly conserved through evolution residue. This 
mutation results in moderate growth defect of relevant yeast cells on glycerol-
containing medium at 37ºC. The phenotype observed indicates partial disruption of 
Maf1 activity as previously described (see also Fig. 16). To obtain suppressor 
mutants a rapid method for localized mutagenesis (“Gap-repair”) was applied as for 
library of Maf1 mutants construction (Muhlrad et al., 1992). Using low-fidelity PCR,  
the sequence encoding BC domain (174-375 aa) of K35E-maf1 allele was 
mutagenized and co-transformed to YPH500 maf1∆ S. cerevisiae strain with 
linearized plasmid carrying K35E mutation in MAF1 sequence encoding A domain 
and gap in the sequence encoding BC domain. In vivo homologous recombination 
allowed for repair of gapped plasmid with the mutated sequence encoding BC 
domain of Maf1. As a result the library of maf1 alleles mutated in the sequences 
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encoding both: A and BC domains was achieved (Fig. 29). Obtained library of 
mutated Maf1s was screened for recovery of growth ability on glycerol-containing 
medium at 37 ºC (WT growth phenotype). Almost 1 000 potential suppressors were 
analyzed (Malgorzata Legowiak, master thesis). Selected transformants exhibiting 
WT growth phenotype were used to isolate plasmids carrying maf1 allele and 
subsequently retransform to YPH500 maf1∆ S. cerevisiae strain to confirm that the 
phenotype observed results from mutations in maf1 allele. Among investigated maf1 
alleles 6 represented WT growth on glycerol-containing medium (Table 6). However, 
sequencing revealed that only 2 maf1 alleles carried mutations localized in either A 
domain or the BC domain that resulted in recovery of WT growth. Remaining could 
possibly demonstrate spontaneous mutations outside MAF1 gene (3 plasmids 
pML13-15, Table 6) and 1 showed reversion of initial mutation K35E to nonmutated 
MAF1 sequence (plasmid pML16, Table 6). The suppositious, spontaneous 
revertants outside MAF1 gene were not subjected to further analysis. 
Identified suppressor mutants in plasmids pML11 and pML12 harbored maf1 
carrying initial K35E mutation in sequence encoding A domain and respectively 
suppressor mutations in the sequence encoding BC domain with single D250E and 
double V260D-N344I amino acid substitutions (positions of the mutations are 
shown on Fig. 29).  
Phenotypic analysis of identified suppressor mutants K35E-D250E-maf1 and 
K35E-V260D-N344I-maf1 revealed indeed WT growth on glycerol-containing 
medium at 37ºC contrary to parental K35E-maf1 mutant in sequence encoding A 
domain. This phenotypic suppression indicates genetic interaction between the 
Maf1 A and BC domains (Fig. 29). 
 
Plasmid 
Amino acid 
substitutions 
Changes in codon YPGly 
pAG70 K35 → E AAG → GAG +/- 
pML11 K35 → E D250→E 
AAG → GAG 
GAT → GAG WT 
pML12 
K35 → E 
V260 → D 
N344 → I 
AAG → GAG 
GTC → GAC 
AAT → ATT 
WT 
pML13 K35 → E AAG → GAG WT 
pML14 K35 → E AAG → GAG WT 
pML15 K35 → E AAG → GAG WT 
pML16 K35 → E → K AAG → GAG → AAG WT 
 
Table 6. Plasmids carrying maf1 mutated allele obtained in screen for suppressors of K35E A 
domain mutated Maf1 K35E-maf1 (pAG70). Growth phenotype on glycerol-containing medium at 
37ºC (YPGly) tested by replica plating. (+/-) moderate growth defect, WT, wild-type - no growth defect. 
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Figure 29. Schematic representation of experimental strategy applied for screening suppressor 
mutations localized in the BC domain of Maf1 that compensate the effect of single point 
mutation identified in the Maf1 A domain. Mutated A domain indicated with blue-red colour with 
signed identified amino acid substitution K35E. Maf1 BC domain indicated with green colour, “Gap-
repair” system based on homological recombination in vivo has been presented. Mutated by low-fidelity 
PCR sequence encoding BC domain is designated with blue star. Resulting plasmid harbouring maf1 
mutated in the sequence encoding both: A and BC domains of Maf1 is shown on the right.  
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Figure 30. Phenotypic characterization of the two suppressor strains shows that they 
compensate for the defect of growth on glycerol-containing medium at 37ºC (YPGly) of the 
primary K35E mutation. Tenfold serial dilutions of cells were plated on medium containing glucose 
(YPD) or glycerol (YPGly) and incubated at indicated temperatures. The control WT is YPH500 maf1∆ 
strain transformed with pRS315-MAF1 plasmid. Suppressor strains are YPH500 maf1∆ strain 
transformed with plasmids harboring: K35E-V260D-N344I (pML12) and K35E-D250E (pML11) maf1 
alleles as well as initial K35E-maf1 allele (pAG70). Location of the respective mutations in Maf1 amino 
acid sequence is presented below. 
 
• Separation of identified suppressor mutations. 
Identified suppressor mutations were subsequently separated from initial K35E 
mutation to distinguish the effect of second-site mutations from the cooperative 
effect. To introduce D250E, N344I, V260D and V260D-N344I mutations to  
pRS315-MAF1 plasmid the QuickChange Site-Directed Mutagenesis Kit (Stratagene) 
was used. Growth phenotype on glycerol medium was tested. Separated mutations: 
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D250E, V260D and N344I did not influence growth of relevant yeast cells indicating 
no disturbance in Maf1 activity (Fig. 31). Contrary the double V260D-N344I mutant 
caused moderate growth defect. That accentuate the collective effect of joint: K35E 
and V260D-N344I mutations as a support for genetic interaction between the A and 
BC domains of Maf1 in yeast cells presenting recover of growth on glycerol-
containing medium. Meaning, that the presence of V260D-N344I mutation, which 
separately causes disturbance in Maf1 activity, in joint with K35E mutation, which 
separately also causes disturbance in Maf1 activity, all together abolish their 
negative effect as deduced by recovery of the growth phenotype on glycerol-
containing medium. 
 
Figure 31. Phenotypic characterization of the strains harboring maf1 allele with separated 
mutations that were originally found in suppressors of the K35E maf1 allele. Tenfold serial 
dilutions of cells were plated on medium containing glucose (YPD) or glycerol (YPGly) and incubated at 
indicated temperatures. As described in legend to Fig. 30, all presented maf1 alleles (harbored on the 
plasmid) were tested in YPH500 maf1∆ background strain. Location of the respective mutations in 
Maf1 amino acid sequence is presented below.  
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2.1.2 Suppressor mutations in BC domain recover the function of Maf1 
mutated in A domain. 
• Suppressor mutations recover the capacity of Maf1 mutated in A domain to 
repress Pol III in correlation to growth phenotype on glycerol-containing 
medium.  
To inspect the effect of K35E mutation in Maf1 on Pol III activity, RNA isolated 
from cells grown in the presence of glucose and transferred to glycerol medium at 
37ºC was analyzed by Northern blotting using probes for pre-tRNALeu and tRNAPhe 
(Figure 32A). Following transfer to the medium with the nonfermentable carbon 
source, pre-tRNA levels (that indicate the level of transcription) were decreased in 
the wild type but not in maf1∆ cells (Figure 32A, compare lanes 1, 5 and 6, 10). 
Similarly to maf1∆, the K35E mutant was defective in its ability to repress pre-tRNA 
synthesis upon transfer to glycerol medium (Figure 32A, lanes 2 and 7). Thus, the 
single missense mutation within the Maf1 A domain precluded Pol III repression in 
K35E-maf1 strain. 
Phenotypic characterization of the two suppressor strains showed that they 
compensate for the defect of growth on glycerol medium at 37ºC of the primary 
K35E mutation (Figure 32B). The increased growth capacity of the suppressors on 
glycerol medium was due to a compensation of the defect in Pol III regulation 
observed for the K35E mutation. As determined by Northern blotting, the 
suppressor mutations restored the ability to repress pre-tRNA synthesis upon 
transfer from glucose to glycerol medium (Figure 32A, compare lanes 3, 4 and 8, 9). 
These results indicate that the detected genetic interaction between the two 
Maf1 domains is a functional one.  
Moreover, the separated mutations D250E, V260D and N344I neither influenced 
growth capacity of relevant yeast cells on glycerol-containing medium (Fig. 33B and 
18D) nor affected repression of Pol III in analogous conditions (Fig. 33A, compare 
lanes 2 and 6; Fig. 33C, compare lanes 1, 2 and 4, 5). Contrary, the double V260D-
N344I mutant that showed a temperature-sensitive growth in glycerol-containing 
medium, was also defected in regulation of tRNA synthesis (Fig. 33A, compare lanes 
3, 7 and 18B).  
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Figure 32. Regulation of Pol III transcription and growth is impaired by the K35E mutation in 
region encoding A domain and restored by second-site suppressor mutations in the BC domain 
of MAF1. maf1∆, K35E-maf1, K35E-D250E-maf1 and K35E-V260D-N344I-maf1 mutants (harbored on 
a plasmid) and isogenic wild type strain YPH500 maf1∆ strain transformed with pRS315-MAF1 
plasmid (WT) were used. A. Cells were grown to exponential phase in glucose medium (YPD) at 30ºC, 
then transferred to glycerol medium (YPGly) and incubated at 37ºC for 1.5 h. Total RNA isolated from 
cells was tested by Northern blotting with pre-tRNALeu and tRNAPhe probes. B. Ten-fold serial dilutions 
of cells grown to exponential phase in glucose medium were plated on glucose medium (YPD) and 
incubated at 30ºC or on glycerol medium (YPGly) and incubated at 37ºC for 2-3 days.  
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Figure 33. Regulation of Pol III transcription is correlated with growth of mutants originating 
from suppressor strains. Mutations were generated in the BC domain of Maf1 in the context of the 
wild type A domain. Double mutations V260D-N344I impaired regulation of tRNA synthesis and 
growth of yeast on glycerol-containing medium, whereas single mutation D250E (A) V260D and N344I 
(C) showed no effect. Cells were grown to exponential phase in YPD glucose medium at 30ºC (Exp), 
then transferred to glycerol YPGly medium and incubated at 37ºC for 1.5 h. Total RNA isolated from 
cells was tested by Northern blotting with pre-tRNALeu and tRNAPhe probes. (B,D) Ten-fold serial 
dilutions of cells grown to exponential phase in glucose medium were plated on glucose medium (YPD) 
and incubated at 30ºC or on glycerol medium (YPGly) and incubated at 37ºC for 2-3 days. 
 
•  Suppressor mutations overcome the defect in dephosphorylation of Maf1 
mutated in A domain.  
As shown before, phosphorylation of Maf1 precluded Pol III repression when  
S. cerevisiae cells were grown on glucose medium (Towpik et al., 2008). Transfer of 
yeast cells to a nonfermentable carbon source resulted in Maf1 dephosphorylation, 
import of Maf1 into the nucleus and inhibition of tRNA synthesis (Ciesla et al., 
2007).  
As the phosphorylation and subsequent dephosphorylation of Maf1 is linked to 
the regulation of Maf1 activity , I have studied this phenomena in Maf1 mutated in 
A domain (K35E-maf1), identified suppressor mutants (K35E-D250E-maf1 and 
K35E-V260D-N344I-maf1) and Maf1 mutated in the BC domain with D250E, 
V260D, N344I and V260D-N344I mutations separated from initial mutation K35E. 
Differentially phosphorylated forms of Maf1 were resolved by SDS-PAGE and 
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identified by immunoblotting at various times after culture transfer from glucose to 
glycerol medium (Fig. 34).  
As reported previously, wild type Maf1 was quickly dephosphorylated upon this 
transition. Remarkably, the K35E mutation in A domain appeared to preclude the 
dephosphorylation of Maf1. Significantly suppressor mutations, restoring the 
capability of Maf1 to repress Pol III, K35E-D250E (pLM11) and K35E-V260D-N344I 
(pLM12) re-established rapid dephosphorylation of Maf1 following transfer from 
glucose to a nonfermentable carbon source (Fig. 34A). Maf1 dephosphorylation in 
the suppressor mutants was only a little slower than in the wild type strain. The 
relative ratio between phosphorylated and nonphosphorylated form of Maf1 
normalized to that observed in exponential growth phase for each strain supplied 
underneath the pictures shows approximate speed of Maf1 dephosphorylation in 
mutants strains (quantification is shown in supplementary material - Table S6).  
 
Figure 34. Mutations altering Maf1 dependent Pol III repression affect kinetics of Maf1 
dephosphorylation upon transfer of S. cerevisiae cells from glucose to medium containing 
glycerol. A. K35E-maf1, K35E-D250E-maf1 and K35E-V260D-N344I-maf1 mutant strains and 
isogenic YPH500 maf1∆ strain transformed with pRS315-MAF1 plasmid (WT) were grown to 
exponential phase in YPD glucose medium (Exp), then transferred to glycerol YPGly medium, 
incubated at 37ºC and harvested as indicated. Cell crude extracts were subsequently analyzed by 
SDS-PAGE with a modified acrylamide:bisacrylamide ratio followed by immunoblotting with polyclonal 
anti-Maf1 antibodies. The slower migrating diffuse bands correspond to phosphorylated forms of Maf1. 
B. D250E-maf1, V260D-maf1, N344I-maf1 mutants originating from identified suppressor mutants 
were constructed in the BC domain of Maf1 in the context of the wild type A domain. Yeast cells were 
subjected to analogous analysis as described above. Double V260D-N344I mutations precluded 
dephosphorylation of Maf1 upon transfer of yeast to glycerol medium, whereas single D250E, V260D 
and N344I mutations showed no effect. Values below each lane indicate the relative ratio between 
phosphorylated and nonphosphorylated Maf1 form normalized to Exp. Quantification is supplied in 
Table S6-S7. 
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Interestingly, double V260D-N344I mutation in context of wild type A domain 
visibly delayed Maf1 dephosphorylation upon transfer of S. cerevisiae to glycerol 
medium (Fig. 34B, quantification is shown in supplementary Table S7) in 
correlation to observed previously defect in growth on glycerol medium and inability 
to repress Pol III after transition to nonfermentable carbon source. In opposite 
separated mutations D250E, V260D and N344I showed dephosphorylation as rapid 
and efficient as WT strain that corresponds to the WT growth phenotype and 
nondefected repression of Pol III.  
• Suppressor mutations recover defected cellular transport of Maf1 mutated 
in A domain. 
Immunofluorescence microscopy indicates that the wild type Maf1 is visible 
through all cell during exponential phase of growth in glucose medium. Subsequent 
transfer to glycerol medium causes accumulation of fluorescence signal in nucleus 
in correlation with Maf1 nuclear activity towards RNA Pol III repression (Fig. 35A).  
In single point A domain mutant (K35E-maf1) Maf1 is distributed in exponential 
phase through all cell. Transfer of yeast cells to glycerol-containing medium causes 
translocation of K35E-maf1 to nucleus but its transport is visibly impaired 
comparing to the wild type Maf1. After 2 hours of incubation in medium with 
glycerol there is almost 3 times less cells with K35E-maf1 located in nucleus (29%) 
in comparison to wild type cells (84%) (Fig. 35B). It might be related to the 
observation of impaired dephosphorylation of K35E-maf1 mutant. The fluorescence 
signal of Maf1 in suppressor mutants (K35E-D250E-maf1 and K35E-V260D-N344I-
maf1) follows Maf1 localization in wild type cells (Fig. 35A) but the percentage 
amount of cells with nuclear Maf1 in suppressors is slightly lower than in wild type 
strain (67% and 61% respectively) comparing to wild type cells (84%) (Fig. 35B). 
Observed dissimilarity could be related to the slight delay in Maf1 
dephosphorylation in suppressor mutants in comparison to wild type Maf1. 
Detailed quantification of cells with nuclear and cytoplasmatic localization of 
mutated Maf1 (K35E-maf1, K35E-D250E-maf1 and K35E-V260D-N344I-maf1) in 
exponential growth phase and after transition to glycerol-containing medium is 
presented in supplementary Table S8. 
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Figure 35. Defect in cellular transport of Maf1 mutated in A domain is abolished by suppressor 
mutations in the BC domain. A. K35E-maf1, K35E-D250E-maf1 and K35E-V260D-N344I-maf1 
mutants and isogenic WT (YPH500 maf1∆ strain transformed with pRS315-MAF1 plasmid) were grown 
to exponential phase in YPD glucose medium (Exp), then transferred to glycerol YPGly medium, 
incubated at 37ºC for 2 hours. Cells were harvested as indicated. Maf1 localization was analyzed by 
immunofluorescence microscopy using polyclonal anti-Maf1 antibodies. Nuclei were stained with 4’,6-
diamidino-2-phenylindole (DAPI). B. Graph presents average quantity of cells with nuclear localization 
of Maf1 in cells incubated in glucose containing medium and subsequently transferred to glycerol 
medium (Quantity estimated in two independent experiments). In WT strain upon transfer to glycerol 
medium Maf1 is enriched in nucleus (84%). K35E-maf1 strain presents defect in nuclear transport of 
Maf1 (29%), K35E-D250E-maf1 and K35E-V260D-N344I-maf1 mutant suppressor strains present 
recovery of Maf1 nuclear transport (67%, 61% respectively). Detailed quantification is presented in 
Table S8. 
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2.1.3 Summary 
 
The mutations localized in the BC domain of Maf1, that compensate defect 
caused by K35E mutation in A domain, were identified. Obtained suppressor 
mutants K35E-D250E-maf1 and K35E-V260D-N344I-maf1 were characterized due 
to cellular functionality. In opposite to initial K35E-maf1 mutant, these suppressors 
are able to repress Pol III transcription during transition from glucose to glycerol-
containing medium in correlation to suppression of the thermosensitive growth 
phenotype. Observed suppression is correlated with Western blotting analysis 
revealing recovery of WT dephosphorylation of Maf1 in suppressor mutants contrary 
to constantly phosphorylated Maf1 in K35E-maf1 mutant. Moreover, presence of 
suppressor mutations in the BC domain recovers defect of transport from 
cytoplasm to nucleus of K35E mutated Maf1 as established by immunofluorescence 
microscopy. Taken together, these results indicate that Maf1 mutated in A domain 
is defected in its activity unless additional mutations in the BC domain occur. That 
clearly shows the genetic interaction between Maf1 domains.  
2.2. Physical interaction between evolutionarily conserved regions – A 
and BC domains of S. cerevisiae Maf1. 
 
To investigate further if the genetic interaction between domains of S. cerevisiae 
Maf1 appears as a physical contact of two domains, resembling H. sapiens Maf1 
domains interaction, an analysis based on yeast-two-hybrid system (Y2H) has been 
performed. As the boundaries of the A and BC domains of S. cerevisiae Maf1 are not 
defined, I have performed a secondary sequence analysis to identify structures that 
could be involved in supposititious interaction of Maf1 domains 
The Hydrophobic Cluster Analysis (HCA) (http://smi.snv.jussieu.fr/hca/hca-
form.html) is a tool to investigate protein folding that uses two-dimensional (2D) 
helical representation of protein sequences in order to identify possible hydrophobic 
cores formed by several residues (Callebaut et al, 1997). The HCA analysis revealed 
the presence of two regions rich in hydrophobic cores corresponding to the A and 
BC domains of S. cerevisiae Maf1 (Fig. 11, “Introduction”). Between them a region 
poor in hydrophobic residues was found which, according to the alignment of Maf1 
eukaryotic sequences, corresponds to the linker region between the A and BC 
domains. Similar analysis in human Maf1 revealed the same organization of two 
clusters of hydrophobic cores separated by a short region free of hydrophobic 
clusters. These domains of Maf1 correspond to the two fragments resistant to mild 
proteolysis and that interact together as shown by pull-down and size-exclusion 
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chromatography (Fig. 15, “Introduction”, results obtained by Christoph Müller’s 
group in EMBL Heidelberg, Appendix 1).  
Supported on potential tertiary structures predictions by HCA, 8 different 
constructs encoding A domain (aa: 1-42, 1-57, 1-59, 1-77, 1-79, 1-91, 1-111, 1-
172) and 4 encoding the BC domain (aa: 165-349, 165-367, 196-349, 196-367) of 
Maf1 have been designed (Fig. 36). A two series of plasmids for Y2H carrying 
fusions of sequence encoding several parts of the Maf1 A and BC domains with 
sequence encoding respectively Gal4 binding domain (pAS2-Maf1-A, pAS2-Maf1-
BC) and Gal4 activating domain (pACT2-Maf1-A, pACT2-Maf1-BC) have been 
created (Fig. 36). These constructs were co-expressed in the yeast reporter strain 
Y190. Interactions between fusion proteins should result in activation of the β-
galactosidase and histidine (HIS3) auxotrophy reporter genes. Using this approach, 
I have found a physical interaction between the BC domain of Maf1 encoded by all 
tested plasmids pAS2-Maf1-BC and fragments of A domain of Maf1 encoded by all 
plasmids pACT2-Maf1-A. Reciprocal interactions were impossible to study because 
the presence of pAS-Maf1-A activates reporter genes in the absence of a pACT2 
fusion.  
Figure 36 presents results of β-galactosidase overlay plate assay for  pACT2-
Maf1A(1-42) and pAS2-Maf1BC(196-349) evaluating the interaction observed in all 
tested combinations. The β-galactosidase activity for presented pair of the Maf1 A  
(1-42 aa) and the BC domain (196-349 aa) fragments generated in presence of Gal4 
activating domain and Gal4 binding domain respectively (pACT2-Maf1A(1-42) and 
pAS2-Maf1BC(196-349)) with respective pairs of negative controls (pACT2-Maf1-
A(1-42) with empty pAS2 and pAS2-Maf1-BC(196-349) with empty pACT2) and 
positive control (plasmids encoding τ95/τ55, two TFIIIC subunits – pair of known 
interactors) (Manaud et al., 1998) has been measured in β-galactosidase activity 
liquid assay. Both negative controls showed no detectable β-galactosidase activity 
(Fig. 36). In contrast β-galactosidase activity, in case of plasmids expressing 
fragments of Maf1 domains the interaction observed was almost 5 times higher 
than this observed in positive control - τ95/τ55, two TFIIIC subunits, which 
indicates a strong and direct interaction between the A and BC domains of Maf1  
(Fig. 36).  
Apart from β-galactosidase activity overlay plate assay, presented interaction 
was confirmed by test of auxotrophy for histidine. Y190 strain co-expressing  
pACT2-Maf1-A(1-42) and pAS2-Maf1-BC(196-349) and both negative and positive 
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controls were replica plated on selective medium containing no histidine (-His) 
supplied with 10 mM 3 aminotriazole (3-amino-1,2,4-triazole). 
3 aminotriazole is a competitive inhibitor of HIS3 gene product blocking 
histidine synthesis pathway. In presence of 3 aminotriazole, only high affinity 
binding between two tested proteins activates enough transcription of HIS3 gene to 
a level that impaires the competitive inhibition and enables S. cerevisiae cells to 
grow. In this conditions only Y190 yeast cells expressing pair of pACT2-Maf1-A(1-
42) and pAS2-Maf1-BC(196-349) and τ95/τ55 TFIIIC subunits grown efficiently 
(Fig. 36). 
Furthermore, no interaction of pAS2 full-length Maf1 with both the pACT2-
Maf1-full-length and pACT2-Maf1-A was observed.  
 
 
Figure 36. The A and BC domains of Maf1 physically interact. Yeast-two-hybrid system (Y2H) 
reveals interaction of all tested fragments of A domain of Maf1 encoded by: pACT2-Maf1-A(1-42), 
pACT2-Maf1-A(1-57), pACT2-Maf1-A(1-59), pACT2-Maf1-A(1-77), pACT2-Maf1-A(1-79), pACT2-Maf1-
A(1-91), pACT2-Maf1-A(1-111) and pACT2-Maf1-A(1-172) with all tested fragments of the BC domain 
of Maf1 encoded by pAS2-Maf1-BC(165-349), pAS2-Maf1-BC(165-367), pAS2-Maf1-BC(196-349) and 
pAS2-Maf1-BC(196-367). Plasmids were transformed individually together with pAS2 (control plasmid 
for pACT2-Maf1-A) or pACT2 (control plasmid for pAS2-Maf1-BC) and reciprocally in all combinations 
into yeast reporter strain Y190. Transformants were assayed for β-galactosidase expression using 
overlay plate assay. As an example presented interaction between pACT2-Maf1-A(1-42) and pAS2-
Maf1-BC(196-349) and respective negative controls with empty plasmid pACT2 and pAS2 and positive 
control of known interactors (τ95/τ55, two TFIIIC subunits) (Manaud et al., 1998). Interaction 
confirmed by test for histidine (His) auxotrophy with 10 mM 3-aminotriazol (3-amino-1,2,4-triazole), 
an inhibitor of His3. β-galactosidase activity units with standard deviation, obtained in β-galactosidase 
liquid assay for presented interactions are indicated. 
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Importantly pAS2-Maf1-BC was also negative tested with pACT2-Maf1-BC (data not 
shown). These results demonstrate the specificity of the two-hybrid interaction 
between Maf1 domains. 
Taken together, results as described above suggest a strong, direct interaction of 
the A and BC domains of S. cerevisiae Maf1. 
2.2.1 Minimal fragment of A domain of Maf1 involved in interaction 
with BC domain. 
 
Since all tested fragments of A domain exhibited strong interaction with tested 
fragments of the BC domain of Maf1, an effort to minimize the region of A domain 
involved in observed interaction has been made. Bioinformatic analysis of the A 
domain with the usage of a protein structure prediction software (PSIPRED v 2.6) 
(http://bioinf4.cs.ucl.ac.uk:3000/psipred/) (Bryson et al., 2005) identified two  
α-helices (aa: 7-16 and 40-56) separated by two adjacent β-strands (aa: 24-27 and 
29-35) (Fig. 37). The minimal part of A Maf1 domain involved in observed 
interaction was 1-42 aa in the previously described interaction. According to 
PSIPRED analysis the shorter fragments of A domain with broken β-strand 
structure (aa: 1-39, 1-34, 1-23 and 1-16) and first α-helice structure (1-12 aa) have 
been designated (Fig. 37). 
The putative BC domain of S. cerevisiae Maf1 (196-349 aa) fused to the DNA-
binding domain of Gal4 was co-expressed with every single shortened version of A 
domain fused to the Gal4 activation domain in the yeast reporter strain Y190. Using 
this approach, I have observed a physical interaction between the BC domain of 
Maf1 encoded by plasmid pAS2-Maf1-BC(196-349) and fragments of A domain of 
Maf1 encoded by plasmids pACT2-Maf1-A(1-42), pACT2-Maf1-A(1-39) and pACT2-
Maf1-A(1-34) (Figure 38). The BC domain failed to interact with shorter fragments 
of A domain encoded by pACT2-Maf1-A(1-12), pACT2-Maf1-A(1-16) or pACT2-Maf1-
A(1-23). Cells containing the pair pAS2-Maf1-BC and empty pACT2 had no 
detectable β-galactosidase activity (0.1 +/- 0 units). Either the pair pACT2-Maf1-A 
and empty pAS2 did not activated reporter gene (0.3 +/- 0.1 units). (data not shown 
in the figure). 
A Western blotting analysis was used with anti-HA antibodies to determine the 
relative expression levels of the short versions of A domain cloned in pACT2-Maf1-A 
that are HA-tagged. All fusions were expressed (Fig. 39) indicating that observed fail 
in interaction of aa: 1-23, 1-16 and 1-12 fragments of A domain is not abolished 
due to lack of their expression. The levels of aa: 1-42 and 1-23 fusions were little 
higher then others, but this difference was not significant for interaction  
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Figure 37. Secondary structure prediction of Maf1 protein. PSIPRED v 2.6 protein structure 
prediction software was used to identify secondary structure of S. cerevisiae Maf1 protein. Only A 
domains is presented. Green tube (or H letter), yellow arrow (or E letter) or black line (or C letter) 
represent alpha helix, beta strand or coil, respectively. 
 
 
Figure 38. Determination of the minimal fragment of the A domain responsible for interaction 
with the BC domain. pACT2-Maf1-A(1-12), pACT2-Maf1-A(1-16), pACT2-Maf1-A(1-23), pACT2-Maf1-
A(1-34), pACT2-Maf1-A(1-39) and pACT2-Maf1-A(1-42) plasmids were transformed individually 
together with pAS2 (control plasmid) or pAS2-Maf1- BC(196-349) plasmids into yeast strain Y190. 
Transformants were assayed for β-galactosidase expression using overlay plate assay. The relative 
levels of β-galactosidase activity measured in liquid assay were respectively: 170 +/- 6, 322 +/- 61, 
161 +/- 37 units for interacting with the BC domain fragments of the A domain (aa: 1-42, 1-39 and 1-
34) and respectively: 0, 11, 4 units for not interacting with the BC domain fragments of the A domain 
(aa: 1-23, 1-16 and 1-12). 
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Figure 39. Expression of the truncated versions of Maf1 A domain fused to Gal4 Activating 
domain determined by Western blotting with HA-specific antibodies. (-) – empty pACT2 plasmid.  
 
with the BC domain (there are no relationship between expression level and  
β-galactosidase activity as compared to results presented in Figure 38). 
The attempt to minimize the Maf1 A domain identified 1-34 aa as the smallest 
fragment still enabling interaction with the domains. Thus let hypothesize that the 
interaction between the A and BC domains requires the first α-helix and two 
adjacent β-strands of the A domain. 
2.2.2 The physical interaction between Maf1 domains is required for  
Pol III repression. 
• Mutations identified in mutant and suppressor strains affects the 
interaction between A and BC domains. 
As the Pol III regulation is defective in the presence of Maf1 mutated in the A 
domain (K35E) and recovered by the presence of additional suppressor mutations in 
the BC domain (D250E, V260D-N344I), an attempt to check possible influence of 
identified mutations on the physical interaction between the Maf1 A and BC 
domains was studied. The effects of K35E, D250E, V260D, N344I and double 
V260D-N344I mutations identified in the mutant and suppressor strains were 
studied by using the Y2H approach.  
The respective mutations were generated (see Materials and Methods) in the 
Maf1 A domain fragment fused to the Gal4 activation domain in the pACT2-Maf1-
A(1-42) plasmid and the Maf1-BC domain fused to the DNA-binding domain of Gal4 
in pAS2-Maf1-BC(196-349) (Fig. 40). Various combinations of plasmids, one 
encoding a wild type Maf1 domain and the other with a mutated domain, both 
fused to the respective Gal domains, were co-expressed in the yeast reporter strain 
Y190 followed by determination of β-galactosidase activity liquid assay (Fig. 41). 
 
The K35E mutation of A domain reduced the two-hybrid interaction with the 
wild type BC domain by ca. 40 % (Fig. 41, compare lanes 2 and 1). Similarly, both 
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the single D250E and the double V260D-N344I mutations in the BC domain 
decreased the interaction with wild type A domain by 22 and 62 %, respectively 
(Fig. 41, comparelanes 7 and 8 with lane 1). Confirming the genetic suppressor 
results, a combination of mutated Maf1 domains K35E-D250E and K35E-V260D-
N344I restored their interaction (Fig. 41, compare lanes 3 and 4 with lane 1). 
Rather unexpectedly, the strongest level of two-hybrid interaction, 80% over the 
wild type one, was observed for the combination of the K35E A domain and the BC 
domain with a single V260D mutation (Fig. 41, compare lane 5, with lane 1). 
Furthermore its interaction with the wild type A domain was decreased by almost 
60% (Fig. 41, compare lanes 1 and 9). This indicated that in the double suppressor 
mutations V260D-N344I, identified in genetic screen, the former one is in fact 
sufficient to restore the interaction with K35E A domain while N344I seemed to 
have a minor effect (Fig. 41, lanes 6 and 10). 
Detailed results of β-galactosidase activity liquid assay and values of enzyme 
activity are presented in Table S9. 
Presented Y2H results shows that K35E mutation in A domain disrupts the 
intramolecular interaction between Maf1 domains. Combination of mutated Maf1 
domains restores their interaction and clearly shows that the interaction between 
Maf1 domains is necessary for its activity as a Pol III repressor. 
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Figure 40. Combinations of plasmids co-expressed in yeast reporter strain Y190 to verify the 
effect of identified in mutant (K35E) and suppressor strains (D250E, V260D, N344I and V260D-N344I) 
mutations on the interaction between the A and BC domains of Maf1.  
 
 
Figure 41. Two-hybrid interaction of Maf1 domains is impaired by primary mutations in these 
domains and restored by second-site suppressor mutations. A. pACT2-Maf1-A(1-42) plasmid and 
its mutated version were transformed individually with pAS2-Maf1- BC(196-349) plasmid or its 
mutated versions in yeast strain Y190. Transformants were assayed for β-galactosidase expression. 
Presented profile compares following two-hybrid interactions: wild type A and BC domains of Maf1 (1), 
mutated A domain K35E with wild type BC domain (2); mutated A domain K35E with four versions of 
mutated BC domain: D250E (3), V260D-N344I (4), V260D (5), N344I (6), and wild type A domain with 
mutated BC domain containing single D250E, V260D or N344I and double N344I-V260D mutations 
(7-10). B. Scheme of Maf1 domain interaction. Detailed values of β-galactosidase activity presented in 
Table S9. 
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3. Analysis of protein interactions involving evolutionarily 
conserved regions – A and BC domains of S. cerevisiae 
Maf1. 
 
S. cerevisiae Maf1 was found to interact with the largest subunit of Pol III 
enzyme (C160). Observed interaction has an either genetic or physical form. 
Primarily it was shown that N-terminal part of C160 (1-235 aa) encoded on 
multicopy plasmid suppress thermosensitive phenotype of maf1-1 mutant on 
glycerol-containing medium (Boguta et al., 1997). Furthermore mutations in 
RPC160 gene encoding C160 were identified as spontaneous suppressors of maf1-1 
and maf1∆ (Pluta et al., 2001).  
Finally, the physical interaction between N-terminal part of C160 and Maf1 was 
revealed by „pull-down” assay (Oficjalska-Pham et al., 2006). 
In human cells, similarly to yeast cells, an analogous interaction between Maf1 
and the largest subunit of Pol III (C160) and Brf1 (subunit of transcription factor 
TFIIIB required to tRNA synthesis) was identified. Moreover, it was shown that 
Rpc1, the largest Pol III subunit (S. cerevisiae C160 ortholog) and Brf1 interact with 
different regions of Maf1. It was postulated that the A domain of H. sapiens Maf1 is 
responsible for interaction with Rpc1 Pol III subunit while the BC domain is 
necessary for interaction with Brf1 (Reina et al., 2006).  
According to this data, an effort to establish an interaction between S. cerevisiae 
Maf1 and C160 Pol III with the yeast-two-hybrid system (Y2H), has been made in 
the laboratory of Magdalena Boguta several years ago. These attempts have ended 
with no success.  
The novel data presented in this study upon the importance of the A and BC 
domains interaction aroused a hypothesis, that the negative result of preceding 
investigations, was a consequence of improper protein conformation precluding 
revealing of the interaction. Supported on data obtained upon H. sapiens Maf1 
(Reina et al., 2006) several parts of the S. cerevisiae Maf1 A and BC domains have 
been tested in Y2H for possible interaction with full-length C160 and N-terminal 
part (1-235 aa) of C160.  
In spite of such a strong data referring to Maf1 interaction with C160 Pol III 
subunit, an attempt to reveal region of S. cerevisiae Maf1 responsible for this 
interaction failed in all tested combinations.  
The possible interaction of S. cerevisiae Maf1 (either complete protein or 
fragments of the Maf1 A and BC domains) with Pol III apparatus has been 
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subsequently tested by Y2H either. Performed study also failed to reveal interaction 
between tested parts of S. cerevisiae Maf1 and Pol III holoenzyme subunits.  
Tested combinations of plasmids encoding fusions of Gal4 activating domain or 
Gal4 binding domain with relevant sequences encoding either Maf1 domains or 
components of Pol III apparatus shown in Table 7 and Table 8 were tested by  
β-galactosidase overlay plate assay. 
 
Table 7. Plasmids negatively tested in yeast-two-hybrid system in attempt to detect interaction 
between Maf1 and Pol III apparatus subunits or other proteins. Presented plasmids harbor fusions 
of sequence encoding Gal4 activating domain (AD) with sequences encoding Pol III apparatus 
components and partner plasmids harboring fusions of sequence encoding Gal4 binding domain (BD) 
with sequence encoding different parts of the Maf1 BC domain. All combinations of Gal4 AD fusion 
protein and Gal4 BD fusion protein were tested. 
 
Gal4 AD 
Pol III apparatus 
Gal4 BD 
Maf1 fragments 
pACT-TFIIIA pAS2-Maf1-BC(165-349) 
pACT-TFIIIB70 pAS2-Maf1-BC(165-367) 
pACT-TFIIIB90 pAS2-Maf1-BC(196-349)  
pGA-TBP pAS2-Maf1-BC(196-367) 
pACT-Tau138  
pACT-Tau131  
pACT-Tau95  
pACT-Tau91  
pACT-Tau60  
pACT-Tau55  
pGA-C128  
pACT-C82  
pGA-C53  
pGA-AC40  
pGA-C34  
pACT-C31  
pGA-ABC27  
pACT-C25  
pACT-ABC23  
pGA-AC19  
pACT-C17  
pGA-ABC14,5  
pACT-C11  
pACT-ABC10α  
pGA-ABC10β  
pGAD424-C160  
pGAD424-NTF-C160  
pGA-C160  
Other proteins  
pACT-Sub1  
pACT-Maf1  
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Table 8. Plasmids negatively tested in yeast-two-hybrid system in attempt to detect interaction 
between Maf1 and Pol III apparatus subunits or other proteins. Presented plasmids harbour 
fusions of sequence encoding Gal4 binding domain (BD) with sequence encoding Pol III apparatus 
components and partner plasmids harbouring fusions of sequence encoding Gal4 activating domain 
(AD) with sequence encoding different parts of the Maf1 A and BC domains. All combinations of Gal4 
AD fusion protein and Gal4 BD fusion protein were tested. 
 
Gal4 BD 
Pol III apparatus 
Gal4 AD 
Maf1 fragments 
pAS-TFIIIA pACT2-Maf1-A(1-42) 
pAS-TFIIIB70 pACT2-Maf1-A(1-57) 
pAS-TFIIIB90 pACT2-Maf1-A(1-59) 
pAS-TBP pACT2-Maf1-A(1-77) 
pAS-Tau138 pACT2-Maf1-A(1-79) 
pAS-Tau131 pACT2-Maf1-A(1-91) 
pAS-Tau95 pACT2-Maf1-A(1-111) 
pAS-Tau91 pACT2-Maf1-A(1-172) 
pAS-Tau60 pACT2-Maf1-BC(165-349) 
pAS-Tau55 pACT2-Maf1-BC(165-367) 
pAS-C128 pACT2-Maf1-BC(196-349)  
pAS-C82 pACT2-Maf1-BC(196-367) 
pAS-C53  
pAS-AC40  
pAS-C37  
pAS-C31  
pAS-ABC27  
pAS-C25  
pAS-AC19  
pAS-C17  
pAS-ABC14,5  
pAS-C11  
pAS-ABC10α  
pMA-ABC10β  
pGBT9-C160  
pGBT9-NTF-C160  
pAS-C160  
Other proteins  
pAS-Sub1  
pAS-Maf1  
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IV. DISCUSSION 
1. Interaction between A and BC domains is important for the 
function of Maf1. 
 
The family of all eukaryotic Maf1 share highly conserved amino acid sequence 
with easily recognizable two regions called the A and BC domains. This study is the 
first report relating Maf1 structure to RNA polymerase III (Pol III) transcription 
inhibition in S. cerevisiae. Importantly, the interaction between two Maf1 domains 
is required for its activity as a repressor of Pol III transcription.  
The results of limited proteolysis of H. sapiens Maf1 performed in the laboratory 
of Christoph Műller (supplementary data; Appendix 1) resulted in two stable 
fragments (aa: 1-45 and 75-234) corresponding to the evolutionarily conserved A 
and BC domains. Size-exclusion chromatography of these proteolytic fragments 
corresponding to the two domains, showed their co-elution. Similar fragments were 
co-expressed in bacteria, and have been shown to co-purify and co-migrate during 
size-exclusion chromatography as soluble complex. In contrast, an additional 
construct - 82-236 aa fragment, which included the C-terminal acidic tail eluted as 
soluble aggregate when expressed in the absence of the N-terminal fragment - 1-45 
aa (Gajda et al., 2010). These results suggested that H. sapiens Maf1 A and BC 
domains form modules that do not fold independently but rather need to be co-
expressed to form a stable and soluble entity. On the other side, the connecting 
linker (46-74 aa) and the C-terminal acidic tail (235-256 aa) appear to be solvent-
exposed and unstructured.  
Considering the high conservation of Maf1 in eukaryotes, the domain interaction 
and their functional role was probed in a model organism - yeast Saccharomyces 
cerevisiae.  
Using the yeast-two-hybrid system, I have confirmed the physical interaction 
between the A and BC domains of Maf1 in S. cerevisiae and identified the first 34 
residues as the shortest fragment of the A domain sufficient for interaction with the 
BC domain. Lack of interaction between further truncated fragments of the A 
domain (aa: 1-12, 1-16 or 1-23) with the BC domain shows the specificity of the 
method used and emphasizes the importance of structural features of the A domain 
for its interaction with the BC domain. 
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Figure 42. Secondary structure prediction of Maf1 protein. PSIPRED v 2.6 protein structure 
prediction server was used to identify secondary structure of S. cerevisiae Maf1 protein and H. sapiens 
Maf1. Only A and BC domains are presented. Green tube (or H letter), yellow arrow (or E letter) or 
black line (or C letter) represent alpha helix, beta strand or coil, respectively. Positions of K35E, 
D250E, V260D and N344I mutations in S. cerevisiae Maf1 amino acid sequence are indicated by a red 
cross. Relevant mutations in H. sapiens Maf1 indicated either.  
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Bioinformatic analysis using the protein structure prediction server (PSIPRED v 
2.6) (Jones, 1999; Bryson et al., 2005) provided further support for the study of 
Maf1 domains.  
In A domain, two α-helices (aa: 7-16 and 40-56 – in S. cerevisiae) separated by 
two adjacent β-strands (aa: 24-27 and 29-35 – in S. cerevisiae) are predicted, while 
for the BC domain five α-helices and concomitant four β-strands are predicted  
(Fig. 42). No secondary structure elements are predicted for the linker region.  
The identified 1-34 aa part of the Maf1 A domain, the smallest fragment still 
enabling interaction with the BC domain lead to hypothesis that the interaction 
between domains A and BC requires the first α-helix and two adjacent β-strands 
(Fig. 42).  
The results of yeast-two-hybrid system show that the A and BC domains of  
S. cerevisiae Maf1 together form a stable complex.  
The identified mutant in A domain - K35E-maf1 as described in this study was 
defective in its ability to repress pre-tRNA synthesis upon transfer to glycerol 
medium. Thus the single missense mutation within the Maf1 A domain precluded 
Pol III repression in K35E-maf1 strain in accordance to growth defect observed on 
glycerol-containing medium at 37ºC. Notably, the K35E mutation that precluded  
Pol III repression is located at the end of the second β-strand of the A domain  
(Fig. 42) and just after the smallest fragment (1-34 aa) still enabling interaction with 
the BC domain. 
One approach to confirm that the K35E mutation negatively affects the 
interaction with the BC domain of Maf1 was to identify second-site mutations that 
compensate for the observed defects. Therefore a screen for second-site suppressor 
mutations within the BC-encoding region of MAF1 that allowed K35E-maf1  
S. cerevisiae cells to grow on glycerol medium at 37ºC has been performed. The BC 
domain of ScMaf1 is located between aa: 231 and 338 (size: 108 aa). The 
mutagenesis encompassed a region of 202 aa located between aa: 174 and 375 as 
indicated in the “Results” part so noticeably larger than the BC domain. The 
identification of suppressor mutations in the BC domain by PCR Random 
Mutagenesis was thus not sure. The localization of single D250E and combined 
V260D-N344I mutations, isolated suppressors of K35E mutation in A domain, in 
the BC domain strongly supports the interaction between these domains (Fig. 42). 
The increased growth capacity of the suppressors on glycerol medium was due 
to a compensation of the defect in Pol III regulation observed for the K35E 
mutation. As determined by Northern blotting, the suppressor mutations restored 
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the ability to repress pre-tRNA synthesis upon transfer from glucose to glycerol 
medium. These results indicate that the detected genetic interaction between the 
two Maf1 domains is a functional one. 
Moreover, K35E mutation in A domain appeared to preclude the 
dephosphorylation of Maf1 following transfer from glucose to a nonfermentable 
carbon source. Significantly, the suppressor mutations D250E and V260D-N344I 
re-established rapid dephosphorylation of Maf1 following transfer from glucose to a 
nonfermentable carbon source. The similar effect was observed for cellular 
localization of Maf1 in mutant strains. K35E mutation visibly impaired transport of 
Maf1 to nucleus upon transition to nonfermentable carbon source while presence of 
suppressor mutations recovered transport of mutated Maf1 to nucleus. 
Moreover, as shown by the two-hybrid system, the K35E mutation reduced the 
interaction between the A and BC Maf1 domains by 40%. In support of structural 
and/or functional interactions between the Maf1 domains, isolated second-site 
suppressor mutations within the BC domain that compensated for the defect 
caused by the K35E mutation in A domain also reconstituted the physical 
interaction between the A and BC domains of Maf1. All these results indicated that 
the genetic interaction identified between Maf1 domains corresponds to a physical 
interaction indispensable for the Maf1 function. 
The significance of reconstitution of Maf1 function by suppressor mutations 
support the results of analogous investigation upon separated mutations D250E, 
V260D and N344I originally found in suppressor mutants that have been generated 
in absence of K35E mutation.  
The double V260D-N344I-maf1 mutant was temperature-sensitive as K35E-
maf1 and growth of D250E-maf1, V260D-maf1 or N344I-maf1 strains was 
comparable to wild type. In accordance with growth phenotypes, Northern analysis 
have shown a defect in regulation of tRNA synthesis in V260D-N344I-maf1 mutant 
transferred to glycerol medium whereas repression in D250E-maf1, V260D-maf1 or 
N344I-maf1 mutants was comparable to that observed in wild type.  
Concomitant Western analysis have shown Maf1 dephosphorylation in D250E-
maf1, V260D-maf1 or N344I mutants occurring as in wild type cells transferred to 
glycerol medium contrary to V260D-N344I-maf1 double mutant exhibiting severe 
defect in dephosphorylation of Maf1. Interestingly, double V260D-N344I mutation 
in absence of K35E mutation in A domain precluded interaction between domains 
with the surprising major impact of V260D mutation. Residue 260 in the BC 
domain seemed to be crucial for the interaction with A domain. While the V260D 
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BC domain mutant interacted with the K35E A domain mutants (Fig. 42 and 41) 
over 80% stronger in two-hybrid experiment as did the wild type BC domain, its 
interaction with the wild type A domain was decreased by almost 60% (Fig. 41, 
lanes 5 and 9). In opposite D250E and N344I mutations did not have a great impact 
on observed interaction in accordance to no growth and no Pol III repression defect. 
Taken together mutations: D250E, V260D or N344I separately are silent for 
Maf1 function but the junction of both V260D-N344I mutations causes disturbance 
in Maf1 activity.  
Altogether this analysis clearly shows that the observed reconstitution of Maf1 
activity in suppressor mutants is a result of the both mutated Maf1 A and BC 
domains not the separate effect of mutations identified in the BC domain.  
Thus the interaction of A and BC domains greatly facilitates the activity of Maf1 
as a Pol III repressor. 
2. Insights into the Maf1 protein structure. 
 
The Hydrophobic Cluster Analysis (HCA), a tool to investigate protein stability 
and folding, that uses two-dimensional (2D) helical representation of protein 
sequences, to identify possible hydrophobic cores formed by several residues 
(Callebaut et al., 1997) presented in “Introduction” part for both: H. sapiens and  
S. cerevisiae Maf1 similarly revealed the presence of two regions rich in hydrophobic 
cores corresponding to the A and BC domains of Maf1.(Fig. 11). Between them an 
unstructured region deprived of hydrophobic residues was found which, according 
to the alignment of Maf1 eukaryotic sequences (Fig. 11), corresponds to the linker 
region between the A and BC domains, that is consistent with limited proteolysis 
results of Christoph Műller’s group.  
While this study has been being written, the first crystallographic data on the 
structure of H. sapiens Maf1 were reported on the 7th International Biennial 
Conference on RNA Polymerases I and III “OddPols” in June 2010 (Rieke Ringel of 
the Patrick Cramer laboratory, Gene Center Munich). These data are in accordance 
with the results of Christoph Műller’s group devoted to limited proteolysis and to 
obtained bioinformatic data: HCA (Hydrophobic Cluster Analysis) and PSIPRED 
(prediction of secondary structures present in Maf1) that together firmly revealed 
two highly structured regions in Maf1 separated by unstructured linker, 
independently of the organism studied.  
 - 88 - 
As in the Christoph Műller’s group, in Patric Cramer’s laboratory human Maf1 
was subjected to a mild-proteolysis analysis that revealed the presence of two 
structured regions, corresponding to the A and BC domains, linker and an acidic  
C-terminal tail (published very recently on 1st October 2010 by Vannini et al.). 
Human Maf1 has been overproduced without the acidic tail and without the linker 
between the A and BC domains (all the amino acids of the linker and even some 
amino acids of the C-terminus of the A domain). Maf1 crystals have been obtained 
after 2.5 years of effort (a lot of different construction checked) and allowed to 
define a structure at 1.5 Ångström. 
H. sapiens Maf1 is a globular protein with a hydrophobic core of five-stranded 
antiparallel beta-sheet surrounded by one alpha-helix on one side and three helices 
on the other (Vannini et al., 2010). This new structure has no structural homolog so 
it is not possible to predict a function of Maf1 due to this absence of structural 
homolog. A domain is composed of a beta-sheet (in the middle of the structure) and 
an alpha-helix (outside of the structure) (Fig. 43 kindly provided for the purpose of 
this study by Rieke Ringel). The structure of the A domain seems very similar to 
that predict by PSIPRED (compare Fig 43 and 42). 
Since Maf1 domains are highly conserved between H. sapiens and S. cerevisiae 
(with the exclusion of unstructured linker between domains that is absent in 
presented H. sapiens Maf1 structure) it is plausible to transfer the positions of 
mutations identified in S. cerevisiae Maf1 onto the model of H. sapiens Maf1 to 
visualize their predicted influence on Maf1 domains interaction.  
The position of K35E, D250E, V260D and N344I mutations in S. cerevisiae Maf1 
respond to position of K35, D109, S119 and S209 residues in H. sapiens Maf1 
respectively (Fig. 43 and 42). The position of N344I mutation in S. cerevisiae Maf1 
responding to S209 in H. sapiens Maf1 is not indicated since S209 residue belongs 
to the acidic tail region of H. sapiens Maf1, which was excluded to obtain crystals.  
In presented structure of the H. sapiens Maf1, S109 residue should be found in 
close proximity to C-terminal end – 205 aa.  
Interestingly the mutations that were identified in either in A domain single 
point Maf1 mutant disabled in Pol III repression regulation (K35E-maf1) and two 
suppressor Maf1 mutants recovering Maf1 capability to regulate Pol III transcription 
(K35E-D250E-maf1 and K35E-V260D-N344I-maf1) are localized in close proximity 
(but not in contact) supporting their impact on the interaction between Maf1 
domains as evaluated by genetic approach and yeast-two-hybrid system presented 
in this study.  
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Intriguingly, the V260D mutation in S. cerevisiae Maf1 that was reported to have 
a major impact on Maf1 domains interaction, which corresponds to S119 residue in  
H. sapiens Maf1 is positioned closest to K35 residue supporting the results 
obtained in the yeast-two-hybrid system. 
 
 
Figure 43. The crystal structure of H. sapiens Maf1. Structure presented in two views – The one on 
the right rotated by 90 degree. Structure defined at 1.5 Angstrom (Ǻ). The position of amino acid 
residues identified in S. cerevisiae maf1 mutants: K35E, D250E, and V260D indicated as a respective 
residues in H. sapiens MAF1: K35, D109 and S119 (in green). The N344I responding to S209 is absent 
since S209 belongs to acidic tail excluded while crystallization. Last C-terminal residue (Ct) is 205 aa 
(Prepared by Rieke Ringel for the purpose of this study, 2010).  
3. Elucidation of Maf1 as a member of intrinsically disordered 
proteins family. 
 
We used to consider proteins as a stable structures but there might be also 
proteins that although posses a higher structural organisation they also consist of 
large areas of unstructured regions. They play a crucial role in cell lifespan and are 
called intrinsically unstructured proteins (IUPs) (Garza et al., 2009). 
Structurally, intrinsically disordered proteins range from completely 
unstructured polypeptides through extended partially structured forms up to 
compact disordered ensembles containing substantial secondary structure. 
Intrinsically disordered regions are respectively common in nature. Approximately 
 - 90 - 
~50% of eukaryotic proteins likely contain at least one disordered region that 
exaggerate 30 amino acids in length. Furthermore, many proteins are likely to be 
absolutely disordered (e.g. ~20% of eukaryotic proteins are expected to be mostly 
disordered) (Uversky and Dunker, 2008). In budding yeast S. cerevisiae Gsponer et 
al. (2008) assigned all proteins to one of three groups according to their predicted 
levels of intrinsic disorder: highly ordered proteins (0 to 10% predicted disorder), 
moderately disordered proteins (10 to 30% predicted disorder), and highly 
disordered proteins (30 to 100% predicted disorder). S. cerevisiae Maf1 according to 
this classification might be considered as highly disordered protein thus 182 aa 
part of a total sequence (395 aa) states for unstructured linker region between the A 
and BC domains, which is 46% of Maf1 sequence. Intrinsically disordered proteins 
(and regions) are generally enriched in most polar and charged residues and are 
depleted of hydrophobic residues (other than proline) (Uversky and Dunker, 2008). 
What is characteristic for unstructured proteins, is the presence of PEST motives 
(regions rich in proline, glutamic acid, serine and threonine) (Gsponer et al., 2008), 
which is also the observable feature of the linker region of the H. sapiens and  
S. cerevisiae Maf1.  
Proteins with unstructured regions predominantly play role in transducing 
intracellular signals, regulating processes including the cell division cycle, and 
recognizing various binding partners (e.g. ligands, other proteins and nucleic acids). 
Intrinsically unstructured proteins (IUPs) are often reused in multiple pathways to 
produce different physiological effects (Gsponer et al., 2008). Similarly, S. cerevisiae 
Maf1 was demonstrated to play a central role in coupling different signal 
transduction pathways to Pol III transcriptional machinery. Secretory pathway 
defects, nutrient limitation, DNA damage, low nutrients availability, cell growth 
rate, oxidative stress, transition to respiratory metabolism and chemical treatment 
with different drugs influence repression of the Pol III transcription according to the 
Maf1 activity, the one and only Pol III regulator in S. cerevisiae cells known up to 
date.  
Thus it may support the presence of the linker between the A and BC domains 
of Maf1 that although seems to be redundant for Maf1 activity as a Pol III repressor, 
though evolutionarily not conserved, might be part of cellular adaptation of single 
cell organism as yeast, to rapidly changing life conditions. The presence of other 
regulatory proteins of Pol III in higher eukaryota (e.g. tumour suppressors p53; RB, 
retinoblastoma protein and proto-oncogene, c-Myc in H. sapiens) and developed 
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other mechanisms of Pol III regulation in diverse conditions might be explanation 
for the diminished sequence encoding the linker and its possible marginal function.  
Furthermore literature data state that altered abundance of IUPs can result in 
undesirable interactions (e.g. titration of unrelated proteins by inappropriate 
interaction through exposed peptide motives), thereby disturbing the balance of the 
signaling networks leading to dampened or inappropriate activities. It was shown 
that altered abundance of several intrinsically unstructured proteins (IUPs) has 
been associated with perturbed cellular signalling that may lead to uncontrolled 
proliferation of the cells typical for cancer (Gsponer et al., 2008).  
A general feature of transformed and tumour cells is abnormally high rates of 
Pol III transcription. This was initially discovered in mice with myelomas, where Pol 
III was found to be hyperactive (Schwartz et al., 1974). Since then many type of 
tumour cell lines have also been found to overexpress the products of Pol III 
including ovarian and liver carcinomas (Marshall, 2008). H. sapiens Maf1 was 
shown to represses Pol III transcription in vitro and in vivo (Rollins et al., 2007) and 
is required for maximal Pol III repression after exposure to alkylating agent and 
carcinogen - methyl methanesulfonate (MMS) (Reina et al., 2006). Furthermore, 
Johnson et al., (2007) have shown that changes in H. sapiens Maf1 expression 
affect Pol I- and Pol III-dependent transcription in human glioblastoma lines. The 
phenotypic consequences of reducing Maf1 expression included changes in cell 
morphology and the accumulation of actin stress fibers. Maf1 overexpression 
suppressed anchorage-independent growth. Together with the ability of Maf1 to 
reduce biosynthetic capacity, these findings supported the idea that Maf1 regulates 
the transformation state of cells.  
Above findings support the idea that eukaryotic Maf1s might belong to the 
family of intrinsically unstructured proteins (IUPs).  
What is more, computational studies with a usage of phosphorylation sites 
prediction methods revealed that unstructured regions are enriched in sites that 
may be posttranslationaly modified Gsponer et al. (2008) determined experimentally 
yeast kinase - substrate network, and showed that highly unstructured proteins are 
targeted by many kinases twice more as compared to structured proteins. What is 
more, 85% of the kinases for which, more than 50% of their substrates are highly 
unstructured, were either regulated in a cell cycle–dependent manner (e.g. Cdc28) 
or activated upon exposure to particular stimuli (e.g. Fus3) or stress (e.g. Atg1). 
This suggested that the posttranslational modification of intrinsically unstructured 
proteins (IUPs) through phosphorylation may be an important mechanism in 
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regulating their function and possibly their availability under different conditions 
(Gsponer et al., 2008).  
In correlation, Maf1 is a protein rich in serine residues. (15, 7% serines for  
S. cerevisiae). According to bioinformatic survey with SwissProt PROSITE, Maf1 
posses almost 30 potential phosphorylation sites. The analysis of potential 
phosphorylation sites by NetPhos 2.0 server (Bloom et al., 1999) in four Maf1  
orthologs containing linkers of different lengths revealed that predicted 
phosphorylation sites were mostly found in the long unstructured linkers between 
the Maf1 A and BC domains of S. cerevisiae and C. glabrata relatively, while they 
were more uniformly distributed along Maf1 sequence of C. elegans and H. sapiens, 
although they were also present in their shorter linkers (Fig. 44). Human Maf1 was 
shown to be phosphorylated on at least 5 residues, of which, three S60, S68, S75 
are the main sites. These sites are located between the conserved A and BC 
domains of human Maf1 (Michels et al., 2010; Kantidakis et al., 2010; Shor et al., 
2010). In S. cerevisiae, Maf1 is phosphorylated on at least 6 residues: S90, S101, 
S177, S178, S179, S209 and S210) (Huber et al., 2009; Moir et al., 2006; Willis and 
Moir, 2007). Yet in S. cerevisiae all identified phosphorylation sites lay between the 
A and BC domains. Thus the presence of phosphorylation sites in the region 
separating the A and BC domains has been conserved from yeast to man, even 
though the specific amino acid sequence has not been conserved. 
 
Considering that Maf1 contains two conserved domains it could be proposed 
that the unstructured linker becomes phosphorylated and thus modulates the 
conformational state of Maf1. Accordingly, different forms of Maf1 observed on 
polyacrylamide gels, interpreted as phosphorylated and subsequently 
dephosphorylated form of Maf1, might represent different conformational states 
depending on the interaction between the A and BC domains. Note that, the S90A, 
S101A and S177A, S178A mutations in the linker were found by Lee et al., 2009 to 
change the proportion between slow- and fast-migrating Maf1 forms in favor of the 
former, without strongly affecting the phosphorylation state of Maf1. This might 
indicate that residues in the linker could affect the Maf1 shape even in a 
denaturating electrophoresis.  
 
The interaction between the A and BC domains presented in this study occurred 
not only to be necessary for the full repression of Pol III activity but also to facilitate 
Maf1 dephosphorylation. One might hypothesize that, in the same time, the  
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Figure 44. Predicted phosphorylation sites in Maf1 sequences. Protein sequences were analyzed 
with NetPhos 2.0 Server. Diagram presents probability of phosphorylation in the range [0.000-1.000]. 
The figure presents localization of serine (blue), threonine (green) and tyrosine (red) residues predicted 
to be phosphorylated. Comparison of predicted phosphorylation sites in eukaryotic orthologs of Maf1 
with long (S. cerevisiae and C. glabrata) and short (C. elegans and H. sapiens) linker region between 
the A and BC domains. Percentage ratio of potential phosphorylation sites localized in the linker 
region is indicated. 
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Figure 45. Localization of phosphorylated residues in S. cerevisiae Maf1 sequence. Figure presents localization of serine (blue), threonine (green) and 
tyrosine (red) residues predicted to be phosphorylated in S. cerevisiae Maf1 sequence. Potentially phosphorylated residues (highlighted with orange circles) are 
merged with Hydrophobic Cluster Analysis (Callebaut et al., 1997). Below, schematic representation of Maf1 domains. Percentage ratio of phosphorylated 
residues localized in either A and BC domains or the linker region indicated. 
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interaction between domains of Maf1 is influenced by its phosphorylation state.  
Therefore it is tempting to speculate that the phosphorylation and 
dephosphorylation of the exposed linker evokes a specific conformation of the 
protein that changes the distance between domains modulating their interaction 
and Pol III repression (Fig. 45). The interaction of the domains, mediated by 
dephosphorylation of the linker may affect both, the import of Maf1 into the 
nucleus and its interaction with Pol III. This conjecture is supported by data of 
(Moir et al., 2006) showing that PKA-mediated phosphorylation of serine residues 
located in linker inhibited nuclear import of Maf1 and Pol III repression and further 
researches of Huber et al., (2009) who have proposed that Maf1 phosphorylation by 
Sch9 at phosphorylation sites localized in linker, although not sufficient, 
contributes to prevent Maf1 nuclear localization.  
Also current Maf1 crystalographic data presented by Vannini et al., 2010 seem 
to support this hypothesis. The crystal structure of human Maf1 revealed that the 
two NLS sequences (in S. cerevisiae NLS1 aa: 205-208 and NLS2 aa: 328-332) are 
surface accesible. The N-terminal, NLS1 is part of the linker region and the  
C-terminal, NLS2 is positioned in close proximity to NLS1. Thus it was proposed 
that the phosphorylation of the linker causes structural rearangements of Maf1 that 
mask NLS sequences and prevent Maf1 nuclear localization. 
Taken together we may hypothesize the conformational changes of Maf1 evoked 
by dephosphorylation of linker affects the interaction between the A and BC 
domains of Maf1 thus facilitating Maf1 activity as a Pol III repressor. 
4. Current context of the presented data.  
 
Recent crystallographic data obtained on human Maf1 (Vannini et al., 2010) 
clarified the mechanism of Pol III regulation by Maf1.  
Preceding data upon Maf1 indicated that nuclear pool of Maf1 either binds to Pol 
III preventing Pol III interaction with TFIIIB and promoters (Desai et al., 2005; Moir 
et al., 2006; Roberts et al., 2006) (see Fig. 1 “Introduction”). Maf1-dependent 
repression of Pol III was correlated with decreased Brf1 (a subunit of TFIIIB) and  
Pol III occupancy at class III genes in S. cerevisiae (Oficjalska-Pham et al., 2006; 
Roberts et al., 2006). Similar results have been obtained for human Maf1.  
The current data provided by Vannini et al., 2010 revealed that, according to 
cryo-EM, human Maf1 while binding with Pol III is positioned on top of the Pol III 
“clamp domain” corresponding to published biochemical and genetic interactions of 
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S. cerevisiae and human Maf1 with the N-terminal region of C160, which forms 
most of the “clamp” (Boguta et al., 1997; Oficjalska-Pham et al., 2006; Reina et al., 
2006). Consistent with this location C160, C82 and C34 subunits of Pol III are Maf1 
interacting partners in the yeast interactome (Gavin et al., 2006). Moreover, the 
comparison of cryo-EM structures, revealed that human Maf1 bound to Pol III 
rearranges the C82/34/31 subunits of Pol III (see Fig. 2 and Fig. 1 in 
“Introduction”) preventing Pol III interaction with Brf1 at class III genes promoters 
(Brf1-TBP-DNA complex) and initiation of transcription (Vannini et al., 2010). 
Furthermore, human Maf1 bound to Pol III did not affect nucleic acid binding in the 
active center and RNA synthesis as was shown by in vitro assays (initiation factor-
independent transcription assay and RNA extension assay) (Vannini et al., 2010) 
thus the mechanism of Pol III repression bases on Maf1 dependent abolishment of 
the Pol III interaction with promoter and disabling previously reported reinitiation of 
multiple-round transcription by Pol III (Cabart et al., 2008). In described model of 
Maf1-dependent repression of Pol III, both the A and BC domains of Maf1 seem to 
contribute equally with no individual function of particular domain. That is 
consistent with the data decribed in this study showing that cooperation between 
the A and BC domains of S. cerevisiae Maf1 (the physical interaction) is 
indispensable for Pol III repression. 
The uncovering of Maf1 crystal structure and mechanism, by which, Maf1 
repress Pol III broadens the possibilities of future researches conducted upon 
regulation of Pol III activity. Since deregulation of Pol III activity was shown to 
mediate oncogenic transformation (Marshall et al., 2008a; Marshall et al., 2008b) 
there might be a possibility to construct a terapeutic agents, resembling 
structurally Maf1, that could specifically repress hyperactivated Pol III in tumor 
cells.  
On the other side, currently, there are prerequisites that Maf1 has a dual 
nuclear function and contributes to pre-tRNA proccessing (Karkusiewicz – data 
unpublished). As reported by Kwapisz et al., 2002, inactivation of MAF1 gene 
(maf1∆) results in decreased tRNA nonsense suppressor efficiency. That observation 
seems to argue with the fact that in absence of active Maf1 there is an elevated 
quantity of cellular tRNA, which should lead to increase of tRNA-mediated nonsense 
suppression efficiency. The hypothesis explaining this phenomena assume that 
tRNA synthesized in maf1∆ cells are incorectly or incompletely processed or they fail 
to be appropriately delivered to ribosomes. Recent data of our group, (Karkusiewicz 
- data unpublished) indeed show that, in absence of Maf1, tRNA processing is 
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defected and both: initial tRNA transcript and partially processed, intron containing 
tRNA precursors accumulate. Moreover, that regulation of pre-tRNA proccesing is 
mediated by nuclear form of Maf1 since restriction of Maf1 to the nucleus in an 
msn5∆ S. cerevisiae strain correlates with accelerated tRNA proccessing. Since it is 
known that not all nuclear Maf1 is bound to Pol III and that Maf1 association is 
dynamic it is plausible that apart from interaction with Pol III complex, Maf1 
interacts with other nuclear proteins involved in early steps of tRNA proccessing or 
tRNA export to cytoplasm (Karkusiewicz – data unpublished). This dual function of 
Maf1 in down-regulation of Pol III and positive regulation of processing could be 
separable functions of nuclear Maf1. Thus it would be interesting to test if these 
opposing functions of Maf1 equally involve both, the A and BC Maf1 domains or the 
function in tRNA processing is restricted to particular domain.  
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V. MATERIALS AND METHODS 
 
• Media  
The following media were used for growing yeast: rich media - YPD (2% glucose, 
2% peptone, 1% yeast extract), YPGly (2% glycerol, 2% peptone, 1% yeast extract), 
minimal media - SC (2% glucose, 0.67% yeast nitrogen base without amino acids), 
SC-leu or SC-leu-trp, SC-his contained 20 µg/ml of the amino acids required for 
growth, except for leucine or leucine and tryptophan or histidine respectively 
(Sherman, 2002). As required, the YPD medium was supplemented with rapamycin 
(0,2 µg/ml). Solid media contained 2% agar. All reagents used for media were Difco 
products.  
 
• Yeast S. cerevisiae strains and genetic procedures 
The yeast strains used in this study are listed in Table 9a. For analysis of the 
phenotype, yeast strains grown on YPD were spotted or replica-plated on plates and 
incubated for 3 days at the desired temperatures.  
Yeast cells were transformed with plasmid by using the lithium acetate method 
(Chen et al., 1992) and were cultivated at 30°C in SC selective medium for 3 days. 
Plasmid DNA from yeast cells was isolated using the procedures described 
previously by Rose et al., 1990. The growth rate in liquid cultures was monitored by 
OD600 measurements. 
For long term preservation of yeast strains, 100 µl of fresh stationary phase cells 
were mixed with 1 ml of 15% glycerol in YPD, immediately frozen in liquid nitrogen 
and stored at -80°C. 
 
Table 9a. The yeast strains used in this study. 
Strain Genotype Reference or source 
YPH500 MATα, ade2-101, his3-∆200, leu2-∆1, lys2-801, 
trp1-∆63, ura3-52 
Sikorski and Hieter, 
1989 
YPH500 maf1∆ MATα, ade2-101, his3-∆200, leu2-∆1, lys2-801, 
trp1-∆63, ura3-52, maf1-∆ 
Oficjalska-Pham et al., 
2006 
Y190 MATa, gal4–542, gal80–538, his3, trp1–901, ade2–
101, ura3–52, leu2–3, 112, URA3::GAL1-lacZ, 
LYS2::GAL1(UAS)::HIS3, cyhR 
Harper et al., 1993 
 
• Plasmids 
Yeast/E. coli vectors used in this study are listed in Table 3. Transformation and 
growth of E. coli strains containing plasmids were carried out as described 
(Sambrook and Russell, 2001). LB medium (1% bacto-tryptone, 0.5% yeast extract, 
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1% NaCl; pH 7.5) was used for growing E. coli strains. As required, the LB medium 
was supplemented with ampicillin (60 µg/ml). Solid medium contained 2% agar. All 
reagents used for the medium were Difco products. Standard DNA manipulations 
were performed using E. coli strains listed in Table 2b (Bullock et al., 1987; 
Woodcock et al., 1989). 
 
Table 9b. The E. coli strains used in this study. 
Strain Genotype Reference 
or source 
XL1-blue recA1, endA1, gyrA96, thi-1, hsdR17, supE44, relA1, lac [F – 
proAB, lacIq Z∆M15 Tn10(tetR)] Stratagene 
DH5α F–,Φ80dlacZ∆M15(lacZYA-argF)U169,deoR 
recA1,endA1,hsdR17 (rk-,mk+), supE44, λ-, thi-1, gyrA96, relA1 
Stratagene 
 
Table 10A. Yeast/E. coli vectors used in this study. 
Name of 
plasmid 
Yeast 
gene 
cloned 
Parental 
vector 
E. coli/Yeast 
Markers 
Description Reference 
or source 
pRS315 - - ampR, lacZ / 
LEU2, CEN6 
- Sikorski 
and Hieter 
pRS315-MAF1 MAF1 pRS315 ampR, lacZ / 
LEU2, CEN6 
Graczyk 2010, PhD thesis D.Graczyk 
pAG5, 6, 7, 8, 9, 
10, 11, 12, 13, 
14, 15, 16, 17, 
18, 19, 20, 21, 
22, 23, 24, 25, 
27, 28, 29, 30, 
33, 34, 35, 37, 
38, 40, 42, 43, 
44, 46, 47, 48, 
49, 50, 51, 52, 
53, 54, 55, 56, 
58, 59, 60, 61, 
62, 63, 64, 65, 
66, 67, 68, 69, 
70, 72, 73, 74 
MAF1 pRS315 ampR, lacZ / 
LEU2, CEN6 
maf1 mutants, mutagenesis of 
MAF1 encoding 1-180 aa, *  
this study 
pAG88, 89, 101, 
107, 108, 110, 
111, 113, 114, 
115, 116, 117, 
118, 119, 120, 
121, 123, 124, 
125, 126, 127, 
128, 129, 130, 
131, 132, 133, 
134, 136, 138, 
139, 141, 143, 
144, 145, 146, 
147, 148, 149, 
151, 152, 156, 
158, 161, 163, 
165, 166, 167, 
168, 169, 170, 
171, 172, 173, 
174, 175, 176,  
MAF1 pRS315 ampR, lacZ / 
LEU2, CEN6 
maf1 mutants, mutagenesis of 
MAF1 encoding 174-375 aa, * 
this study 
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Continued: 
Name of 
plasmid 
Yeast 
gene 
cloned 
Parental 
vector 
E. coli/Yeast 
Markers 
Description Reference 
or source 
pML6 MAF1 pRS315 ampR, lacZ / 
LEU2, CEN6 
maf1 mutant, mutagenesis of 
MAF1 encoding 174-375 aa, * 
M.Legowiak 
pMM1, 2, 4 MAF1 pRS315 ampR, lacZ / 
LEU2, CEN6 
maf1 mutants, mutagenesis of 
MAF1 encoding 174-375 aa, * 
M.Maciak 
pML11, 12 MAF1 pRS315 ampR, lacZ / 
LEU2, CEN6 
maf1 mutants, suppressor of 
maf1-K35E, * 
M.Legowiak 
pAG11-1 MAF1 pRS315 ampR, lacZ / 
LEU2, CEN6 
D250E-maf1, derivative of 
pML11 
this study 
pAG12-1 MAF1 pRS315 ampR, lacZ / 
LEU2, CEN6 
V260D-maf1, derivative of 
pML12 
this study 
pAG12-2 MAF1 pRS315 ampR, lacZ / 
LEU2, CEN6 
N344I-maf1, derivative of 
pML12 
this study 
pAG12-3 MAF1 pRS315 ampR, lacZ / 
LEU2, CEN6 
V260D-N344I-maf1, derivative 
of pML12 
this study 
* Precise DNA mutations and corresponding amino acid changes are described in Tables: 1A, 1B and 2 
in “Results” part and Supplementary Tables S1-S5. 
 
 
Table 10B. Yeast/E. coli vectors for yeast-two-hybrid system used in this study. 
Name of 
plasmid 
Yeast 
gene 
cloned 
Parental 
vector 
E. coli/Yeast 
Markers 
Description Reference 
or source 
pACT2 - - ampR/LEU2, 
2µ 
two-hybrid vector carrying Gal4 
activating domain (AD) 
Clonetech 
pAS2 - - ampR/TRP1, 
2µ 
two-hybrid vector carrying Gal4 
binding domain (BD) 
Clonetech 
pACT2-Maf1-A 
(1-12) 
MAF1 pACT2 ampR/LEU2, 
2µ 
two-hybrid vector carrying 
sequence encoding truncated A 
domain (1-12 aa) 
this study 
pACT2-Maf1-A 
(1-16) 
MAF1 pACT2 ampR/LEU2, 
2µ 
two-hybrid vector carrying 
sequence encoding truncated A 
domain (1-16 aa) 
this study 
pACT2-Maf1-A 
(1-23) 
MAF1 pACT2 ampR/LEU2, 
2µ 
two-hybrid vector carrying 
sequence encoding truncated A 
domain (1-23 aa) 
this study 
pACT2-Maf1-A 
(1-34) 
MAF1 pACT2 ampR/LEU2, 
2µ 
two-hybrid vector carrying 
sequence encoding truncated A 
domain (1-34 aa) 
this study 
pACT2-Maf1-A 
(1-39) 
MAF1 pACT2 ampR/LEU2, 
2µ 
two-hybrid vector carrying 
sequence encoding truncated A 
domain (1-39 aa) 
this study 
pACT2-Maf1-A 
(1-42) 
MAF1 pACT2 ampR/LEU2, 
2µ 
two-hybrid vector carrying 
sequence encoding truncated A 
domain (1-42 aa) 
this study 
pACT2-Maf1-A 
(1-57) 
MAF1 pACT2 ampR/LEU2, 
2µ 
two-hybrid vector carrying 
sequence encoding truncated A 
domain (1-57 aa) 
this study 
pACT2-Maf1-A 
(1-59) 
MAF1 pACT2 ampR/LEU2, 
2µ 
two-hybrid vector carrying 
sequence encoding truncated A 
domain (1-59 aa) 
this study 
pACT2-Maf1-A 
(1-77) 
MAF1 pACT2 ampR/LEU2, 
2µ 
two-hybrid vector carrying 
sequence encoding truncated A 
domain (1-77 aa) 
this study 
pACT2-Maf1-A 
(1-79) 
MAF1 pACT2 ampR/LEU2, 
2µ 
two-hybrid vector carrying 
sequence encoding truncated A 
domain (1-79 aa) 
this study 
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Continued: 
Name of 
plasmid 
Yeast 
gene 
cloned 
Parental 
vector 
E. coli/Yeast 
Markers 
Description Reference 
or source 
pACT2-Maf1-A 
(1-91) 
MAF1 pACT2 ampR/LEU2, 
2µ 
two-hybrid vector carrying 
sequence encoding truncated A 
domain (1-91 aa) 
this study 
pACT2-Maf1-A 
(1-111) 
MAF1 pACT2 ampR/LEU2, 
2µ 
two-hybrid vector carrying 
sequence encoding truncated A 
domain (1-111 aa) 
this study 
pACT2-Maf1-A 
(1-172) 
MAF1 pACT2 ampR/LEU2, 
2µ 
two-hybrid vector carrying 
sequence encoding truncated A 
domain (1-172 aa) 
this study 
pAS2-Maf1-BC 
(165-349) 
MAF1 pAS2 ampR/TRP1, 
2µ 
two-hybrid vector carrying 
sequence encoding truncated 
BC domain (165-349 aa) 
this study 
pAS2-Maf1-BC 
(165-367) 
MAF1 pAS2 ampR/TRP1, 
2µ 
two-hybrid vector carrying 
sequence encoding truncated 
BC domain (165-367 aa) 
this study 
pAS2-Maf1-BC 
(196-349) 
MAF1 pAS2 ampR/TRP1, 
2µ 
two-hybrid vector carrying 
sequence encoding truncated 
BC domain (196-349 aa) 
this study 
pAS2-Maf1-BC 
(196-367) 
MAF1 pAS2 ampR/TRP1, 
2µ 
two-hybrid vector carrying 
sequence encoding truncated 
BC domain (196-367 aa) 
this study 
pACT2-Maf1-A 
K35E 
MAF1 pACT2 ampR/LEU2, 
2µ 
two-hybrid vector carrying 
maf1-K35E, derivative of 
pACT2-Maf1-A (1-42) 
this study 
pAS2-Maf1-BC 
D250E 
MAF1 pAS2 ampR/TRP1, 
2µ 
two-hybrid vector carrying 
maf1-D250E, derivative of 
pAS2-Maf1-BC (196-349) 
this study 
pAS2-Maf1-BC 
V260D 
MAF1 pAS2 ampR/TRP1, 
2µ 
two-hybrid vector carrying 
maf1-V260D, derivative of 
pAS2-Maf1-BC (196-349) 
this study 
pAS2-Maf1-BC 
N344I 
MAF1 pAS2 ampR/TRP1, 
2µ 
two-hybrid vector carrying 
maf1-N344I, derivative of pAS2-
Maf1-BC (196-349) 
this study 
pAS2-Maf1-BC 
V260D-N344I 
MAF1 pAS2 ampR/TRP1, 
2µ 
two-hybrid vector carrying 
maf1-V260D-N344I, derivative 
of pAS2-Maf1-BC (196-349) 
this study 
pGAD424 - - ampR/LEU2, 
2µ 
two-hybrid vector carrying Gal4 
activating domain (AD) 
Clontech 
pGBT9 - - ampR/TRP1, 
2µ 
two-hybrid vector carrying Gal4 
binding domain (BD) 
Clontech 
pGAD424-NTF 
C160 
RPC160 pGAD424 ampR/LEU2, 
2µ 
two-hybrid vector carrying 
sequence encoding truncated 
C160 (1-235 aa) 
K. Balicki 
pGBT9-NTF 
C160 
RPC160 pGBT9 ampR/TRP1, 
2µ 
two-hybrid vector carrying 
sequence encoding truncated 
C160 (1-235 aa) 
K. Balicki 
pGAD424-C160 RPC160 pGAD424 ampR/LEU2, 
2µ 
- M.Boguta 
pGAD2F-C160 RPC160 pGAD424 ampR/LEU2, 
2µ 
- SBIGeM* 
pACT-TFIIIA PZF1 pACT2 ampR/LEU2, 
2µ 
- SBIGeM* 
pACT-TFIIIB70 BRF1 pACT2 ampR/LEU2, 
2µ 
- SBIGeM* 
pACT-TFIIIB90 BDP1 pACT2 ampR/LEU2, 
2µ 
- SBIGeM* 
pGA-TBP TBP1 pGAD424 ampR/LEU2, 
2µ 
- SBIGeM* 
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Continued: 
Name of 
plasmid 
Yeast 
gene 
cloned 
Parental 
vector 
E. coli/Yeast 
Markers 
Description Reference 
or source 
pACT-Tau138 TFC3 pACT2 ampR/LEU2, 
2µ 
- SBIGeM* 
pACT-Tau131 TFC4 pACT2 ampR/LEU2, 
2µ 
- SBIGeM* 
pACT-Tau95 TFC1 pACT2 ampR/LEU2, 
2µ 
- SBIGeM* 
pACT-Tau91 TFC6 pACT2 ampR/LEU2, 
2µ 
- SBIGeM* 
pACT-Tau60 TFC8 pACT2 ampR/LEU2, 
2µ 
- SBIGeM* 
pACT-Tau55 TFC7 pACT2 ampR/LEU2, 
2µ 
- SBIGeM* 
pGA-C128 RET1 pGAD424 ampR/LEU2, 
2µ 
- SBIGeM* 
pACT-C82 RPC82 pACT2 ampR/LEU2, 
2µ 
- SBIGeM* 
pGA-C53 RPC53 pGAD424 ampR/LEU2, 
2µ 
- SBIGeM* 
pGA-AC40 RPC40 pGAD424 ampR/LEU2, 
2µ 
- SBIGeM* 
pGA-C34 RPC34 pGAD424 ampR/LEU2, 
2µ 
- SBIGeM* 
pACT-C31 RPC31 pACT2 ampR/LEU2, 
2µ 
- SBIGeM* 
pGA-ABC27 RPB5 pGAD424 ampR/LEU2, 
2µ 
- SBIGeM* 
pACT-C25 RPC25 pACT2 ampR/LEU2, 
2µ 
- SBIGeM* 
pACT-ABC23 RPO26 pACT2 ampR/LEU2, 
2µ 
- SBIGeM* 
pGA-AC19 RPC19 pGAD424 ampR/LEU2, 
2µ 
- SBIGeM* 
pACT-C17 RPC17 pACT2 ampR/LEU2, 
2µ 
- SBIGeM* 
pGA-ABC14,5 RPB8 pGAD424 ampR/LEU2, 
2µ 
- SBIGeM* 
pACT-C11 RPC11 pACT2 ampR/LEU2, 
2µ 
- SBIGeM* 
pACT-ABC10α RPC10 pACT2 ampR/LEU2, 
2µ 
- SBIGeM* 
pGA-ABC10β RPB10 pGAD424 ampR/LEU2, 
2µ 
- SBIGeM* 
pACT-Sub1 SUB1 pACT2 ampR/LEU2, 
2µ 
- SBIGeM* 
pACT-Maf1 MAF1 pACT2 ampR/LEU2, 
2µ 
- SBIGeM* 
pAS-TFIIIA PZF1 pAS2 ampR/TRP1, 
2µ 
- SBIGeM* 
pAS-TFIIIB70 BRF1 pAS2 ampR/TRP1, 
2µ 
- SBIGeM* 
pAS-TFIIIB90 BDP1 pAS2 ampR/TRP1, 
2µ 
- SBIGeM* 
pAS-TBP TBP1 pAS2 ampR/TRP1, 
2µ 
- SBIGeM* 
pAS-Tau138 TFC3 pAS2 ampR/TRP1, 
2µ 
- SBIGeM* 
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Continued: 
Name of 
plasmid 
Yeast 
gene 
cloned 
Parental 
vector 
E. coli/Yeast 
Markers 
Description Reference 
or source 
pAS-Tau131 TFC4 pAS2 ampR/TRP1, 
2µ 
- SBIGeM* 
pAS-Tau95 TFC1 pAS2 ampR/TRP1, 
2µ 
- SBIGeM* 
pAS-Tau91 TFC6 pAS2 ampR/TRP1, 
2µ 
- SBIGeM* 
pAS-Tau60 TFC8 pAS2 ampR/TRP1, 
2µ 
- SBIGeM* 
pAS-Tau55 TFC7 pAS2 ampR/TRP1, 
2µ 
- SBIGeM* 
pAS-C128 RET1 pAS2 ampR/TRP1, 
2µ 
- SBIGeM* 
pAS-C82 RPC82 pAS2 ampR/TRP1, 
2µ 
- SBIGeM* 
pAS-C53 RPC53 pAS2 ampR/TRP1, 
2µ 
- SBIGeM* 
pAS-AC40 RPC40 pAS2 ampR/TRP1, 
2µ 
- SBIGeM* 
pAS-C37 RPC34 pAS2 ampR/TRP1, 
2µ 
- SBIGeM* 
pAS-C31 RPC31 pAS2 ampR/TRP1, 
2µ 
- SBIGeM* 
pAS-ABC27 RPB5 pAS2 ampR/TRP1, 
2µ 
- SBIGeM* 
pAS-C25 RPC25 pAS2 ampR/TRP1, 
2µ 
- SBIGeM* 
pAS-AC19 RPC19 pAS2 ampR/TRP1, 
2µ 
- SBIGeM* 
pAS-C17 RPC17 pAS2 ampR/TRP1, 
2µ 
- SBIGeM* 
pAS-ABC14,5 RPB8 pAS2 ampR/TRP1, 
2µ 
- SBIGeM* 
pAS-C11 RPC11 pAS2 ampR/TRP1, 
2µ 
- SBIGeM* 
pAS-ABC10α RPC10 pAS2 ampR/TRP1, 
2µ 
- SBIGeM* 
pMA-ABC10β RPB10 pGBT9 ampR/TRP1, 
2µ 
- SBIGeM* 
pGBT9-C160 RPC160 pGBT9 ampR/TRP1, 
2µ 
- M.Boguta 
pAS-C160 RPC160 pAS2 ampR/TRP1, 
2µ 
- SBIGeM* 
pAS-Sub1 SUB1 pAS2 ampR/TRP1, 
2µ 
- SBIGeM* 
pAS-Maf1 MAF1 pAS2 ampR/TRP1, 
2µ 
- SBIGeM* 
* Service de Biologie Intégrative et Génétique Moléculaire, Institut de Biologie et de Technologies de 
Saclay (CEA/Saclay) 
 
• Standard DNA manipulation 
Routine DNA techniques: plasmid preparation, digestion, cloning and Tris-
acetate-EDTA (TAE) agarose gel electrophoresis were carried out as described by 
Sambrook and Russell, 2001. Plasmid DNA was isolated with QIAprep Spin 
Miniprep Kit (Qiagen). Restriction and DNA-modifying enzymes and DNA ligase were 
 - 104 - 
purchased from Invitrogen, Fermentas, Promega, New England Biolabs and Gibco 
BRL and used in accordance with the manufacturers’ instructions. PCR reactions 
were catalyzed by Taq DNA polymerase (Promega or Finnzymes) or polymerase with 
proofreading activity (Expand High Fidelity PCR System, Roche), used according to 
the manufacturers’ instructions. pGEM-T Easy Vector (Promega) was used to clone  
products of PCR. PCR products were purified on QIAquick PCR Purification Kit 
(Qiagen). DNA fragments were purified from TAE-agarose gel with QIAEX II Agarose 
Gel Extraction Kit (Qiagen) and NucleoSpin extraction kit (Macherey-Nagel) 
according to the manufacturer’s instructions. Sequencing of plasmid DNA was 
performed with BigDye Terminator 3.1 Kit and by the Laboratory of DNA 
Sequencing and Oligonucleotide Synthesis, IBB PAN. DNA sequences were analyzed 
with FinchTV v 1.4 and Chromas Lite v 2.01 software. 
 
• Oligonucleotides 
All oligonucleotide primers were produced in the Laboratory of DNA 
Sequencing and Oligonucleotide Synthesis, IBB PAS except: MAF12F, MAF12R, 
MAF16F, MAF16R, MAF23F and MAF23R that were produced by Sigma-Genosys 
(Table 11).  
 
• Generation of yeast S. cerevisiae Maf1 mutants strains 
 Maf1 mutated in the A domain.  
MAF1 gene was cut from pFL44-MAF1 (Boguta et al., 1997) subcloned in 
pRS315 (LEU2, CEN) plasmid (Sikorski and Hieter, 1989) resulting in pRS315-
MAF1 (Graczyk, 2010 – PhD thesis). The plasmids harboring maf1 were derived 
from pRS315-MAF1 using a rapid method for localized mutagenesis (Muhlrad et al., 
1992). For this purpose MAF1 fragment encoding 1-180 aa was PCR-amplified from 
pRS315-MAF1 under mutagenic conditions (3, 5) using MAF1-1 and MAF1-2 
primers and Diversify PCR Random Mutagenesis Kit (Clontech). The product of the 
low-fidelity PCR was transformed together with gapped linear plasmid pRS315-
MAF1 (digested with BclI and BsgI, New England Biolabs) into the YPH500 maf1∆ 
strain (Muhlrad et al., 1992). Transformants, selected on minimal medium lacking 
leucine (SC-leu), were subsequently tested for thermosensitivity by replica-plating 
on YPGly and incubation at 37ºC for three days.  
The potential maf1 mutants were used to isolate plasmid DNA, which was 
subsequently tested by PCR with MAF1-1 and MAF1-2 primers to confirm the 
presence of the mutagenized region. Selected plasmids were amplified in E. coli and  
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Table 11. Oligonucleotide primers used in this study. 
Primer Sequence 5’ – 3’ Description Purpose Reference  
or source 
MAF1-1 CGAGTTGCTTGTCAATCAGG forward primer for the A domain region, 276 
bp upstream of MAF1 translation start site 
mutagenesis of the A domain this study 
MAF1-2 CTGCTACTGCTCCTTCTTCT reverse primer for the A domain region, 619 
bp downstream of MAF1 translation start site 
mutagenesis of the A domain this study 
MAF1-5 GTCCGTATTCGGTCCTCATT forward primer for the region 502 bp 
upstream of MAF1 translation start site 
sequencing of DNA encoding Maf1 A 
domain 
this study 
MAF1-6 TTGCGGCTTGACGGTTCGTT reverse primer for the region 1778 bp 
downstream of MAF1 translation start site 
sequencing of DNA encoding Maf1 A 
domain 
this study 
MAF1-8 TTGCCAAGGCATCTTCCACT reverse primer for the region 1146 bp 
downstream of MAF1 translation start site 
sequencing of DNA encoding Maf1 A 
domain 
this study 
MAF1-3 AGAAGAAGGAGCAGTAGCAG forward primer for the region 600 bp 
downstream of MAF1 translation start site 
mutagenesis of the BC domain this study 
MAF1-9 CGTATTCTCCTTCGTATTCA reverse primer for the region 1206 bp 
downstream of MAF1 translation start site 
mutagenesis of the BC domain this study 
MAF1-4 CAGCCTGATTGAAGTTCCGT reverse primer for the region 1528 bp 
downstream of MAF1 translation start site 
sequencing of DNA encoding Maf1 
BC domain 
this study 
MAF1-7 TTGGAAGATGAGCCTGGCTA forward primer for the region 1011 bp 
downstream of MAF1 translation start site 
sequencing of DNA encoding Maf1 
BC domain 
this study 
MAF1-10 CTGGACCTAATGGTTCTTCT forward primer for the region 454 bp 
upstream of MAF1 translation start site 
sequencing of DNA encoding Maf1 
BC domain 
this study 
MAF12Fcut GATCCGAATGAAATTTATTGATGAGC
TAGATATAGAGAGAGTGC 
synthetic (+) ssDNA encoding 1-12 aa of the A 
domain, sticky ends for XhoI, BamHI clonning 
two-hybrid system, generation of the 
truncated A domain 
this study 
MAF12Rcut TCGAGCACTCTCTCTATATCTAGCTC
ATCAATAAATTTCATTCG 
synthetic (-) ssDNA encoding 1-12 aa of the A 
domain, sticky ends for XhoI, BamHI clonning 
two-hybrid system, generation of the 
truncated A domain 
this study 
MAF16Fcut GATCCGAATGAAATTTATTGATGAGC
TAGATATAGAGAGAGTGAATCAAACT
CTCC 
synthetic (+) ssDNA encoding 1-16 aa of the A 
domain, sticky ends for XhoI, BamHI clonning 
two-hybrid system, generation of  the 
truncated A domain 
this study 
MAF16Rcut TCGAGGAGAGTTTGATTCACTCTCTC
TATATCTAGCTCATCAATAAATTTCAT
TCG 
synthetic (-) ssDNA encoding 1-16 aa of the A 
domain, sticky ends for XhoI, BamHI clonning 
two-hybrid system, generation of the 
truncated A domain 
this study 
MAF23Fcut GATCCGAATGAAATTTATTGATGAGC
TAGATATAGAGAGAGTGAATCAAACT
CTCAATTTCGAGACAAATGACTGTC 
synthetic (+) ssDNA encoding 1-23 aa of the A 
domain, sticky ends for XhoI, BamHI clonning 
two-hybrid system, generation of  the 
truncated A domain 
this study 
MAF23Rcut TCGAGACAGTCATTTGTCTCGAAATT
GAGAGTTTGATTCACTCTCTCTATATC
TAGCTCATCAATAAATTTCATTCG 
synthetic (-) ssDNA encoding 1-23 aa of the A 
domain, sticky ends for XhoI, BamHI clonning 
two-hybrid system, generation of the 
truncated A domain 
this study 
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MAF5A TCATCGGGATCCGAATGAAATTTATT
GATGAGCTAGATATAGAGAGAGTG 
forward primer for the MAF1 ORF, BamHI 
restriction site at 5’ 
two-hybrid system, generation of the 
A domain 
this study 
MAF3A34 TCATCGCTCGAGTGTTGTGAAAATAT
CGCAACTGCC 
reverse primer for the region 182 bp 
downstream of MAF1 translation start site, 
XhoI restriction site at 5’ 
two-hybrid system, generation of the 
truncated A domain 
this study 
MAF3A39 TCATCGCTCGAGTGATGCAACCGCC
TTTGTTGTG 
reverse primer for the region 197 bp 
downstream of MAF1 translation start site, 
XhoI restriction site at 5’ 
two-hybrid system, generation of the 
truncated A domain 
this study 
MAF3A42 TCATCGCTCGAGTTTTCTATCTGATG
CAACCGC 
reverse primer for the region 206 bp 
downstream of MAF1 ORF 
two-hybrid system, generation of the 
A domain 
this study 
MAF3A57 TCATCGCTCGAGTTCCTGTAAAATAG
TATCCAAATGCTG 
reverse primer for the region 251 bp 
downstream of  MAF1 translation start site, 
XhoI restriction site at 5’ 
two-hybrid system, generation of the 
A domain 
this study 
MAF3A59 TCATCGCTCGAGCTCATTTTCCTGTA
AAATAGTATCC 
reverse primer for the region 257 bp down 
stream of MAF1 translation start site, XhoI 
restriction site at 5’ 
two-hybrid system, generation of the 
A domain 
this study 
MAF3A77 TCATCGCTCGAGTGATTGGTTTGTTT
CGGGAGC 
reverse primer for the region 311 bp down 
stream of MAF1 translation start site, XhoI 
restriction site at 5’ 
two-hybrid system, generation of the 
A domain 
this study 
MAF3A79 TCATCGCTCGAGGCAGGGTGATTGG
TTTGTTTC 
reverse primer for the region 317 bp 
downstream of MAF1 translation start site, 
XhoI restriction site at 5’ 
two-hybrid system, generation of the 
A domain 
this study 
MAF3A91 TCATCGCTCGAGGTTGCTATCCCTCC
TATTAG 
reverse primer for the region 353 bp 
downstream of MAF1 translation start site, 
XhoI restriction site at 5’ 
two-hybrid system, generation of the 
A domain 
this study 
MAF3A111 TCATCGCTCGAGAGTGTTATTATTGC
TATTG 
reverse primer for the region 413 bp 
downstream of MAF1 translation start site, 
XhoI restriction site at 5’ 
two-hybrid system, generation of the 
A domain 
this study 
MAF3A172 TCATCGCTCGAGCCTCTCATCATTCT
TAGAAGAAG 
reverse primer for the region 596 bp 
downstream of MAF1 translation start site, 
XhoI restriction site at 5’ 
two-hybrid system, generation of the 
A domain 
this study 
MAF5BC165 TCATCGGGATCCGATCTTCTTCTAAG
AATGATGAGAGG 
forward primer for the region 575 bp 
downstream of MAF1 translation start site, 
BamHI restriction site at 5’ 
two-hybrid system, generation of the 
BC domain 
this study 
MAF5BC196 TCATCGGGATCCGATCTGGTACAGC
AACCAACAATG 
forward primer for the region 668 bp 
downstream of MAF1 translation start site, 
BamHI restriction site at 5’ 
two-hybrid system, generation of the 
BC domain 
this study 
MAF3BC349 TCATCGCTCGAGTTCGCCTGTACTCG
AATTTAG 
reverse primer for the region 1127 bp 
downstream of MAF1 translation start site, 
XhoI restriction site at 5’ 
two-hybrid system, generation of the 
BC domain 
this study 
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MAF3BC367 TCATCGCTCGAGGCCATCATCTATTA
TAAGCTTTCC 
reverse primer for the region 1181 bp 
downstream of MAF1 translation start site, 
XhoI restriction site at 5’ 
two-hybrid system, generation of the 
BC domain 
this study 
T7Prom TAATACGACTCACTATAGGG sequencing primer for pGEM-T plasmid verification of pGEM-T plasmids 
harboring sequence encoding the A 
or BC domain 
this study 
Gal4BD TCATCGGAAGAGAGTAG forward primer complementary to region 
flanking polylinker in pAS2 
verification of pAS2 plasmids 
harboring sequence encoding  
truncated A domain 
this study 
G203 CGGAATTAGCTTGGCTGC reverse primer complementary to region 
flanking polylinker in pAS2 
verification of pAS2 plasmids 
harboring sequence encoding  
truncated A domain  
SBIGeM * 
G242F CTATTCGATGATGAAGATACC forward primer complementary to region 
flanking polylinker in pACT2 
verification of pACT2 plasmids 
harboring sequence encoding  
truncated A domain 
SBIGeM* 
G244R CAGTTGAAGTGAACTTGCG reverse primer complementary to region 
flanking polylinker in pACT2 
verification of pACT2 plasmids 
harboring sequence encoding  
truncated A domain 
SBIGeM* 
Gal4AD TACCACTACAATGGATG sequencing primer for pACT2 plasmid and its 
derivatives 
verification of pACT2 plasmids 
harboring sequence encoding MAF1 
this study 
N344I TCATCGCTCGAGTTCGCCTGTACTCG
AAATTAGACGCGAGC 
derivative of MAF3BC349 primer modified to 
introduce N344I mutation 
generation of N344I mutation in 
pAS2-Maf1-BC(196-349) plasmid 
this study 
D250E-f CGCTTCTTATCCTGACCATGAGTTTT
CATCGGTTGAGCCAACGG 
forward primer for site directed mutagenesis 
modified to introduce mutation D250E 
separation of suppressor mutations this study 
D250E-r CCGTTGGCTCAACCGATGAAAACTCA
TGGTCAGGATAAGAAGCG 
reverse primer for site directed mutagenesis 
modified to introduce mutation D250E 
separation of suppressor mutations this study 
V260D-f GAGCCAACGGATTTTGACAAAACATC
ATTG 
forward primer for site directed mutagenesis 
modified to introduce mutation V260D 
separation of suppressor mutations this study 
V260D-r CAATGATGTTTTGACAAAATCCGTTG
GCTC 
reverse primer for site directed mutagenesis 
modified to introduce mutation V260D 
separation of suppressor mutations this study 
N344I-f GCTCGCGTCTAATCTCGAGTACAGG
CGAAG 
forward primer for site directed mutagenesis 
modified to introduce mutation N344I 
separation of suppressor mutations this study 
N344I-r CTTCGCCTGTACTCGAGATTAGACGC
GAGC 
reverse primer for site directed mutagenesis 
modified to introduce mutation N344I 
separation of suppressor mutations this study 
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analyzed with endonuclease EcoRI (Fermentas). Plasmids giving appropriate 
restriction pattern were retransformed to YPH500 maf1∆ S. cerevisiae strain due to 
confirmation of temperature-sensitive phenotype. Sequencing revealed type of 
mutation in each plasmid carrying MAF1 mutated A domain. Mutated plasmids 
were sequenced using primers: MAF1-5 , MAF1-6, MAF1-8. Obtained plasmids were 
listed in Table 10A. 
 
 Maf1 mutated in the BC domain. 
pRS315-MAF1 (constructed as previously described) was digested with BsaBI 
and Bsu36I (New England Biolabs) and introduced into the YPH500 maf1∆ strain 
together with a MAF1 fragment encoding the BC domain (174-375 aa) PCR-
amplified under mutagenic conditions (1, 3) using primers: MAF1-3 , MAF1-9 and 
Diversify PCR Random Mutagenesis Kit (Clontech) (Muhlrad et al., 1992). 
Transformants, selected on minimal medium lacking leucine (SC-leu), were 
subsequently tested for thermosensitivity by replica-plating on YPGly and 
incubation at 37ºC for three days. 
The obtained library of potential maf1 mutants was screened for 
thermosensitivity on YPGly medium as described previously. Sequencing revealed 
type of mutation in each plasmid carrying MAF1 the mutated BC domain. Mutated 
plasmids were sequenced using primers: MAF1-4 , MAF1-7, MAF1-10. Obtained 
plasmids were listed in Table 10A. 
 
 Maf1 mutated suppressor strains. 
Among 38 independent mutants, pAG70 (K35E-maf1) was selected from colonies 
that showed defective growth. To isolate pML11 (K35E-D250E-maf1) and pML12 
(K35E-V260D-N344I-maf1) plasmids carrying suppressor mutations plasmid 
pAG70 (carrying the previously isolated maf1 allele with the K35E mutation) was 
digested with BsaBI and Bsu36I (New England Biolabs) and introduced into the 
YPH500 maf1∆ strain together with a MAF1 fragment encoding the BC domain  
(174-375 aa) PCR-amplified under mutagenic conditions (1) using primers: MAF1-3,  
MAF1-9 and Diversify PCR Random Mutagenesis Kit (Clontech) (Muhlrad et al., 
1992). Transformants, selected on minimal medium lacking leucine (SC-leu). The 
obtained library of potential suppressor mutants was screened for overcoming the 
thermosensitivity on YPGly medium caused by the K35E mutation. Plasmids from 
selected mutants were retransformed to YPH500 maf1∆ S. cerevisiae strain due to 
confirmation of temperature WT phenotype. Sequencing revealed type of mutation 
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in each plasmid carrying mutated MAF1. Mutated plasmids were sequenced in 
regions encoding both, the A and BC Maf1 domains using primers: MAF1-4, MAF1-
5, MAF1-6, MAF1-7, MAF1-8, MAF1-10. 
D250E, N344I, V260D and V260D-N344I mutations were introduced to  
pRS315-MAF1 plasmid with QuickChange Site-Directed Mutagenesis Kit 
(Stratagene) and following primers: D250E-f, D250E-r, V260D-f, V260D-r, N344I-f, 
N344I-r.  
Obtained plasmids were listed in Table 10A. 
 
• Construction of plasmids to express fragments of S. cerevisiae Maf1 
protein for two-hybrid study. 
DNA encoding fragments aa: 1-12, 1-16 and 1-23 of the A domain of  
S. cerevisiae Maf1 were synthesized de novo as oligonucleotides designed in a 
manner that enabled direct cloning to pACT2 and pAS2 two-hybrid vectors on 
BamHI and XhoI restriction sites. Oligonucleotides were hybridized in pairs: 
MAF12F-MAF12R, MAF16F-MAF16R, MAF23F-MAF23R, kinased with a T4 
polynucleotide kinase (New England Biolabs) and directly cloned to MATCHMAKER 
GAL4 Two-Hybrid Vectors (Clontech) – either the pACT2 plasmid (on BamHI, XhoI 
restriction sites) carrying the activation domain of Gal4 or the pAS2 plasmid (on 
BamHI, SalI restriction sites) carrying the binding domain of Gal4 (Fig. 46). 
Presence of sequence encoding A domain was confirmed by the standard PCR 
reaction with primers complementary to region flanking cloned sequence: G242F 
and G244R for pACT2 derivatives and Gal4BD and G203 for pAS2 derivatives. 
Products of PCR were resolved by electrophoresis on 4% agarose gel. Selected 
plasmids harboring sequence encoding truncated Maf1 A domain were verified for 
nonspecific mutations by sequencing with primers Gal4AD for pACT2 derivatives, 
Gal4BD for pAS2 derivatives. 
The larger DNA sequences, encoding aa: 1-34, 1-39, 1-42, 1-57,  
1-59, 1-77, 1-79, 1-91, 1-111 and 1-172 fragments were amplified from pRS315-
MAF1 plasmid using forward primer MAF5A and respective reverse primers: 
MAF3A34, MAF3A39, MAF3A42, MAF3A57, MAF3A59, MAF3A77, MAF3A79, 
MAF3A91, MAF3A111, MAF3A172 with Expand High Fidelity PLUS PCR System 
(Roche). The intron sequence of the MAF1 gene (localized between nt 7 and 87) was 
excluded.  
DNA encoding fragments aa: 165-349, 165-367, 196-349 and 196-367 of the BC 
domain were amplified from pRS315-MAF1 with respective forward primers: 
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MAF5BC165 and MAF5BC196 and respective reverse primers: MAF3BC349 and 
MAF3BC367 with with Expand High Fidelity PLUS PCR System (Roche).  
All MAF1 parts were amplified with BamHI and XhoI termini fragments, cloned 
into pGEM-T Vector System (Promega) and verified by sequencing with primer 
T7Prom for nonspecific mutations. Selected plasmids were digested with BamHI and 
XhoI restriction endonucleases (New England Biolabs) and inserted into 
MATCHMAKER GAL4 Two-Hybrid Vectors (Clontech) – either the pACT2 plasmid 
carrying the activation domain of Gal4 (on BamHI, XhoI sites) or the pAS2 plasmid 
carrying the binding domain of Gal4 (on BamHI, SalI sites) (Fig. 46).  
The resulting plasmids harboring sequence encoding A domain and plasmids 
harboring the sequence encoding BC domain listed in Table 10B. Expression of 
fusion proteins involving HA-tagged truncated versions of the A and BC domains 
was verified by Western blotting.  
 
 
Figure 46. MATCHMAKER GAL4 Two-Hybrid Vectors (Clontech) – pACT2 plasmid carrying the 
activation domain of Gal4 (AD) and pAS2 plasmid carrying the binding domain of Gal4 (BD). 
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To generate mutations in the two-hybrid plasmids carrying fragments encoding 
Maf1 domains, the fragment encoding 1-42 aa of Maf1 was PCR-amplified from the 
pAG70 maf1 allele K35E with forward primer MAF5A and reverse primer MAF3A42, 
digested with BamHI XhoI restriction endonucleases (New England Biolabs) and 
cloned to pACT2 plasmid (BamHI, XhoI restriction sites) (Fig. 46). 
Similarly the mutations found in pML11 and pML12 were introduced into pAS2 
plasmid by PCR amplification of the fragment encoding 196-349 aa of Maf1 from 
the pML11 and pML12 maf1 alleles with forward primer MAF5BC196 and reverse 
primer MAF3BC349, subsequent digestion (BamHI, XhoI) and cloning on BamHI, 
SalI restriction sites in pAS2 (Fig. 46). The N344I mutation found in the pML12 
plasmid was introduced to pAS2 as described above but the fragment encoding 
196-349 aa of Maf1 was PCR-amplified by using a modified reverse primer N344I-r 
with a mutation leading to the desired amino acid substitution. Resulting plasmids 
listed in Table 10B. 
 
• β - galactosidase activity assay 
Each of the derivatives of pACT2 and the single derivative of pAS2, were co-
expressed pairwise in the two-hybrid reporter strain Y190. Cells containing these 
two plasmids were patched on SC medium lacking leucine and tryptophan. The 
patches were then examined for β-galactosidase activity using an overlay plate 
assay (Werner et al., 1993). The intensity of the coloration was calibrated by 
comparison with a pair of known interactors (τ95/τ55, two TFIIIC subunits), for 
which, the β-galactosidase activity had been measured previously (Manaud et al., 
1998). For a β-galactosidase liquid assay cell lysates were prepared and the activity 
was measured colorimetrically as nmoles of ONPG (o-nitrophenyl- β-D-
galactopiranoside) hydrolyzed per minute per mg of protein. Conversion 0.0045 x 
A420 = 1 nmole ONPG cleaved was used (Werner et al., 1993). Protein content were 
determined by Bradford. 
 
• Northern analysis 
Cells (50 ml of liquid culture, OD600 of about 0.8) were harvested by 
centrifugation and resuspended in 50 mM Na acetate, pH 5.3, 10 mM EDTA. Total 
RNA was isolated by heating and freezing the cells in the presence of SDS and 
phenol as described previously (Schmitt et al., 1990). RNA (5 µg per sample) was 
resolved by electrophoresis in 10% PAGE with 8 M urea, transferred to Hybond-N+ 
membrane (Amersham) by electroblotting in 0.5 x TBE (Tris-borate-EDTA) and 
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crosslinked by UV radiation (1200 mJ/cm2). The membrane was prehybridized in 
7% SDS; 0.5 M sodium phosphate pH 7.2; 1 mM EDTA pH 7.0; 1% BSA and 
hybridized at 37ºC in the same solution with oligonucleotide probes labeled with [γ-
32P]-ATP and T4 polynucleotide kinase (New England Biolabs). The probes were: 
5'TATTCCCACAGTTAACTGCGG3’ for tRNALeu(CAA), 5'CCTCCAGATGACTTGACCG3’ 
for tRNAPhe(GAA) and 5'GGATTGCGGACCAAGCTAA3’ for U3 snoRNA. After 
hybridization the blots were washed 2 x 10 min. with 1×SSC, 1% SDS and 3 x 10 
min. with 0.5×SSC (Sodium chloride-Sodium citrate), 0.1% SDS at 37ºC and 
exposed to an X-ray film or a phosphoimager screen (Molecular Dynamics). RNA 
was measured using the PhosphorImager STORM 820 (Molecular Dynamics).  
 
• Protein Extraction and Immunoblotting 
To avoid action of endogenous kinases or phosphatases during cell harvesting 
and protein extraction, yeast cells were rapidly harvested by centrifugation at 4°C, 
and 20% trichloroacetic acid (TCA) was added to the cell pellet as described earlier 
(Ciesla et al., 2007; Oficjalska-Pham et al., 2006). Cells were broken with acid-
washed glass beads (15 min., 4°C), the supernatant was retained and TCA-
precipitated proteins were pelleted by centrifugation (10 min., 4°C, 15000 rpm). The 
pellet was resuspended in sample buffer (pH 8.8) and boiled for 5 min. Protein 
extracts were separated on SDS-PAGE using a modified acrylamide: bisacrylamide 
ratio (33.5:0.3). One lane was loaded with protein from 1 OD of cell culture (10–20 
µg). The membrane was blocked for 30 min. in TBST (10 mM Tris, 150 mM NaCl, 
0.05% Tween 20) containing 5% fat-free dry milk and then incubated for 1 h with 
Maf1- specific antibody at 1:10 000 dilution (Ciesla et al., 2007). After washing with 
TBST, the membrane was incubated with secondary anti-rabbit antibody coupled to 
horseradish peroxidase (DAKO) that, after washing with TBST, was then visualized 
by chemiluminescence using the ECL detection kit (Milipore).  
Alternatively the membranes were incubated with secondary antibodies labelled 
with IRDye 800CW and IRDye 700DX infrared dyes and scanned by OdysseyTM 
Imager (LI-COR Biosciences) (Schutz-Geschwender et al., 2004).  
 
• Immunofluorescence 
Cells were fixed in culture by adding formaldehyde to a final concentration of 
3.7% for 1 h, spun down, washed and converted to spheroplasts, which were 
applied on microscopic slides covered with polylysine and subsequently treated as 
described previously (Oficjalska-Pham et al., 2006). Maf1 antibody was added  
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(1: 500) followed by secondary CY3-conjugated anti-rabbit antibody (1: 1 000). Cells 
were viewed by Microphot-SA (Nikon). Images were collected using Photometrix 
CH350 camera. 
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VI. SUPPLEMMENTAL DATA 
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Table S1. Plasmids carrying truncated maf1 allele. Plasmids organized according to the position of the STOP codon that occurs in maf1. Presented 
plasmids convey thermosensitive growth phenotype on glycerol-containing medium at 37ºC (YPGly). Protein expression was not tested. 
 
Plasmid Amino acid 
substitution 
Change in 
codon 
Silent 
mutations 
Mutations in 
promoter region 
Mutations in 
intron 
Position of the 
STOP codon 
Mutations 
behind STOP 
codon 
pAG28 none none none A → G (-1 nt) none K2 → STOP 
(AAA → TAA) 
none 
pAG60 none none none A → T (-108 nt) none K2 → STOP 
(AAA → TAA) 
„E”57 → D 
(GAA → GAC) 
pAG13 none none none none A → G (14 nt) R11 → STOP 
(AGA → TGA) 
none 
pAG12 none none none A → G (-56 nt) none K40 → STOP 
(AAG → TAG) 
none 
pAG14 none none none none A → G (23 nt) Q56 → STOP 
(CAG → TAG) 
„S”119 → R 
(AGT → AGA) 
pAG18 D40 → V GAT → GTT none T → C (-72 nt) T → C (37 nt) C79 → STOP 
(TGC → TGA) 
none 
pAG15 M1 → T 
Q68 → L 
ATG → ACG 
CAG → CTG 
none T → C (-194 nt) 
T → C (-168 nt) 
none R98 → STOP 
(AGA → TGA) 
none 
pAG20 none none L55 
(TTA → TTG) 
none none R98 → STOP 
(AGA → TGA) 
„S”101 → P 
(TCT → CCT) 
pAG6 N120 → S AAT → AGT I31 
(ATT → ATC) 
none none S166 → STOP 
(TCT → TAG) 
„S”167 → K 
(TCT → AAG) 
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Table S2. Plasmids carrying maf1 mutated allele with frameshift mutations. Plasmids organized according to the order of identification. Presented 
plasmids convey thermosensitive growth phenotype on glycerol-containing medium at 37ºC (YPGly). Protein expression was not tested.  
 
Plasmid Amino acid 
substitution 
Change in 
codon 
Silent 
mutations 
Mutations in 
promoter region 
Mutations in 
intron 
Position of the 
frameshift 
Mutations 
behind 
frameshift 
pAG7 none none L65 
(CTT → CTC) 
T → C (- 74 nt) 
T → X (-20 nt) 
none W94 
(TGG → GG) 
none 
pAG38 none none L65 
(CTT → CTC) 
A → G (- 156 nt) 
C → T (-33 nt) 
none N115 
(AAT → AT) 
none 
pAG42 none none none none none E95 
(GAG → GGAG) 
„N”117 
(AAT → AGT) 
pAG43 none none none A → G (-180 nt) T → C (21 nt) V12 
(GTG → GAGTG) 
„E”104 
(GAA → GAG) 
pAG44 F18 → L 
L55 → S 
TTC → CTC 
TTA → TCA 
none none none Q76 
(CAA → CA) 
none 
pAG46 R11 → S AGA → AGT I31 
(ATT → ATC) 
A → G (-6 nt) A → C (17 nt) 
A → G (85 nt) 
L55 
(TTA → TA) 
none 
pAG52 none none none T → C (-66 nt) none G27 
(GGC → GC) 
none 
pAG54 N60 → D AAT → GAT D89 
(GAT → GAC) 
none none N115 
(AAA → AA) 
none 
pAG55 none none none T → C (-134 nt) 
A → G (-47 nt) 
none N58 
(AAT → AT) 
„N”60 
(AAT → AGT) 
pAG63 none none none none none W94 
(TGG → TGGG) 
„N”117 
(AAT → AGT) 
pAG65 L55 → S TTA → TCA none none none N142 
AAT → AT 
none 
pAG73 N58 → S AAT → AGT none T → C (-132 nt) none N145 
(AAT → AT) 
none 
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Table S3. Plasmids carrying maf1 allele mutated in the sequence encoding BC domain. Table 
presents plasmids harboring maf1 alleles with multiple mutations or maf1 alleles that convey no 
growth defect. Growth phenotype on glycerol-containing medium at 37ºC (YPGly) signed as a: lack of 
growth (-); moderate growth defect (+/-) or no growth defect (WT, wild type). Plasmids organized 
according to the growth phenotype resulting from mutated Maf1 and number of mutations that occur. 
Protein expression was not tested. 
 
Plasmid Type of 
mutant 
Amino acid 
substitution 
Change in 
codon 
Silent mutations YPGly 
pAG126 multiple 
(4) 
R280 → G 
I290 → N 
E314 → G 
Y335 → C 
AGA → GGA 
ATT → AAT 
GAG → GGG 
TAC → TGC 
P215 (CCA → CCG) 
S230 (TCA → TCG) 
- 
pAG145 multiple 
(4) 
T257 → A 
E288 → G 
S307 → P 
L321 → P 
ACG → GCG 
GAG → GGC 
TCA → CCA 
CTT → CCT 
none - 
pAG163 multiple 
(4) 
F259 → S 
N273 → Y 
N308 → S 
L354 → S 
TTT → TCT 
AAC → TAC 
AAC → AGC 
TTG → TCG 
S305 (TCA → TCG) 
L336 (CTT → CTA) 
L338 (TTG → CTG) 
- 
pAG174 multiple 
(4) 
T257 → S 
M294 → L 
R332 → G 
L343 → Q 
ACG → TCG 
ATG → TTG 
AGA → GGA 
CTA → CAA 
K356 (AAA → AAG) - 
pAG108 multiple 
(5) 
I226 → M 
E228 → G 
L238 → P 
K265 → E 
Y317 → N 
ATA → ATG 
GAA → GGA 
CTG → CCG 
AAA → GAA 
TAT → AAT 
none - 
pAG133 multiple 
(5) 
I241 → T 
S277 → P 
L301 → R 
L318 → H 
N320 → T 
ATC → ACC 
TCT → CCT 
CTT → CGT 
CTT → CAC 
AAT → ACC 
P256 (CCA → CCT) 
I268 (ATT → ATA) 
- 
pAG161 multiple 
(5) 
E213 → A 
L238 → P 
S277 → P 
K329 → N 
T347 → S 
GAA → GCA 
CTG → CCG 
TCT → CCT 
AAA → AAT 
ACA → TCA 
T198 (ACA → ACC) 
S230 (TCA → TCG) 
L278 (CTT → CTC) 
S307 (TCA → TCC) 
G316 (GGC → GGT) 
- 
pAG111 multiple 
(6) 
I181 → N 
S189 → L 
S209 → T 
L242 → H 
Y246 → N 
M294 → V 
ATT → AAT 
TCA → TTA 
TCT → ACT 
CTC → CAC 
TAT → AAT 
ATG → GTG 
A199 (GCA → GCT) 
L218 (TTA → CTA) 
- 
pAG170 multiple 
(6) 
F235 → L 
F259 → L 
K270 → N 
W319 → R 
D352 → E 
K356 → R 
TTT → CTT 
TTT → TTA 
AAA → AAT 
TGG → CGG 
GAT → GAA 
AAA → AGA 
Q281 (CAA → CAG) - 
pAG173 multiple 
(6) 
N192 → I 
S231 → G 
K261 → E 
F310 → L 
R328 → W 
S345 → P 
AAT → ATT 
AGC → GGC 
AAA → GAA 
TTT → CTT 
AGG → TGG 
TCG → CCG 
P247 (CCT → CCC) 
L264 (TTG → CTG) 
- 
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Continued: 
Plasmid Type of 
mutant 
Amino acid 
substitution 
Change in 
codon 
Silent mutations YPGly 
pAG123 multiple 
(7) 
V203 → D 
S245 → T 
F251 → L 
F259 → L 
M294 → T 
L325 → H 
N344 → I 
GTT → GAT 
TCT → ACT 
TTT → CTT 
TTT → CTT 
ATG → ACG 
CTT → CAT 
AAT → ATT 
T198 (ACA → ACG) 
E228 (GAA → GAG) 
C299 (TGC → TGT) 
- 
pAG152 multiple 
(7) 
K188 → E 
D248 → V 
H249 → Q 
Q281 → H 
W287 → G 
F324 → I 
K329 → N 
AAA → GAA 
GAC → GTC 
CAT → CAA 
CAA → CAT 
TGG → GGG 
TTT → ATT 
AAA → AAT 
I268 (ATT → ATC) 
L311 (TTG → CTG) 
- 
pAG156 multiple 
(7) 
S209 → T 
S297 → P 
I322 → K 
K329 → I 
R332 → G 
Y337 → L 
TCT → ACT 
TCT → CCT 
ATA → AAA 
AAA → ATA 
AGA → GGA 
TAC → CTC 
L338 (TTG → CTG) 
T347 (ACA → ACT) 
- 
pAG172 multiple 
(7) 
S180 → R 
N193 → S 
F223 → L 
I226 → A 
N291 → S 
F324 → I 
Y335 → F 
AGT → AGA 
AAT → AGT 
TTT → TTA 
ATA → GCA 
AAT → AGT 
TTT → ATT 
TAC → TTC 
P215 (CCA → CCG) 
P306 (CCT → CCA) 
- 
pAG149 multiple 
(8) 
V254 → A 
K261 → I 
K265 → R 
S305 → P 
L321 → H 
I322 → L 
C340 → R 
E349 → G 
GTT → GCT 
AAA → ATA 
AAA → AGA 
TCA → CCA 
CTT → CAT 
ATA → TTA 
TGC → CGC 
GAA → GGA 
L264 (TTG → CTG) 
L311 (TTG → TTA) 
- 
pAG138 multiple 
(5) 
E272 → G 
N291 → Y 
E314 → G 
N344 → D 
K356 → R 
GAA → GGA 
AAT → TAT 
GAG → GGG 
AAT → GAT 
AAA → AGA 
K331 (AAA → AAG) +/- 
pAG175 multiple 
(5) 
N204 → D 
T257 → A 
F267 → L 
S269 → P 
L343 → P 
AAC → GAC 
ACG → GCG 
TTT → CTT 
TCC → CCC 
CTA → CCA 
N191 (AAC → AAT) 
S196 (TCT → TCA) 
A240 (GCT → GCA) 
S245 (TCT → TCC) 
P306 (CCT → CCC) 
+/- 
pAG118 multiple 
(6) 
H249 → Q 
S253 → T 
V286 → A 
M294 → L 
D365 → G 
D366 → V 
CAT → CAA 
TCG → ACG 
GTC → GCC 
ATG → TTG 
GAT → GGT 
GAT → GTT 
none +/- 
pAG88 single K270 → N AAA → AAT G323 (GGT → GGC) 
I364 (ATA → ATT) 
WT 
pAG101 single D389 → E GAT → GAA none WT 
pAG89 double K270 → E 
S307 → P 
AAA → GAA 
TCA → CCA 
S252 (TCA → TCT) WT 
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Table S4. Plasmids carrying truncated maf1 alleles Table represents plasmids encoding Maf1 mutated in the BC domain. Growth phenotype on glycerol-
containing medium at 37ºC (YPGly) signed as: (-) – growth defect, (+/-) – moderate growth defect. Plasmids organized according to the growth phenotype on 
YPGly and position of the STOP codon that occurs in mutated Maf1. Protein expression was not tested. 
 
Plasmid Amino acid 
substitution 
Change in 
codon 
Silent  
mutations 
Position of the STOP 
codon 
Mutations behind STOP 
codon 
YPGly 
pAG151 none none V254 (GTT → GAA) 
T295 (ACT → ACC) 
P306 (CCT → CCC) 
S309 (TCT → TCC) 
K265 → STOP (AAA → TAA) 
 
„L275” → F (TTA → TTC) 
„S307” → P (TCA → CCA) 
„R328” → K (AGG → AAG) 
- 
pAG146 K265 → E AAA → GAA F267 (TTT → TTC) 
S305 (TCA → TCT) 
L362 (CTT → CTG) 
R280 → STOP (AGA → TGA) „Q281” → H (CAA → CAT) 
„Y317” → H (TAT → CAT) 
„E351” → V (GAA → GTA) 
„D352” → G (GAT → GGT) 
„Q359” → L (CAG → CTG) 
- 
pAG166 F251 → S 
K265 → I 
TTT → TCT 
AAA → ATA 
V254 (GTT → GTC) 
K261 (AAA → AAG) 
L325 (CTT → CTA) 
W285 → STOP (TGG → TAG) „L338” → S (TTG → TCG) - 
pAG165 T257 → A 
T262 → S 
K270 → R 
ACG → GCG 
ACA → TCA 
AAA → AGA 
C299 (TGC → TGT) 
D366 (GAT → GAC) 
Y304 → STOP (TAT → TAA) 
K331 → STOP (AAA → TAA) 
„N327” → Y (AAC → TAC) 
„I339” → F (ATT → TTT) 
- 
pAG168 none none none Y317 → STOP (TAT → TAG) none - 
pAG117 
pAG120 
F251 → L 
T266 → A 
I290 → N 
TTT → CTT 
ACT → GCT 
ATT → AAT 
none L338 → STOP  (TTG → TAG) none - 
pAG128 none none I239 (ATT → ATA) S263 → STOP  (TCA → TAA) „R280” → I (AGA → ATA) 
„I322” → M (ATA → ATG) 
+/- 
pAG176 E288 → G 
H293 → L 
L336 → P 
GAG → GGG  
CAC → CTC 
CTT → CCT 
GAA → GAG (E349) 
CCT → CCC (P358) 
L354 → STOP (TTG → TAG) none +/- 
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Table S5. Plasmids carrying maf1 allele with frameshift mutations. Table represents plasmids encoding Maf1 mutated in the BC domain. All plasmids 
convey growth defect on glycerol-containing medium at 37ºC (YPGly). Plasmids organized according to the order of identification. Protein expression not tested. 
 
Plasmid Amino acid 
substitution 
Change in 
codon 
Silent  
mutations 
Position of the 
frameshift 
Mutations behind 
frameshift 
pAG114 N204 → S AAC → AGC none S231 (AGC → GC)  „E255” (GAG → GGG) 
„F267” (TTT → TTA) 
„H293” (CAC → CGC) 
pAG115 T200 → A ACC → GCC S183 (AGT → AGC) 
T198 (ACA → ACG) 
T295 (ACT → ACA) 
S297 (TCT → TCA) 
L311 (TTG → G) „C340” (TGC → GGC) 
„D352” (GAT → AAT) 
pAG121 F251 → L 
F271 → S 
TTT → CTT 
TTT → TCT 
S245 (TCT → TCC) 
N320 (AAT → AAC) 
I339 (ATT → ATA) 
H293 (CAC → C) none 
pAG124 H249 → L 
F271 → L 
CAT → CTT 
TTT → CTT 
none P315 (CCT → CC) „D352” (GAT → GGT) 
pAG125 none none none I268 (ATT → TATT) „N344” (AAT → GAT) 
„L336” (CTT → CCT) 
pAG129 R206 → S 
K233 → R 
AGA → AGT 
AAA → AGA 
L218 (TTA → CTA) E288 (GAG → GA) „L325” (CTT → CCT) 
pAG130 none none K205 (AAA → AAG) 
I234 (ATA → ATT) 
I239 (ATT → AT) „K261” (AAA → ATA) 
„Y317” (TAT → CAT) 
„L354” (TTG → ATG) 
pAG131 none none F310 (TTT → TTC) P282 (CCA → CA) „E314” (GAG → GGG) 
pAG134 Y246 → D TAT → GAT GTA → GTT (V289) S252 (TCA → CA) „S297” (TCT → CCT) 
„W319” (TGG → CGG) 
pAG141 none none G197 (GGT → GGC) 
Y237 (TAT → TAC) 
E272 (GAA → GAG) 
K261 (AAA → A) „D366” (GAT → GAA) 
pAG143 K185 → E 
S186 → G 
AAA → GAA 
AGT → GGT 
I268 (ATT → ATC) 
P282 (CCA → CCT) 
D366 (GAT → GAC) 
K188 (AAA → AA) „N227” (AAC → ACC) 
pAG144 S252 → T TCA → ACA none Y276 (TAT → T) none 
pAG158 none none S252 (TCA → TCG) 
I339 (ATT → ATC) 
V254 (GTT → GT) „T266” (ACT → GCT) 
„F271” (TTT → TCT) 
„Y337” (TAC → AAC) 
pAG169 L336 → P CTT → CCT S309 (TCT → TCC) 
L325 (CTT → CTC) 
K329 (AAA → AAG) 
N344 (AAT → AT) „S346” (AGT → GGT) 
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Table S6. Quantification of the relative amounts of the phosphorylated and nonphosphorylated Maf1 forms of K35E mutant and its suppressors 
(K35E-D250E and K35EV260D-N344I). Table presents relative ratio between phosphorylated and non-phosphorylated form of Maf1 for each time point after 
transfer to glycerol-containing medium (Fig. 19A). Bands intensities were quantified using Multi Gauge v 3.0 (Fujifilm) software. Ratio were normalized to that 
characteristic for exponentially growing cells (Exp). The relative ratio between phosphorylated and nonphosphorylated form of Maf1 normalized to that 
observed in exponential growth phase for each strain shows approximate speed of Maf1 dephosphorylation in mutants strains.  
 
 glycerol 
 Maf1 phospho-form Exp. 15’ 30’ 60’ 90’ 120’ 
WT Phosphorylated 115 167 56 326 26 497 43 991 31 520 35 092 
 Nonphosphorylated 87 569 185 210 234 162 173 818 198 230 249 981 
Ratio  1.3 0.3 0.1 0.3 0.2 0.1 
Normalization to Exp.  1 0.2 0.1 0.2 0.1 0.1 
 
 glycerol 
 Maf1 phospho-form Exp. 15’ 30’ 60’ 90’ 120’ 
K35E Phosphorylated 90 102 148 252 109 899 154 009 98 210 96 377 
 Nonphosphorylated 142 862 218 559 200 084 168 037 194 546 184 242 
Ratio  0.6 0.7 0.5 0.9 0.5 0.5 
Normalization to Exp.  1 1.1 0.9 1.5 0.8 0.8 
 
 glycerol 
 Maf1 phospho-form Exp. 15’ 30’ 60’ 90’ 120’ 
K35E-D250E Phosphorylated 183 815 64 782 23 038 39 042 45 542 44 913 
 Nonphosphorylated 96 533 138 514 130 264 165 668 144 117 160 710 
Ratio  1.9 0.5 0.2 0.2 0.3 0.3 
Normalization to Exp.  1 0.2 0.1 0.1 0.2 0.1 
 
 glycerol 
 Maf1 phospho-form Exp. 15’ 30’ 60’ 90’ 120’ 
K35E-V260D-N344I Phosphorylated 106 601 54 230 15 050 25 410 51 437 60 560 
 Nonphosphorylated 65 740 136 488 107 371 122 913 120 832 90 695 
Ratio  1.6 0.4 0.1 0.2 0.4 0.7 
Normalization to Exp.  1 0.2 0.1 0.1 0.3 0.4 
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Table S7. Quantification of the relative amounts of the phosphorylated and nonphosphorylated Maf1 forms of D250E, V260D, N344I and double 
V260D-N344I mutants originating from identified suppressors of K35E mutant. Table presents relative ratio between phosphorylated and non-
phosphorylated form of Maf1 for each time point after transfer to glycerol-containing medium (Fig. 19B). Bands intensities were quantified as described in 
legend to Table S5. The relative ratio between phosphorylated and nonphosphorylated form of Maf1 normalized to that observed in exponential growth phase 
for each strain shows approximate speed of Maf1 dephosphorylation in mutants strains. 
 
 glycerol 
 Maf1 phospho-form Exp. 15' 30' 60' 90' 120' 
D250E Phosphorylated 104 832 11 061 3 584 679 1 282 373 
 Nonphosphorylated 82 936 185 164 89 361 75 468 108 617 55 941 
Ratio  1.3 0.1 - - - - 
Normalization to Exp. 1 - - - - - 
 
 glycerol 
 Maf1 phospho-form Exp. 15' 30' 60' 90' 120' 
V260D Phosphorylated 92 695 68 791 38 313 33 100 36 337 22 008 
 Nonphosphorylated 93 034 227 208 228 189 228 991 222 350 206 794 
Ratio  1.0 0.3 0.2 0.1 0.2 0.1 
Normalization to Exp. 1 0.3 0.2 0.1 0.2 0.1 
 
 glycerol 
 Maf1 phospho-form Exp. 15' 30' 60' 90' 120' 
N344I Phosphorylated 57 604 2 762 2 433 675 44 468 
 Nonphosphorylated 59 963 91 103 75 041 132 937 91 283 45 077 
Ratio  1 - - - - - 
Normalization to Exp. 1 - - - - - 
 
 glycerol 
 Maf1 phospho-form Exp. 15' 30' 60' 90' 120' 
V260D-N344I Phosphorylated 193 535 168 536 118 593 40 355 46 709 56 806 
 Nonphosphorylated 76 941 184 554 180 032 204 832 206 615 232 277 
Ratio  2.5 0.9 0.7 0.2 0.2 0.2 
Normalization to Exp. 1 0.4 0.3 0.1 0.1 0.1 
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Table S8. Quantity of cells with nuclear localization of Maf1 during incubation in glucose medium and after transfer to glycerol-containing medium. 
K35E-maf1, K35E-D250E-maf1 and K35E-V260D-N344I-maf1 mutant strains and isogenic WT (YPH500 maf1∆ strain transformed with pRS315-MAF1 
plasmid) were grown to exponential phase in YPD glucose medium (Exp), then transferred to glycerol YPGly medium, incubated at 37ºC for 2 hours. Cells were 
harvested as indicated. Maf1 localization was analysed by immunofluorescence microscopy using polyclonal anti-Maf1 antibodies. Nuclei were stained with 
4’,6-diamidino-2-phenylindole (DAPI). Quantified cells were partitioned into three groups of Maf1 localization: nuclear, cytoplasmatic and these of ambiguous 
localization in both compartments – cytoplasm and nucleus with a tendency to concentrate in nucleus (nuclear tendency). Quantification was performed from 
two independent experiments. Quantification was performed as a number of cells of particular kind per 100 cells evaluated (%).The average quantity is 
indicated below. 
 
glucose glycerol 
 
Nucleus 
(%° 
Nuclear 
tendency 
(%) 
Cytoplasm 
(%) 
Nucleus 
(%) 
Nuclear 
tendency 
(%) 
Cytoplasm 
(%) 
WT 1 0 16 84 91 8 1 
2 0 30 70 77 21 2 
average 0 23 77 84 15 1 
 glucose glycerol 
  
Nucleus 
(%) 
Nuclear 
tendency 
(%) 
Cytoplasm 
(%) 
Nucleus 
(%) 
Nuclear 
tendency 
(%) 
Cytoplasm 
(%) 
K35E 1 0 25 75 33 48 19 
2 1 7 92 25 32 43 
average 1 16 83 29 40 31 
 glucose glycerol 
  
Nucleus 
(%) 
Nuclear 
tendency 
(%) 
Cytoplasm 
(%) 
Nucleus 
(%) 
Nuclear 
tendency 
(%) 
Cytoplasm 
(%) 
K35E-D250E 1 6 31 63 89 3 8 
2 2 27 71 44 21 35 
average 4 29 67 67 12 21 
 glucose glycerol 
  
Nucleus 
(%) 
Nuclear 
tendency 
(%) 
Cytoplasm 
(%) 
Nucleus 
(%) 
Nuclear 
tendency 
(%) 
Cytoplasm 
(%) 
K35E-V260D-N344I 1 2 26 72 76 2 22 
2 11 32 57 46 25 29 
 average 6 29 65 61 14 25 
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Table S9. Evaluation of β-galactosidase activity for two-hybrid interaction of mutated Maf1 
domains. Table presents values of β-galactosidase activity  in units (u) and as a relative percentage 
activity. 100% is assumed for interaction of nonmutated A and BC domains of Maf1. Table represents 
data for interactions presented in Figure 27. A. pACT2-Maf1-A(1-42) plasmid and its mutated version 
were transformed individually with pAS2-Maf1- BC(196-349) plasmid or its mutated versions in yeast 
strain Y190. Transformants were assayed for β-galactosidase expression. Presented profile compares 
following two-hybrid interactions: wild type A and BC domains of Maf1 (1), mutated A domain K35E 
with wild type BC domain (2); mutated A domain K35E with four versions of mutated BC domain: 
D250E (3), V260D-N344I (4), V260D (5), N344I (6), and wild type A domain with mutated BC domain 
containing single D250E, V260D or N344I and double N344I-V260D mutations (7-10); SD, standard 
deviation; n, number of independent measures. 
 
 
Tested interaction 
ßgal 
activity 
(u) 
SD 
of (u) 
n 
ßgal activity 
(%) 
SD  
of (%) 
A WT + BC WT 170 6 3 100% 4 
A K35E + BC WT 103 18 4 61% 11 
A K35E + BC D250E  159 16 4 94% 9 
A K35E + BC V260D-N344I 148 35 5 87% 21 
A K35E + BC V260D 307 72 3 181% 42 
A K35E + BC N344I 141 29 3 83% 17 
A WT + BC D250E 133 41 5 78% 24 
A WT + BC V260D-N344I 65 28 5 38% 16 
A WT + BC V260D 70 10 3 41% 6 
A WT + BC N344I 169 38 3 99% 22 
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Maf1, first identified in yeast Saccharomyces cerevisiae, is a
general negative regulator ofRNApolymerase III (pol III). Tran-
scription regulation by Maf1 is important under stress condi-
tions and during the switch between fermentation and respira-
tion. Maf1 is composed of two domains conserved during
evolution. We report here that these two domains of human
Maf1 are resistant to mild proteolysis and interact together as
shownby pulldown and size exclusion chromatography and that
the comparable domains of yeast Maf1 interact in a two-hybrid
assay. Additionally, in yeast, a mutation in the N-terminal do-
main is compensated by mutations in the C-terminal domain.
Integrity of both domains and their direct interaction are nec-
essary forMaf1dephosphorylation and subsequent inhibitionof
RNA pol III transcription on a nonfermentable carbon source.
These data are the report relatingMaf1 structure to RNA pol III
transcription inhibition.
In eukaryotic cells, RNA polymerases (pol)3 I and III are
responsible for the synthesis of RNA species involved in ribo-
some biogenesis and the translation process. RNA synthesis by
pol I and pol III represents .80% of all yeast nuclear transcrip-
tion activity and is controlled in a coordinated way in response
to various cellular and environmental conditions (1–3).
Pol III is responsible for the transcription of ;300 different
genes in yeast (class III genes), mostly tRNA genes (4–6). Anal-
yses of the pol III transcription system in yeast have revealed a
series of protein-DNA and protein-protein interactions leading
to the recruitment of pol III to its target tRNA genes: binding of
the six-subunit TFIIIC factor to the intragenic promoter,
TFIIIC-directed recruitment and assembly of the three compo-
nents of TFIIIB (TBP, Brf1, and Bdp1), and subsequent recruit-
ment of the 17-subunit pol III enzyme (7). Whereas the essen-
tial factors and the basal mechanisms of class III gene
transcription are well defined, much less is known about the
molecular mechanisms of pol III regulation.
The unique global negative regulator of pol III transcription
in yeast is the Maf1 protein that mediates several signaling
pathways, but is not essential (8, 9). In addition to the down-
regulation that normally occurs in the stationary phase and in
response to various drugs, also DNA damage, oxidative stress,
secretory defects, and respiratory growth require Maf1 to
achieve pol III repression (8, 10–12). The activity of Maf1 is
regulated by its phosphorylation, which occurs in favorable
conditions. Apart from decreasing direct Maf1 binding to pol
III (13), this phosphorylation acts both to relocate the nuclear
pool of Maf1 to the cytoplasm (14) and to prevent import of
cytoplasmicMaf1 to the nucleus (15). Diverse unfavorable con-
ditions lead to rapid Maf1 dephosphorylation and its nuclear
accumulation, physical association of the dephosphorylated
Maf1 with pol III, and genome-wide Maf1 targeting to poI III-
transcribed genes (13, 16).
The pol IIImachinery is remarkably conserved between yeast
and human. The most conserved components are those
involved in transcription complex assembly: the t131 subunit
of TFIIIC and two components of TFIIIB (TBP, Brf1). The five
pol III-specific subunits in yeast (C31, C34, C37, C53, andC82),
all have structural and functional homologs in human cells (17).
Also,Maf1 is conserved across eukaryotic organisms fromyeast
to man (9). This conservation is of particular interest consider-
ing that misregulation of pol III in human has been linked to
malignant transformation. Excessive activation of pol III-di-
rected transcription can lead to tumorgenesis (18–21), and, in
line with this observation, two mammalian tumor suppressors,
Rb and p53, have been shown to act as global repressors of pol
III transcription (22). Recent results of several groups report
Maf1-mediated repression of pol III transcription in human
implicating HsMaf1 ortholog as a new class of mammalian pol
III regulators (23–26). The involvement of HsMaf1 in the aber-
rant control of pol III transcription in cancer cells remains to be
studied. In the light of the high evolutionary conservation of the
pol III machinery including Maf1, insights into pol III (mis)-
regulation by Maf1 gained by studying model organisms, such
* This work was supported by Ministry of Science and Higher Education,
Poland, Grant N301 023 32/1117, French National Research Agency Grant
ANR-07-BLAN-0039-01, and Association pour la Recherche contre le Can-
cer Grant 1078.
□S The on-line version of this article (available at http://www.jbc.org) contains
supplemental Figs. S1–S8 and Table S1.
1 To whom correspondence may be addressed. Tel.: 33 1 69 08 59 57; Fax: 33
1 69 08 47 12; E-mail: Olivier.Lefebvre@Cea.Fr.
2 To whom correspondence may be addressed: Institute of Biochemistry and
Biophysics, Polish Academy of Sciences, Pawinskiego 5a, 02-106 Warsaw,
Poland. Tel.: 4822 592 1312; Fax: 4822 592 2190; E-mail: magda@ibb.
waw.pl.
3 The abbreviations used are: pol, polymerase; aa, amino acids.
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as yeast, should provide some insight into the role of HsMaf1 in
cancer.
Our current interest concerns the relation between Maf1
structure and activity. All members of the Maf1 family have
three fairly conserved segments (9) which, however, show no
significant homology with protein domains of known function
resulting in the striking lack of information on the functional
significance of those regions. Point mutations have only high-
lighted the importance of several serine residues (mostly not
phylogenetically conserved) and two nuclear localization
sequences (15, 16, 27). We describe here identification of two
conserved domains in HsMaf1 and show that the correspond-
ing regions in yeastMaf1 interact. This interaction is crucial for
the regulation of Maf1 activity by phosphorylation. Our data
provide the first insight into the Maf1 structure in relation to
pol III regulation.
EXPERIMENTAL PROCEDURES
Expression and Purification of HsMaf1 Protein—Human full-
length Maf1 (HsMaf1) (aa 1–256) was expressed as a C-termi-
nalHis6-tagged protein (HsMaf1-CHis) in insect cells. The pro-
tein was purified using cobalt affinity resin (Clontech). As a
final purification step, the protein was applied to size exclusion
chromatography equilibrated in buffer I (10 mM Tris, pH 7.4,
150 mM NaCl, 1 mM DTT).
HsMaf1 fragments consisting of aa 1–45, 1–59, 1–63, 1–74,
and 85–210 were co-expressed for 15 h at 18 °C in Escherichia
coli BL21 Gold (DE3) cells (Stratagene) using expression vector
pETMCN-His (C. Romier, IGBMC) coding for tobacco etch
virus-cleavable N-terminal His-tagged HsMaf1 aa 1–45, 1–59,
1–63, and 1–74 and expression vector pETMCN (as above)
coding for nontagged Maf1 aa 85–210. The complex was puri-
fied by nickel affinity chromatography (nickel-nitrilotriacetic
acid; Qiagen) followed by tobacco etch virus protease cleavage
and a second nickel affinity chromatography to remove the His
tag. The complex was further purified by anion-exchange chro-
matography (MonoQ 10/100; GE Healthcare) and size exclu-
sion chromatography.
HsMaf1 fragment(82–236) was expressed from pETM11
(EMBL) as a potentially tobacco etch virus-cleavable, N-termi-
nal His-tagged protein that was purified by nickel affinity chro-
matography (chelating Sepharose; GE Healthcare). However,
the purified tagged protein HsMaf1(82–236) could not be
cleaved by tobacco etch virus protease, most likely due to its
aggregated state. The tagged protein was further purified by
anion exchange chromatography (5-ml HiTrap Q-Sepharose
HP; GE Healthcare) and size exclusion chromatography (S200
10/300; GE Healthcare).
Limited Proteolysis of HsMaf1 Protein—hMaf1-CHis protein
at a concentration of 1 mg/ml was digested with trypsin for 30
min at 4 °C in buffer I using a protease:protein ratio of 1:150
(w/w). The reaction was stopped by adding PMSF to a final
concentration of 1 mM. The proteolysis product was concen-
trated to 2mg/ml using an AmiconMWCO 3000 concentrator
(Millipore) and subsequently purified using two consecutive
Superdex 200 10/300 columns (GEHealthcare) to improve res-
olution in buffer I. Purified HsMaf1 fragments were unambig-
uously identified using a combination of Edman degradation
and mass spectrometry (quantitative time of flight).
Yeast Saccharomyces cerevisiae Strains and Media—The
yeast strains used in this study included wild type YPH500
(MATa, ade2-101, his3-D200, leu2-D1, lys2-801, trp1-D63,
ura3-52), maf1-D, a derivative of YPH500 (13), and the two-
hybrid reporter strain Y190 (MATa, gal4-542, gal80-538, his3,
trp1-901, ade2-101, ura3-52, leu2-3, 112, URA3::GAL1-lacZ,
LYS2::GAL1(UAS):: HIS3, cyhR) (28). Rich media contained 1%
yeast extract, 2% peptone, and 2% glucose (YPD) or 2% glycerol
(YPGly). The minimal medium (SC) contained 2% glucose and
0.67% yeast nitrogen base without aa (29). Solid media con-
tained 2% agar. All reagents were from Difco.
Construction of Plasmids to Express Fragments of Yeast Maf1
Protein for Two-hybrid Study—DNA encoding fragments(1–
12), (1–16), and (1–23) of domain A of yeastMaf1 were synthe-
sized as oligonucleotides. The larger DNA sequences, encoding
aa 1–34, 1–39, and 1–42 were amplified using forward primer
59-TCATCGGGATCCGAATGAAATTTATTGATGAGCT-
AGATATAGAGAGAGTG-39 and reverse primers 59-TCAT-
CGCTCGAGTTTTCTATCTGATGCAACCGC-39, 59-TCAT-
CGCTCGAGTGATGCAACCGCCTTTGTTGTG-39, and 59-
TCATCGCTCGAGTGTTGTGAAAATATCGCAACTGCC-
39, respectively. The intron sequence of the MAF1 gene
(localized between bp 7 and 87) was excluded. DNA encoding
the amino acid 196–349 fragment of BC domain was amplified
with primers 59-TCATCGGGATCCGATCTGGTACAGCA-
ACCAACAATG-39 and 59-TCATCGCTCGAGTTCGCCTG-
TACTCGAATTTAG-39. All MAF1 parts were amplified with
BamHI and XhoI termini fragments and inserted into
MATCHMAKER GAL4 Two-hybrid Vectors (Clontech),
either the pACT2 plasmid carrying the activation domain of
Gal4 or the pAS2 plasmid carrying the binding domain of Gal4.
The resulting plasmids were named pACT2-Maf1-A(1–12),
pACT2-Maf1-A(1–16), pACT2-Maf1-A(1–23), pACT2-Maf1-
A(1–34), pACT2-Maf1-A(1–39), pACT2-Maf1-A(1–42), and
pAS2-Maf1-BC(196–349). Expression of fusion proteins
involving HA-tagged truncated versions of A domain was ver-
ified byWestern blotting. Each of the derivatives of pACT2 and
the single derivative of pAS2 were co-expressed pairwise in the
two-hybrid reporter strain Y190. Cells containing these two
plasmidswere patched on SCmedium lacking leucine and tryp-
tophan. The patches were then examined for b-galactosidase
activity using an overlay plate assay (30). The intensity of the
coloration was calibrated by comparison with a pair of known
interactors (t95/t55, two TFIIIC subunits) for which the b-ga-
lactosidase activity had been measured previously (31). For a
b-galactosidase liquid assay, cell lysates were prepared, and the
activity was measured colorimetrically as nmol of o-nitrophe-
nyl-b-D-galactopiranoside hydrolyzed per minute per mg of
protein. Conversion 0.0045 3 A420 5 1 nmol of o-nitrophenyl-
b-D-galactopyranoside cleaved was used (30).
Generation of Yeast S. cerevisiae Maf1 Mutant Strains—
MAF1 gene was cut from pFL44-MAF1 (32) subcloned in
pRS315 (LEU2, CEN) plasmid (33) resulting in pRS315-MAF1.
The pAG70, pLM11 and pLM12 plasmids were derived from
pRS315-MAF1 using a rapid method for localized mutagenesis
(34). For this purpose,MAF1 fragment(1–180)was PCR-ampli-
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fied from pRS315-MAF1 under mutagenic conditions using
59-CGAGTTGCTTGTCAATCAGG-39 and 59-CTGCTACT-
GCTCCTTCTTCT-39 primers and a Diversify PCR Random
Mutagenesis kit (Clontech). The product of the low fidelity PCR
was transformed together with gapped linear plasmid pRS315-
MAF1 (digested with BclI and BsgI) into the YPH500 maf1-D
strain (13). Transformants, selected on minimal medium lack-
ing leucine, were subsequently tested for Maf1 activity by rep-
lica-plating on YPGly and incubation at 37 °C for 3 days; among
38 independent mutants, pAG70 (maf1-K35E) was selected
from colonies that showed defective growth. To isolate pML11
(maf1-K35E/D250E) and pML12 (maf1-K35E/V260D/N344I)
plasmids carrying suppressor mutations, pRS315 plasmid
pAG70 (carrying the previously isolated maf1 allele with the
K35Emutation) was digested with BsaBI and Bsu36I and intro-
duced into the YPH500 maf1-D strain together with a MAF1
fragment encoding BC domain (aa 174–375) PCR-amplified
under mutagenic conditions using primers 59-AGAAGAAG-
GAGCAGTAGCAG-39 and 59-CGTATTCTCCTTCGTAT-
TCA-39. The obtained library of potential suppressor mutants
was screened for overcoming the thermosensitivity on YPGly
medium caused by the K35E mutation. This screen resulted in
identification of pLM11 and pLM12 suppressor mutations in
the BC domain of Maf1.
To generate mutations in the two-hybrid plasmids carrying
fragments encodingMaf1 domains, the BamHI-XhoI fragment
encoding aa 1–42 of Maf1 in the pACT2-Maf1-A(1–42) plas-
midwas substitutedwith a PCR-amplified fragment of themaf1
allele K35E from pAG70. Similarly, the mutations found in
pML11 and pML12 were introduced in pAS2-Maf1-BC(196–
349). The N344I mutation found in the pML12 plasmid was
introduced to pAS2-Maf1-BC(196–349) by using a modified
reverse primer 39-TCATCGCTCGAGTTCGCCTGTACTC-
GAAATTAGACGCGAGC-59 with a mutation leading to the
desired amino acid substitution.
A QuikChange Site-directed Mutagenesis kit (Stratagene)
was used to introduce D250E, N344I, V260D, and V260D/
N344I to pRS315-MAF1. The sequences of primers used are
available upon request.
NorthernBlot Analysis—Cells (50ml of liquid culture,A600 of
approximately 0.8) were harvested by centrifugation and resus-
pended in 50 mM sodium acetate, pH 5.3, 10 mM EDTA. Total
RNA was isolated by heating and freezing the cells in the pres-
ence of SDS andphenol as described previously (12, 35). RNA (5
mg/sample) was resolved by electrophoresis in 10% PAGE with
8 M urea, transferred to Hybond N1 membrane (Amersham
Biosciences) by electroblotting in 0.53 TBE, and cross-linked
byUV radiation (1200mJ/cm2). Themembranewas prehybrid-
ized in 7% SDS, 0.5 M sodium phosphate, pH 7.2, 1 mM EDTA,
pH 7.0, 1% BSA and hybridized at 37 °C in the same solution
with oligonucleotide probes labeled with [g-32P]ATP and T4
polynucleotide kinase (New England Biolabs). The probes were
59-TATTCCCACAGTTAACTGCGG-39 for tRNALeu(CAA),
59-CCTCCAGATGACTTGACCG-39 for tRNAPhe(GAA),
and 59-GGATTGCGGACCAAGCTAA-39 for U3 snoRNA.
After hybridization, the blots were washed 2 3 10min with 13
SSC and 1% SDS and 3 3 10 min with 0.53 SSC and 0.1% SDS
at 37 °C and exposed to an x-ray film or a PhosphorImager
screen (Molecular Dynamics).
Protein Extraction and Immunoblotting—To avoid action of
endogenous kinases or phosphatases during cell harvesting and
protein extraction, yeast cells were rapidly harvested by centri-
fugation at 4 °C, and 20% trichloroacetic acid was added to the
cell pellet as described earlier (12, 13). Cells were broken with
acid-washed glass beads, the supernatant was retained, and tri-
chloroacetic acid-precipitated proteins were pelleted by centri-
fugation. The pellet was resuspended in sample buffer, pH 8.8,
and boiled for 5 min. Protein extracts were separated on SDS-
PAGE using a modified acrylamide:bisacrylamide ratio (33.5:
0.3). One lanewas loadedwith protein from1ODof cell culture
(10–20 mg). The membrane was blocked for 30 min in TBST
(10 mM Tris, 150 mM NaCl, 0.05% Tween 20) containing 5%
fat-free dry milk and then incubated for 1 h with Maf1-specific
antibody at 1:10,000 dilution (12). The membrane was incu-
batedwith secondary anti-rabbit antibody coupled to horserad-
ish peroxidase (DAKO) which was then visualized by chemilu-
minescence using the ECL detection kit (Millipore).
RESULTS
Two Domains of Maf1 Do Interact—The yeast MAF1 gene
encodes a hydrophilic protein of 395 aa rich in serine and aspar-
agine residues, with a predicted molecular mass of 44.7 kDa.
Screening of multiple databases with the yeast Maf1 sequence
revealed numerous orthologs in other eukaryotes: 1 in human,
50 in animals, 28 in plants, and 27 in lower eukaryotes, but none
in prokaryotes. Maf1 proteins contain three phylogenetically
conserved sequence regions, labeled A, B, and C (9). The simi-
larity of the yeast and human Maf1 sequences is presented in
Fig. 1, andmoreMaf1 proteins are aligned in supplemental Fig.
S1. Because the distance between the B and C segments of ;10
aa is constant in evolution, with the exception of Aspergillus
nidulans (insertion of 15 aa), we consider this region could be a
single domainnamedhere as BC. In contrast, the space between
regions A and B largely varies between species. The A and BC
domains are fused in Encephalitozoon cuniculi whereas in the
yeast S. cerevisiae andCandida glabrata they are separated by a
long linker of 182 and 174 aa, respectively. Within the BC
domain signature sequences for theMaf1 protein family can be
identified (PDYDFS and LWSFnYFFYNKklKR; supplemental
Fig. S1) (9). These sequence “motifs” are not reported in the
PROSITE database. Interestingly, in the majority of Maf1
orthologs, the second motif includes a nuclear targeting signal,
which was proved to be functional in S. cerevisiaeMaf1 (15).
To characterize the structure organization of human Maf1
(HsMaf1) experimentally, we carried out limited proteolysis
experiments in combination with size exclusion chromatogra-
phy as shown in Fig. 2. Proteolytically stable fragments are con-
sidered to be structurally well defined, whereas protease-sensi-
tive sites often correlatewith disordered regions of the proteins.
Using limited proteolysis with trypsin, HsMaf1 protein (256 aa)
was digested into two major stable fragments that were identi-
fied as HsMaf1(1–45) and Maf1(75–234) using a combination
of N-terminal sequencing andmass spectrometry (quantitative
time of flight). The HsMaf1 linker region between those frag-
ments (aa 46–74) and the C-terminal acidic tail (aa 235–256)
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was degraded and thus presumably unstructured (Fig. 2A, lane
2). Both fragments were further analyzed by size exclusion
chromatography. Surprisingly, the two HsMaf1 fragments,
although of substantially different molecular masses, co-eluted
in an apparent 1:1 stoichiometry, suggesting an intramolecular
interaction between them (Fig. 2B, red profile).
Taking into account the limited proteolysis and secondary
structure prediction results (data not shown), we designed N-
and C-terminal constructs of HsMaf1 for co-expression in bac-
teria. The N-terminal construct aa 1–45 corresponds to the
minimal domain defined by proteolysis whereas fragment
encoding aa 85–210 was designed slightly shorter than the ini-
tial proteolytic fragment. During purification His tag-contain-
ing recombinant HsMaf1 fragment(1–45) but also slightly
larger constructs (1–59), (1–63), and (1–74) co-precipitate the
untagged C-terminal construct (85–210) in an apparent 1:1
stoichiometry, suggesting a direct interaction between the N-
and C-terminal fragments (supplemental Fig. S2).
Analysis by size exclusion chromatography supports the
results obtained for the proteolytic fragments. Constructs(1–
45) and (85–210) co-elute as a single peak at a volume corre-
sponding to the expected molecular mass of ;20 kDa (Fig. 2B).
These results provide further support for a direct interaction
between A and BC domains of HsMaf1. Interestingly, the co-
expressed complex is considerably more compact compared
with the full-length protein, presumably because it is lacking
the C-terminal acidic tail. In contrast, an additional construct
of aa 82–236 that includes the C-terminal acidic tail eluted as
soluble aggregate (Fig. 2B, bottom panel) when expressed in the
absence of theN-terminal fragment of aa 1–45.We also tried to
express theN-terminal fragment of aa 1–45 as GST fusion pro-
tein, but we only obtained minimal amounts presumably
because the protein aggregates after tobacco etch virus cleavage
(data not shown). Apparently, N- and C-terminal domains of
HsMaf1 are both required for the soluble expression of HsMaf1
and co-elute during size exclusion chromatography, indicating
a direct interaction between them.
To investigate whether the interaction between domains of
Maf1 is conserved through evolution,we analyzed the proposed
interaction in yeast, an organismmore amenable to study struc-
ture-function relationships of Maf1 using the two-hybrid sys-
tem. The putative BC domain of S. cerevisiae Maf1 (aa 196–
349) was fused to the DNA-binding domain of Gal4 and
co-expressed with various Maf1 A domain constructs fused to
the Gal4 activation domain in the yeast reporter strain Y190.
Interactions between fusion proteins should result in activation
of the b-galactosidase reporter gene. Using this approach, we
observed a physical interaction between theBCdomain ofMaf1
encoded by plasmid pAS2-Maf1-BC(196–349) and fragments
of domain A of Maf1 encoded by plasmids pACT2-Maf1-A(1–
42), pACT2-Maf1-A(1–39), and pACT2-Maf1-A(1–34) (Fig.
3). Domain BC failed to interact with shorter fragments of
domain A encoded by pACT2-Maf1-A(1–12), pACT2-Maf1-
A(1–16), or pACT2-Maf1-A(1–23). Cells containing the pair
pAS2-Maf1-BC and empty pACT2 had no detectable b-galac-
tosidase activity (data not shown in the figure). These results
demonstrate the specificity of the two-hybrid interaction
betweenMaf1 domains and define aa 1–34 as the smallestMaf1
A domain still able to bind the BC domain. Reciprocal interac-
tions were impossible to study because the presence of pAS-
Maf1-A activates the reporter gene in the absence of a
pACT2 fusion. Importantly, pAS2-Maf1-BC was also nega-
tive tested with pACT2 encoding fusions of several genes
unrelated to Maf1 and encoding components of pol III com-
plex. Taken together, our results as described above suggest
a strong, direct interaction of the A and BC domains of
human and yeast Maf1.
Interaction between A and BC Domains Is Important for the
Function of Maf1—Limited proteolysis and two-hybrid results
show that the A and BC domains ofMaf1 together form a stable
complex, possibly reflecting an active conformation of Maf1.
To evaluate the physiological significance of the interaction
between the Maf1 domains, we screened for mutants impaired
in Maf1 function that were located in domain A and presum-
ably compromised in domain BC binding. MAF1 fragment(1–
180) was PCR-amplified under mutagenic conditions and
transformed into maf1-D cells together with a gapped single-
copy plasmid encoding Maf1. Transformants were selected for
poor growth at 37 °C on glycerolmedium, suggesting a defect of
Maf1 function in pol III repression (12). Sequencing of plasmid
pAG70 encodingmutantMaf1 isolated in this manner revealed
mutation K35E located in domain A.
To inspect the effect of the K35Emutation inMaf1 on pol III
activity, RNA isolated from cells grown in the presence of glu-
cose and transferred to glycerol medium at 37 °C was analyzed
by Northern blotting using probes for pre-tRNALeu and
FIGURE 1. Similarity of S. cerevisiae (Sc) and H. sapiens (Hs) Maf1 sequences. Alignment of conserved A and BC domains is shown. A and BC domains are
boxed, and conserved aa are highlighted. Stars indicate positions of K35E, D250E, and V260D mutations.
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tRNAPhe (Fig. 4A). Following trans-
fer to the medium with the nonfer-
mentable carbon source, pre-tRNA
levels were decreased in the wild
type but not inmaf1-D cells (Fig. 4A,
compare lanes 1, 5 and 6, 10). Simi-
larly to maf1-D, the K35E mutant
was defective in its ability to repress
pre-tRNA transcription upon trans-
fer to glycerol medium (Fig. 4A,
lanes 2 and I7). Thus, the singlemis-
sense mutation within the Maf1 A
domain precluded pol III repression
inmaf1-K35E strain.
One approach to confirm that the
K35E mutation negatively affects
the interaction with the BC domain
of Maf1 is to identify second-site
mutations that compensate for the
observed defects. We looked there-
fore for second-site suppressor
mutations within the BC-encoding
region of MAF1 that allowed maf1
K35E yeast cells to grow on glycerol
medium at 37 °C. DNA encoding aa
174–375ofMaf1was randomlymu-
tagenized by PCR, and the mutant
pool was co-transformed with the
pAG70 plasmid containing the pri-
mary K35E mutation and gapped
within the region of the BC domain.
Sequencing of in vivo reconstituted
MAF1 from six transformants
showing reversion of the original
defect identified two plasmids with
suppressor mutations: pLM11
(maf1-K35E/D250E) and pLM12
(maf1-K35E/V260D,N344I). The
remaining transformants were
either back-revertants of K35E
mutation or contained suppressor
mutations outside the MAF1 gene.
Both isolated suppressors of K35E
mutation in A domain, single
D250E, and combined V260D/
N344I were located in the BC
domain, thus supporting the inter-
action between these domains.
Phenotypic characterization of
the two suppressor strains showed
that they compensate for the defect
of growth on glycerol medium at
37 °C of the primary K35Emutation
(Fig. 4B). The increased growth
capacity of the suppressors on glyc-
erol medium was due to a compen-
sation of the defect in pol III reg-
ulation observed for the K35E
FIGURE 2. Domain structure of human Maf1. A, limited proteolysis and resulting proteolytic fragments of
HsMaf1. PAGE of full-length human HsMaf1 protein (1, black) that is digested into two stable fragments(1–45)
and (75–234) using trypsin are indicated as 2, red. Bacterially co-expressed and co-purified HsMaf1 domains of
aa 1–45 and 85–210 are shown as 4, green. HsMaf1 aa 82–236 (3, blue) lacking the N-terminal 45 residues was
expressed as a control. B, size exclusion chromatography profiles. Samples presented in A were separated on
single or tandem Superdex 200 10/300 size exclusion columns (GE Healthcare). Only HsMaf1 construct 82–236
elutes in the void volume of the Superdex 200 size exclusion column, whereas all other samples are monodis-
perse and elute approximately at volumes corresponding to monomers. The elution profile of different molec-
ular mass standards is shown as a dashed line. Peaks I, II, III, and IV correspond to ovalbumin (Mr 5 44,000),
carbonic anhydrase (Mr 5 29,000), ribonuclease A (Mr 5 13,700) and aprotinin (Mr 5 6,500), respectively.
Fractions corresponding to the red and green elution profiles were analyzed by denaturing gel electrophoresis
and are shown as insets. Fragment(1–45) co-elutes with proteolytic fragments(75–234) and (75–262) (red
profile) and with the recombinant fragment(85–210) (green profile).
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mutation. As determined by Northern blotting, the suppressor
mutations restored the ability to repress pre-tRNA transcrip-
tion upon transfer from glucose to glycerol medium (Fig. 4A,
lanes 3, 4, 8, and 9). These results indicate that the detected
genetic interaction between the two Maf1 domains is a func-
tional one.
To characterize the association ofA andBCdomains further,
we sought to verify the effects of K35E, D250E, V260D, and
N344I mutations, identified in the mutant and suppressor
strains, on the interaction of Maf1 domains in the two-hybrid
system. The respectivemutationswere generated in theMaf1A
domain fragment fused to the Gal4 activation domain in the
pACT2-Maf1-A(1–42) plasmid or the Maf1-BC domain fused
to the DNA-binding domain of Gal4 in pAS2-Maf1-BC(196–
349). Various combinations of plasmids, one encoding a wild
type Maf1 domain and the other with a mutated domain, both
fused to the respective Gal domains, were co-expressed in the
yeast reporter strain followed by determination of b-galactosi-
dase activity (Fig. 5). The K35E mutation of domain A reduced
the two-hybrid interaction with wild type BC domain by
approximately 40% (Fig. 5, compare lanes 2 and 1). Similarly,
both the single D250E and the double V260D/N344Imutations
in BC domain decreased the interaction with wild type A
domain by 22 and 62%, respectively (Fig. 5, compare lanes 7 and
8 with lane 1). Moreover, the double V260D/N344I mutant
showed a defect in regulation of tRNA transcription and tem-
perature-sensitive growth in glycerol medium (supplemental
Fig. S3).
FIGURE 3. Two-hybrid interaction of Maf1 domains. pACT2-Maf1-A(1–12),
pACT2-Maf1-A(1–16), pACT2-Maf1-A(1–23), pACT2-Maf1-A(1–34), pACT2-
Maf1-A(1–39), and pACT2-Maf1-A(1–42) plasmids were transformed individ-
ually together with pAS2 (control plasmid) or pAS2-Maf1-BC(196–349) plas-
mids into yeast strain Y190. Transformants were assayed for b-galactosidase
expression using an overlay plate assay.
FIGURE 4. Regulation of pol III transcription and growth is impaired by
the K35E mutation in region encoding A domain and restored by second-
site suppressor mutations in BC domain of MAF1. maf1-D, maf1-K35E,
maf1-K35E/D250E, and maf1-K35E/V260D/N344I mutants and isogenic wild
type strain YPH500 (WT) were used. A, cells were grown to exponential phase
in glucose medium (YPD) at 30 °C, then transferred to glycerol medium
(YPGly) and incubated at 37 °C for 1.5 h. Total RNA isolated from cells was
tested by Northern blotting with pre-tRNALeu and tRNAPhe probes. B, 10-fold
serial dilutions of cells grown to exponential phase in glucose medium were
plated on glucose medium (YPD) and incubated at 30 °C or on glycerol
medium (YPGly) and incubated at 37 °C for 2–3 days.
FIGURE 5. Two-hybrid interaction of Maf1 domains is impaired by pri-
mary mutations in these domains and restored by second-site suppres-
sor mutations. A, pACT2-Maf1-A(1–42) plasmid and its mutated version
were transformed individually with pAS2-Maf1-BC(196–349) plasmid or its
mutated versions in yeast strain Y190. Transformants were assayed for b-ga-
lactosidase expression. Presented profile compares following two-hybrid
interactions: wild type A and BC domains of Maf1 (1); mutated A domain K35E
with wild type BC domain (2); mutated A domain K35E with four versions of
mutated BC domain: D250E (3), V260D/N344I (4), V260D (5), N344I (6); and
wild type A domain with mutated BC domain containing single D250E,
V260D, or N344I and double N344I/V260D mutations (7-10). B, scheme of
Maf1 domain interaction is shown.
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Confirming the genetic suppressor results, a combination of
mutated Maf1 domains restored their interaction (Fig. 5, com-
pare lanes 3 and 4 with lane 1). Rather unexpectedly, the
strongest level of two-hybrid interaction, 80%over thewild type
one, was observed for the combination of K35E domain A and
domain BCwith a single V260Dmutation (Fig. 5, compare lane
5 with lane 1). This indicated that in the double suppressor
mutation V260D/N344I, identified in genetic screen, the for-
mer one is in fact sufficient to restore the interactionwith K35E
domain A.
Domain Interaction Supports Maf1 Dephosphorylation upon
Transfer of Cells to a Nonfermentable Source—As shown be-
fore, phosphorylation of Maf1 precluded pol III repression
when yeast cells were grown on glucose medium (14). Transfer
of yeast cells to a nonfermentable carbon source resulted in
Maf1 dephosphorylation, import of Maf1 into the nucleus, and
inhibition of tRNA synthesis (12). Because we showed that the
interaction between the Maf1 A and BC domains is crucial for
its regulatory action onpol III, we nowaskedwhether this inter-
action is also required for efficient regulation of Maf1 activity.
To investigate whether the altered domain interactions in
the Maf1 mutant proteins were correlated with changes in the
phosphorylation of Maf1, differentially phosphorylated forms
of Maf1 were resolved by SDS-PAGE and identified by immu-
noblotting at various times after culture transfer from glucose
to glycerol medium (Fig. 6). As reported previously, wild type
Maf1 was quickly dephosphorylated upon this transition.
Remarkably, the K35E mutation in domain A, preventing its
interaction with the BC domain, appeared to preclude the
dephosphorylation ofMaf1. Significantly, restoring the domain
interaction with D250E (pLM11) and V260D/N344I (pLM12)
suppressormutations reestablished rapid dephosphorylation of
Maf1 following transfer from glucose to a nonfermentable car-
bon source.Maf1 dephosphorylation in the suppressormutants
was only a little slower than in the wild type strain (supplemen-
tal Table S1). Interestingly, double V260D/N344I mutation in
the context of wild type A domain precluded interaction
between domains (Fig. 5) and slowed the rate of dephosphory-
lation of Maf1 upon transfer of yeast to glycerol medium (sup-
plemental Fig. S4). Altogether, these results suggest that the
interaction of A and BC domain greatly facilitates the dephos-
phorylation of Maf1.
DISCUSSION
In this paper we describe the importance of the interaction
between two Maf1 domains for its activity as a repressor of pol
III transcription. Limited proteolysis of HsMaf1 resulted in two
stable fragments(1–45) and (75–234) corresponding to the
evolutionarily conserved A and BC domains. Size exclusion
chromatography of the proteolytic fragments corresponding to
the two domains showed their co-elution. Similar fragments
were co-expressed in bacteria, where they co-purified and co-
migrated during size exclusion chromatography as a soluble
complex. In contrast, both fragments behaved poorly when
individually expressed. Our results suggest thatMaf1 A and BC
domains form modules that do not fold independently but
rather need to be co-expressed to form a stable and soluble
entity. In contrast, the connecting linker (aa 46–74) and the
C-terminal acidic tail (aa 235–256) appear solvent-exposed and
unstructured as suggested by hydrophobic cluster analysis
(supplemental Fig. S6).
Considering the high conservation ofMaf1 in eukaryotes, the
domain interaction and its functional role were probed in the
model organism yeast S. cerevisiae. Using the yeast two-hybrid
system we confirmed the physical interaction between A and
BC domains ofMaf1 in yeast and identified the first 34 residues
as the shortest fragment of the A domain sufficient for interac-
tion with the BC domain. Lack of interaction between further
truncated fragments of the A domain (aa 1–12, 1–16 or 1–23)
with the BC domain shows the specificity of the method used
and emphasizes the importance of structural features of the A
domain for its interaction with the BC domain.
To investigate further the role of domain A we isolated sin-
gle-point mutant K35E (on plasmid pAG70). In accordance
with its growth characteristics, this mutant failed to repress pol
III activity. Moreover, as shown by the two-hybrid system, the
K35E mutation reduced the interaction between the A and BC
Maf1 domains by 40%. In support of structural and/or func-
tional interactions between theMaf1 domains, we isolated sec-
ond-site suppressormutationswithin the BCdomain that com-
pensated for the defect caused by the K35Emutation in domain
A. We found two such suppressors: D250E and V260D/N344I.
Further phenotypic characterization of the suppressor strains
revealed that these additional mutations in the BC domain
restored not only the ability of the K35E-mutatedMaf1 to grow
on glycerolmedium at 37 °C, but also its ability to repress pol III
activity. Interestingly, residue 260 in domain BC seems to be
crucial for the interaction with domain A. Although the V260D
mutant BC domain interacted with K35E mutant domain A
.80% stronger than did wild type domain BC, its interaction
with the wild type domain A was decreased by almost 60% (Fig.
5, fifth and ninth lanes). All of these results indicated that the
genetic interaction identified between Maf1 domains corre-
sponds to a physical interaction indispensable for the Maf1
function.
Bioinformatic analysis using the protein structure prediction
server (PSIPRED version 2.6) (36, 37) provides further support
for our biochemical analysis. In the yeast and human Maf1 A
FIGURE 6. Mutations altering interaction of Maf1 domains affect kinetics
of Maf1 dephosphorylation upon transfer of yeast from glucose to
medium with nonfermentable carbon source. maf1-K35E, maf1-K35E/
D250E, and maf1-K35E/V260D/N344I mutant strains and isogenic wild type
strain YPH500 (WT)weregrown toexponential phase inYPDglucosemedium
(Exp), then transferred to glycerol YPGly medium, incubated at 37 °C, and
harvested as indicated. Protein extracts of lysed cells were analyzed by West-
ern blotting with polyclonal anti-Maf1 antibodies.
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domain, two a-helices (aa 7–16 and 40–56) separated by two
adjacent b-strands (aa 24–27 and 29–35) are predicted,
whereas for the BCdomain fivea-helices and concomitant four
b-strands are predicted (supplemental Fig. S5). No secondary
structure elements are predicted for the linker region. Notably,
the K35E mutation is located at the end of the second b-strand
of the A domain. Our attempts tominimize theMaf1 A domain
identified aa 1–34 as the smallest fragment still enabling inter-
action with the domains. We hypothesize that the interaction
between domains A and BC requires the first a-helix and two
adjacent b-strands. We also applied hydrophobic cluster anal-
ysis, a tool to investigate protein stability and folding that uses
two-dimensional helical representation of protein sequences to
identify possible hydrophobic cores formed by several residues
(38). The hydrophobic cluster analysis revealed the presence of
two regions rich in hydrophobic cores corresponding to the A
and BC domains of S. cerevisiae Maf1 (supplemental Fig. S6).
Between thema region poor in hydrophobic residueswas found
which, according to the alignment of Maf1 eukaryotic
sequences, corresponds to the linker region between the A and
BC domains. Similar analysis in humanMaf1 revealed the same
organization of two clusters of hydrophobic cores separated by
a short region free of hydrophobic clusters consistent with our
limited proteolysis results.
We found the interaction between the A and BC domains,
facilitatingMaf1 dephosphorylation, to be necessary for the full
repression of pol III activity. One might hypothesize that in the
same time the interaction between domains of Maf1 is influ-
enced by its phosphorylation state. Accordingly, different
forms of Maf1 observed on polyacrylamide gels, interpreted as
phosphorylated and subsequently dephosphorylated form of
Maf1, might represent different conformational states depend-
ing on the interaction between A and BC domains. Note that
the S90A, S101A, and S177A/S178A mutations in the linker
were found to change the proportion between slow and fast
migrating Maf1 forms in favor of the former, without strongly
affecting the phosphorylation status of Maf1, thus indicating
that residues in the linker could stronglymodify theMaf1 shape
(39).
Considering that Maf1 contains two conserved domains, we
propose the unstructured linker to becomephosphorylated and
thus modulating the conformational state of Maf1. To investi-
gate this question furtherwe used theNetPhos 2.0 server (40) to
predict possible phosphorylation sites in four Maf1 orthologs
containing linkers of different lengths. Predicted phosphoryla-
tion sites are frequently found in the long linkers between the
Maf1 A and BC domains of S. cerevisiae and C. glabrata rela-
tively, whereas they are more uniformly distributed along the
Maf1 sequences of Caenorhabditis elegans and Homo sapiens,
although they are also present in their shorter linkers (supple-
mental Fig. S7). We therefore speculate that phosphorylation
and dephosphorylation of the exposed linker evoke a specific
conformation of the protein that changes the distance between
domains modulating their interaction and pol III repression
(supplemental Fig. S8). The interaction of the domains, medi-
ated by dephosphorylation of the linker may affect both the
import of Maf1 into the nucleus and its interaction with pol III.
This conjecture is supported by data of Ref. 15, showing that
PKA-mediated phosphorylation of six residues located in linker
inhibited nuclear import of Maf1 and pol III repression.
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2. Résumé substantiel en Français. 
 
• INTRODUCTION 
Dans les cellules eucaryotes, les ARN polymérases (Pol) I et III sont responsables 
de la synthèse d'ARN impliqués dans la biogenèse des ribosomes et dans le 
processus de traduction. La synthèse d'ARN par la Pol I et la Pol III représente plus 
de 80% de l'activité de transcription nucléaire chez la levure Saccharomyces 
cerevisiae et est contrôlée de manière coordonnée en réponse à diverses conditions 
cellulaires et de l’environnement (Willis et al., 2004; Warner, 1999; Warner et al., 
2001). 
Chez la levure, la Pol III est responsable de la transcription d’environ 400 gènes 
(gènes de classe III), codant pour la plupart les ARNt et l’ARNr 5S (Harismendy et 
al., 2003; Roberts et al., 2003; Moqtaderi and Struhl, 2004). L’analyse du système 
de transcription de la Pol III chez la levure a révélé une série d’interactions protéine-
ADN et protéine-protéine conduisant au recrutement de la Pol III sur les gènes 
cibles codant les ARNt. Dans un premier temps, le facteur de transcription TFIIIC 
(six sous-unités) se lie au promoteur intragénique puis dirige le recrutement et 
l'assemblage des trois composants de TFIIIB (TBP, Brf1 et Bdp1) et le recrutement 
ultérieur de l'enzyme Pol III constitué de dix-sept sous-unités (Geiduschek and 
Kassaventis, 2001). Bien que les facteurs essentiels et les mécanismes de base de la 
transcription des gènes de classe III soient maintenant bien définis, les mécanismes 
moléculaires permettant la régulation de la Pol III sont encore mal connus.  
L'unique régulateur global négatif de la transcription par la Pol III chez la levure 
est la protéine Maf1 qui sert d'intermédiaire dans plusieurs voies de signalisation 
mais qui n'est pas indispensable à la survie cellulaire (Upadhya et al., 2002; Pluta 
et al., 2001). Maf1 est requis pour permettre l’inhibition de la transcription qui se 
produit normalement pendant la phase de croissance stationnaire mais aussi en 
réponse à diverses drogues induisant des dommages de l'ADN, un stress oxydatif, 
des défauts de la voie sécrétoire ou encore lors de la phase de croissance post-
diauxique (Upadhya et al., 2002; Boisnard et al., 2009; Desai et al., 2005; Ciesla et 
al., 2007). L'activité de Maf1 est liée à sa phosphorylation lors de conditions 
favorables de croissance. Seule la forme déphosphorylée de Maf1 peut se lier à la 
Pol III (Oficjalska-Pham et al., 2006). Cette phosphorylation est observée lorsque la 
protéine Maf1 est re-localisée du noyau vers le cytoplasme (Towpik et al., 2008) et 
semble empêcher l’importation de Maf1 du cytoplasme vers le noyau (Moir et al., 
2006). Diverses conditions défavorables conduisent à la déphosphorylation rapide 
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de Maf1, à son accumulation dans le noyau ainsi qu’à l'association physique de la 
forme déphosphorylée de Maf1 avec la Pol III et à l'ensemble du génome transcrit 
par la PoI III (Oficjalska-Pham et al., 2006; Roberts et al., 2006).  
La machinerie de la transcription par la Pol III est remarquablement conservée 
entre la levure et l'homme. Les composants les plus conservés sont ceux impliqués 
dans l'assemblage complexe de transcription: la sous-unité τ131 de TFIIIC et deux 
composantes de TFIIIB (TBP et Brf1). Les cinq sous-unités spécifiques de la Pol III 
chez la levure S. cerevisiae (C31, C34, C37, C53 et C82) ont tous des homologues 
structurels et fonctionnels dans les cellules humaines (Schramm and Hernandez, 
2002). Maf1 est aussi conservée chez tous les organismes eucaryotes de la levure à 
l'homme (Pluta et al., 2001). Cette conservation est très intéressante car la 
dérégulation de la transcription par la Pol III chez l'homme est liée à la 
transformation maligne. De plus, une activation excessive de la transcription par la 
Pol III peut générer des tumeurs (Marshall, 2008; Marshall et al., 2008; Marshall 
and White, 2008; Johnson et al., 2008). Enfin chez les mammifères, deux 
suppresseurs de tumeurs, Rb et p53, agissent comme des répresseurs globaux de 
la transcription par la Pol III (White, 2008). Des résultats récents de plusieurs 
groupes rapportent que Maf1 est aussi un régulateur de la transcription par la 
Pol III chez l'homme (Goodfellow et al., 2008; Reina et al., 2006; Johnson et al., 
2007; Rollins et al., 2007). L'implication de la protéine Maf1 humaine dans le 
contrôle aberrant de la transcription par la Pol III dans les cellules cancéreuses 
reste à étudier. Néanmoins, la conservation de la machinerie de la Pol III (dont fait 
partie Maf1) lors de l'évolution indique que l’étude d’organisme modèle tel que la 
levure devrait donner des informations quant au rôle de la protéine Maf1 humaine 
dans le cancer 
 
• BUT DE CE TRAVAIL 
Mon travail de thèse consiste à étudier la relation entre la structure et la 
fonction de Maf1. Tous les membres de la famille Maf1 comportent trois domaines 
protéiques (nommées A, B et C) assez bien conservés au cours de l’évolution (Pluta 
et al., 2001) et ne montrant cependant aucune homologie significative avec des 
domaines protéiques de fonction connue. Nous ne disposons pas actuellement 
d'information sur la fonction de ces régions. Des mutations ponctuelles ont 
seulement soulignées l'importance de plusieurs résidus sérine (qui ne sont pas 
phylogénétiquement conservés) et de deux séquences de localisation nucléaire (Moir 
et al., 2006; Roberts et al., 2006; Huber et al., 2009). Au cours de mon travail de 
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thèse, j’ai pu identifier chez S. cerevisiae deux domaines de la protéine Maf1 qui 
sont conservés et qui interagissent entre eux. Cette interaction est cruciale pour la 
régulation de l'activité de Maf1 par phosphorylation. Les données présentées dans 
cette étude fournissent un premier aperçu de la structure Maf1 par rapport à la 
régulation de la Pol III. 
 
• RESULTATS 
1. Construction de mutations de la protéine Maf1 de S. cerevisiae au niveau 
des régions A et BC conservés au cours de l’évolution. 
 
Une approche habituelle pour analyser la relation entre la séquence primaire 
d'une protéine et son activité est de construire plusieurs mutants dans le gène 
codant cette protéine et d’étudier son changement de comportement cellulaire en 
fonction de la mutation effectuée. Le gène MAF1 a été muté pour isoler des mutants 
définis et localisés dans chaque domaine particulier afin d'acquérir une meilleure 
compréhension des fonctions de Maf1 dans la cellule de levure S. cerevisiae. Les 
mutants maf1 qui ont été obtenus ont été caractérisés dans un premier temps pour 
définir les substitutions d'acides aminés et le phénotype de croissance. La méthode 
rapide de mutagenèse localisée du « Gap repair » a été utilisée pour obtenir une 
banque de protéines Maf1 mutées dans les domaines A, B et C qui sont conservés 
au cours de l'évolution (Muhlrad et al., 1992). La stratégie de construction des 
mutants est basée sur une PCR basse fidélité. L’ADN codant le domaine A et un 
domaine non structuré (aa 1-180) ou le domaine B et C (aa 174-375) a été amplifié 
dans des conditions permettant d’obtenir 1 à 2 mutations dans ces régions. Les 
produits des PCR réalisées en condition de « faible fidélité » sont ensuite co-
transformés dans une souche maf1-∆ avec un plasmide linéarisé ne contenant que 
les régions flanquantes du domaine A ou du domaine B et C. La recombinaison in 
vivo et la sélection sur un milieu permettant la croissance grâce au marqueur 
d’auxotrophie porté par le plasmide permet d’obtenir un gène maf1 complet mais 
muté. Un phénotype de croissance thermosensible sur milieu contenant du glycérol 
(phénotype caractéristique des souches maf1 mutées ; Boguta et al., 1997) indique 
que la protéine Maf1 est soit absente soit non fonctionnelle et donc incapable de 
réprimer la transcription par la Pol III. L’identification de ces mutants a été 
confirmée par re-transformation des plasmides purifiés dans une souche dont le 
gène maf1 été supprimé (YPH500 maf1-∆). Le séquençage des plasmides a ensuite 
permis d’identifier les différentes mutations isolées. Des expériences de Western 
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blot utilisant des anticorps polyclonaux anti-Maf1 ont permis de tester l’expression 
de la protéine Maf1 dans les différentes souches mutantes. 
La perturbation de cette répression peut correspondre à plusieurs déficiences de 
l’activité de Maf1 tels des problèmes d’expression, d’état de phosphorylation, de 
transport du cytoplasme vers le noyau ou d’interaction avec la Pol III.  
L’analyse des positions des mutations parmi les allèles maf1 n’a pas permis 
d’identifier une région de Maf1 plus particulièrement indispensable à l’activité de 
Maf1 en tant que répresseur de la transcription par la Pol III. 
Plusieurs mutants maf1, représentatifs de mutations de différentes régions de 
Maf1 et de phénotypes de croissance différents, ont fait l’objet d’une étude plus 
approfondie. Une attention plus particulière a été portée sur des mutations du 
domaine BC car ce domaine est le plus conservé au cours de l’évolution en 
comparaison avec le domaine A et pourrait donc être plus crucial pour l’activité de 
Maf1. De plus les mutations dans le domaine BC semblent avoir plus 
particulièrement un effet sur le niveau de synthèse de la protéine Maf1 ou sur sa 
dégradation comme le montre le profile d’expression des mutants maf1 L242P-
H249Q (pAG147), S305P-N327D-N344D (pAG148), N243S-F267S (pAG167), 
N327Y-I339T-S341P (pAG127), M294R-L354S (pAG136), I241F-R332G (pML6), 
E272L-C299R-Q359L (pMM2) et L242S-L325P-Y326F-L354S-L363Q (pMM1) maf1 
mutants. De plus, ces mutants maf1 présentent différents profils de 
phosphorylation tout en gardant la capacité de pouvoir être déphosphorylé sur 
milieu contenant du glycérol. Un examen plus minutieux de ces mutants a montré 
que des défauts dans la phosphorylation et la déphosphorylation ne sont pas liés 
plus particulièrement à certaines mutations du domaine BC. Les modifications des 
acides aminés suite aux mutations introduites changent vraisemblablement la 
spécificité des très nombreux sites de phosphorylation de Maf1 comme l’a montré 
une analyse informatique. Différents profils de phosphorylation définissant des 
classes ont pu être mis en évidence par électrophorèse en conditions dénaturantes. 
Ces classes pourraient correspondrent à certains changements de la structure de 
Maf1 en fonction du niveau de phosphorylation de cette protéine. Aucune 
corrélation n’a pu être mise en évidence entre la capacité de Maf1 d’être 
phosphorylée ou déphosphorylée (respectivement en absence ou en présence de 
rapamycine) et une localisation cellulaire plus particulière de cette protéine 
(nucléaire ou cytoplasmique). Les autres mécanismes moléculaires impliquant Maf1 
(interaction avec la Pol III, inhibition de la transcription par la Pol III, la sortie du 
noyau après élimination de la rapamycine, etc) devront êtres étudiés dans le futur 
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pour essayer d’identifier s’il y a une relation entre un profil de phosphorylation et 
une fonction de Maf1. 
 
2. La répression complète de la transcription par l'ARN polymérase III 
exige une interaction entre deux domaines de son régulateur négatif Maf1. 
 
• Deux domaines de Maf1 interagissent entre eux physiquement 
Le gène MAF1 de la levure S. cerevisiae code une protéine de 395 acides aminés 
hydrophile et riche en résidus serine et asparagine. La masse moléculaire théorique 
est de 44,7 kDa. L’analyse des bases de données indique qu’il y a des orthologues 
chez tous les eucaryotes dont l’homme, les animaux (50), les plantes (28) et même 
les eucaryotes dit « inférieurs » mais pas chez les procaryotes (voir la Figure 2 pour 
quelques exemples). Les protéines Maf1 sont constituées de trois régions 
phylogénétiquement conservées et appelées A, B et C (Pluta et al., 2001). Les 
similarités de séquence entre S. cerevisiae et l’homme sont présentées dans la 
Figure 1. La Figure 2 présente un alignement de plusieurs séquences de protéine 
Maf1 différentes. 
Comme la distance de 10 acides aminés qui sépare les domaines B et C est est 
constante au cours de l’évolution, à l’exception d’Aspergilus nidulans (insertion of 
15 acides aminés), nous considérons que cette région est un domaine unique que 
nous avons appelé BC. Par contre, la distance entre les régions A et B varie 
largement selon les espèces. Les domaines A et BC sont fusionnés chez 
Encephalitozoon cuniculi mais séparés de 182 et 174 acides aminés (séquence 
« linker ») respectivement chez S. cerevisiae et Candida glabrata (Figure 2). 
 
 
 
Figure 1. Similarité des séquences des protéines Maf1 de H. sapiens (Hs) et S. cerevisiae (Sc). 
Les domaines A et BC sont encadrés. Les séquences des domaines A et BC sont alignées et les acides 
aminés identiques sont mis en évidence par une couleur gris foncé. Les étoiles indiquent la position 
des mutations K35E, D250E et V260D. 
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Figure 2. Alignement de séquences de protéines Maf1 de différents organismes. Les séquences 
des protéines ont été alignées avec le logiciel d’alignement multiple MUSCLE (41) et la figure a été créé 
avec le logiciel Geneious Pro 4.5.4. Représentation schématique de séquences de protéine Maf1 de 
différentes espèces : Encephalitozoon cuniculi (gi|19069247|, taille : 161 aa), Caenorhabditis elegans 
(gi|17506011|, taille : 245 aa), Arabidopsis thaliana (gi|22326767|, taille : 224 aa), Dictyostelium 
discoideum (gi|66816633|, taille : 278 aa), Ciona intestinalis gi|198415188|, taille : 233 aa), 
Drosophila melanogaster (gi|46409204|, taille : 226 aa), Danio rerio ( gi|47087413|, taille : 247 aa), 
Homo sapiens (gi|49065352|, size : 256 aa), Aspergillus nidulans (gi|67901388|, taille : 314 aa), 
Schizosaccharomyces pombe (gi|254745531|, taille : 238 aa), Candida glabrata (gi|49529111|, taille : 
391 aa) et Saccharomyces cerevisiae (gi|1170854|, taille : 395 aa). Les domaines conservés sont 
encadrés et nommés par des lettres : A, B et C dans la partie haute de la figure. Les alignements des 
séquences de chacun des domaines conservés (A, B et C) sont montrés dans la partie basse de la 
figure. Les histogrammes aux dessus des alignements indiquent le pourcentage d’identité entre les 
séquences. Les séquences consensus sont indiquées sous les alignements. Les positions des 
mutations K35E, D250E et V260D sont montrées par des étoiles sous les alignements (la mutation 
N344I est localisé 6 acides aminés après le domaine BC et n’est donc pas représentée). 
 - 132 - 
Deux séquences « signatures » de la famille des protéines Maf1 sont localisées 
dans le domaine BC (les motifs PDYDFS et LWSFnYFFYNKklKR, Figure 2) (Pluta et 
al., 2001). Ces séquences ne sont pas fonctionnellement caractérisées dans la base 
de donnée PROSITE. De manière intéressante, le second motif LWSFnYFFYNKklKR, 
présent dans la grande majorité des orthologues de Maf1, contient un signal de 
localisation nucléaire qui a été montré comme fonctionnel chez S. cerevisiae (Moir et 
al., 2006).  
Une étude détaillée de la protéine Maf1 humaine (H. sapiens Maf1 ou HsMaf1) a 
été réalisée dans le laboratoire de Christoph Müller (EMBL Heidelberg) en 
collaboration avec le laboratoire dirigé par Olivier Lefebvre (CEA/Saclay). Cette 
étude a permis de caractériser expérimentalement l’organisation structurelle de la 
protéine HsMaf1 après protéolyse ménagée (Appendix 1, Gajda et al., 2010). En 
effet, des fragments protéolytiques stables sont considérés comme structurellement 
bien définis tandis que des sites sensibles à la protéase sont souvent corrélés à des 
régions désordonnées de la protéine. L’utilisation de trypsine pour effectuer une 
protéolyse ménagée a permis de digérer la protéine HsMaf1 (256 acides aminés) en 
deux fragments qui ont été identifiés aux acides aminés 1-45 et 75-234 par une 
combinaison de séquence N-terminale et d’analyse de spectrométrie de masse  
(Q-tof). Ces fragments correspondent aux domaines A et BC de la protéine HsMaf1. 
Le domaine « linker » entre ces fragments (aa 46-74) et l’extrémité C-terminale acide 
(aa 235-256) ont été dégradés et sont donc vraisemblablement non structurés. Les 
deux fragments ont ensuite été analysés par une chromatographie d’exclusion 
(tamisage moléculaire). De manière étonnante, les deux fragments de HsMaf1, bien 
que de masses moléculaires très différentes, éluent de manière concomitante avec 
une stœchiométrie apparente de 1 pour 1 ce qui suggère qu’ils interagissent 
physiquement. De plus, la co-expression de ces fragments N- et C-terminals de 
HsMaf1 dans des bactéries et leurs purifications indiquent que le fragment A 
étiqueté par une séquence de 6 histidines co-précipite le fragment BC non étiqueté 
avec une stœchiométrie apparente de 1 pour 1 suggérant, là aussi, une interaction 
directe. Ces protéines recombinantes éluent de manière concomitante lors d’une 
chromatographie d’exclusion ce qui renforce encore l’idée que les domaines A et BC 
interagissent directement. 
Ces résultats obtenus dans l’équipe de Christoph Müller avec la protéine 
HSMaf1 ainsi que la très bonne conservation de séquence des domaines A et BC au 
cours de l’évolution nous ont permis d’étudier les relations entre les domaines A et 
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BC chez la levure S. cerevisiae, un organisme modèle très pratique pour étudier les 
relations entre la structure et la fonction d’une protéine. 
Nous avons utilisé dans un premier temps la technique du double hybride afin 
de vérifier si une interaction entre les domaines A et BC existe chez cette levure. Le 
domaine putatif BC (aa 196-349) a été fusionné au domaine de liaison à l’ADN de 
Gal4 (plasmide pAS2) et co-exprimé avec diverses constructions du domaine A 
fusionné avec le domaine d’activation de la transcription de Gal4 (plasmide pACT2) 
dans la souche de levure Y190 dont l'activité β-galactosidase est mesurée. En effet, 
l’interaction entre les protéines de fusion devrait entraîner l’expression du gène 
exprimant la β-galactosidase. En utilisant cette approche, nous avons observé une 
interaction physique entre les domaines BC de Maf1 codé par le plasmide pAS2-
Maf1-BC(196-349) et des fragments du domaines A de Maf1 codés par les 
plasmides pACT2-Maf1-A(1-42), pACT2-Maf1-A(1-39) et pACT2-Maf1-A(1-34) 
(Figure 3). Nous n’avons pas pu mettre en évidence d’interaction entre le domaine 
BC avec des fragments plus réduits du domaine A et codés par les plasmides 
pACT2-Maf1-A(1-12), pACT2-Maf1-A(1-16) ou pACT2-Maf1-A(1-23). Les cellules 
contenant les plasmides pAS2-Maf1-BC et pACT2 vide ne permettent pas de 
détecter d’activité β-galactosidase. Ces résultats démontrent la spécificité de 
l’interaction révélée par la technique du double-hybride et définissent les acides 
aminés 1-34 comme étant le plus petit fragment du domaine A de ScMaf1 encore 
capable de se lier au domaine BC. Les interactions réciproques n’ont pas pu être 
étudiées car la présence d’un plasmide pAS-Maf1-A même en absence d’un 
plasmide pACT2 active la transcription du gène testeur. Enfin, nous avons aussi 
vérifié que le plasmide pAS2-Maf1-BC en combinaison avec des plasmides pACT2 
codant pour des fusions de la plupart des gènes de la machinerie de transcription 
de la Pol III donnent des résultats négatifs. 
En conclusion, nos résultats suggèrent une forte interaction directe des 
domaines A et BC de Maf1 chez l'homme et chez la levure S. cerevisiae. 
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Figure 3. Interactions des domaines de Maf1 révélées par la technique du double-hybride. Les 
plasmides pACT2-Maf1-A(1-12), pACT2-Maf1-A(1-16), pACT2-Maf1-A(1-23), pACT2-Maf1-A(1-34), 
pACT2-Maf1-A(1-39) et pACT2-Maf1-A(1-42) ont été introduits par transformation individuellement ou 
avec les plasmides pAS2 (contrôle négatif) ou pAS2-Maf1- BC(196-349) dans la souche de levure S. 
cerevisiae Y190. Les transformants ont été testés pour l’expression de la β-galactosidase dans un test 
sur boîte de Petri. 
 
• L’interaction entre les domaines A and BC est importante pour la 
fonction de Maf1.  
 
Les expériences de protéolyse ménagée et de double-hybride montrent que les 
domaines A et BC forment un complexe stable qui pourrait être indispensable à la 
conformation correcte de la protéine Maf1. Pour évaluer le rôle physiologique de 
cette interaction, nous avons cherché des mutations localisées dans le domaine A 
qui affectent la fonction de Maf1 en altérant vraisemblablement la liaison au 
domaine BC. Des fragments d’ADN codant les acides aminés 1-180 ont été amplifiés 
dans des conditions de faible fidélité et introduits par transformation dans des 
cellules maf1-∆ avec un plasmide codant Maf1 et linéarisé dans la région codant le 
domaine A (technique du « Gap repair »). Les transformants ont été sélectionnés 
pour leur faible croissance à 37°C sur milieu contenant du glycérol ; phénotype qui 
est caractéristique d’un défaut de la fonction de Maf1 dans la répression de la 
transcription de la Pol III (Ciesla et al., 2007). Le séquençage du plasmide pAG70 
isolé par ce crible a permis d’identifier la mutation K35E localisée dans le domaine 
A.  
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Pour déterminer l’effet de la mutation K35E dans la protéine Maf1 sur l’activité 
de la Pol III, nous avons isolé les ARN de cellules ayant poussé en présence de 
glucose ou après transfert dans un milieu contenant du glycérol à 37°C. Ces ARN 
ont été analysés par Northern blot en utilisant des sondes codant pour les 
précurseurs des ARNtLeu and ARNtPhe (Figure 4A). Après transfert des cellules dans 
un milieu contenant une source de carbone non fermentable (glycérol), les niveaux 
des précurseurs des ARNt (qui sont un bon indicateur du niveau de transcription in 
vivo de la Pol III) sont diminués dans une souche sauvage mais pas dans des 
cellules maf1-∆ (Figure 4A, comparez les pistes 1 et 5 avec 6 et 10). De manière 
comparable à l’inactivation des cellules maf1-∆, le mutant K35E est défectif dans sa 
capacité à réprimer la synthèse de précurseurs d’ARNt après transfert des cellules 
dans un milieu contenant du glycérol (Figure 4A, pistes 2 et 7). Ainsi, une simple 
mutation ponctuelle dans le domaine A de Maf1 prévient la répression de la 
transcription par la Pol III dans une souche maf1-K35E. 
Une approche pour confirmer que la mutation K35E affecte négativement 
l’interaction avec le domaine BC de Maf1 est d’identifier des sites de mutations 
secondaires qui permettent de compenser l’effet observé. Nous avons donc 
recherché des mutations suppresseurs dans le domaine BC qui permettent aux 
cellules de croître sur milieu glycérol à 37°C. L’ADN codant pour les acides aminés 
174-375 de Maf1 a été muté de manière aléatoire par PCR et introduit par 
transformation dans des cellules maf1-∆ avec un plasmide pAG70 linéarisé dans la 
région codant le domaine BC (technique du « Gap repair »). Le séquençage des gènes 
maf1 reconstitués in vivo à partir des transformants a permis de montrer que les 
mutations codées dans les plasmides pLM11 (maf1-K35E-D250E) et pLM12 (maf1-
K35E-V260D-N344I) permettent de restituer un phénotype sauvage sur milieu 
glycérol à 37°C (Figure 4B). La capacité de croissance restaurée sur milieu glycérol 
indique une compensation du défaut de la régulation de la transcription par la 
Pol III observée pour la mutation K35E. Les deux suppresseurs D250E ou V260D-
N344I de la mutation du domaine A K35E sont localisés dans le domaine BC ce qui 
pourrait révéler une interaction physique entre ces domaines. Une analyse par 
Northern blot a permis de confirmer que les mutations suppresseurs restaure la 
capacité de Maf1 de réprimer la synthèse de précurseurs d’ARNt après transfert des 
cellules d’un milieu contenant du glucose à du glycérol (Figure 4A, comparez les 
pistes 3 et 4 avec 8 et 9). Ces résultats indiquent que l’interaction génétique entre 
les deux domaines de Maf1 est fonctionnelle.  
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Figure 4. La régulation de la transcription par la Pol III et la croissance sur milieu glycérol sont 
affectées par la mutation K35E située dans la région codant le domaine A et restaurée par des 
mutations suppresseurs dans le domaine BC de MAF1. Les mutants maf1-∆, maf1-K35E, maf1-
K35E-D250E et maf1-K35E-V260D-N344I et la souche isogénique YPH500 (WT) ont été utilisés. A. Les 
cellules ont été récoltées en phase exponentielle de croissance après culture dans un milieu contenant 
du glucose (YPD) à 30°C puis transférées dans un milieu contenant du glycérol (YPGly) et incubées à 
37°C pendant 1,5 h. L’ARN total isolé des cellules a été testé par Northern blot avec des sondes codant 
pour les précurseurs des ARNtLeu and ARNtPhe. B. Des dilutions sériées (par 10) de cellules récoltées en 
phase exponentielle de croissance ont été disposées sur des milieux gélifiés contenant du glucose 
(YPD) à 30°C ou du glycérol (YPGly) à 37°C et incubées pendant 2-3 jours.  
 
Pour mieux caractériser l’association des domaines A et BC, nous avons vérifié 
les effets des mutations K35E, D250E, V260D et N344I par la technique du double 
hybride. Les mutations ont été introduites dans le domaine A fusionné au domaine 
d’activation de la transcription de Gal4 codé par le plasmide pACT2-Maf1-A(1-42) 
ou dans le domaine BC fusionné au domaine de liaison à l’ADN de Gal4 codé par le 
plasmide pAS2-Maf1-BC(196-349). Différentes combinaisons de plasmides ont été 
utilisées pour transformer la souche de levure Y190 et l’activité β-galactosidase a 
été déterminée (Figure 5). La mutation K35E réduit l’interaction dans la technique 
du double-hybride de 40% (Figure 5, comparez les pistes 2 et 1). De manière 
similaire, les mutations D250E et V260D-N344I du domaine BC diminuent 
l’interaction du domaine BC avec le domaine A sauvage de respectivement 22 % et 
62 % (Figure 5, comparez les pistes 7 et 8 avec la piste 1). De plus, le mutant maf1-
V260D-N344I présente un défaut de la régulation de la synthèse des ARNt et une 
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sensibilité de croissance sur un milieu contenant du glycérol (Figure 6A, comparez 
les pistes 3 et 7; Figure 6B). 
 
Des combinaisons de domaines mutés de Maf1 permettent de restaurer une 
interaction similaire à celle observée chez le sauvage en accord avec les données de 
suppression génétique (Figure 5, comparez les pistes 3 et 4 avec la piste 1). De 
manière plutôt inattendue, un niveau d’interaction par la technique du double-
hybride de 80% supérieur au niveau sauvage est observé pour la combinaison du 
domaine A portant la mutation K35E avec le domaine BC portant la mutation 
simple V260D (Figure 5, comparez la piste 5 avec la piste 1). Ceci pourrait indiquer 
que dans la mutation double suppresseur V260D-N344I identifiée dans le crible 
génétique, la mutation V260D pourrait permettre à elle seule de restaurer 
l’interaction avec le domaine A portant la mutation K35E. 
 
 
Figure 5. L’interaction des domaines de Maf1 dans la technique du double-hybride est réduite 
par des mutations primaires dans ces domaines et restaurée par des mutations secondaires 
suppresseurs. A. le plasmide pACT2-Maf1-A(1-42) ou ses versions mutées ont été introduites par 
transformation en combinaison avec le plasmide pAS2-Maf1- BC(196-349) ou ses versions mutées 
dans la souche de levure Y190. L’expression de la β-galactosidase a été testée dans les différents 
transformants. L’histogramme permet de comparer les interactions déterminées par la technique du 
double hybride pour différentes combinaisons : domaines A et BC sauvage (1), domaine A ayant la 
mutation K35E avec le domaine BC sauvage (2); domaine A ayant la mutation K35E avec quatre 
versions mutées du domaine BC: D250E (3), V260D-N344I (4), V260D (5), N344I (6), et domaine A 
sauvage avec des versions du domaine BC ayant les mutations : D250E, V260D or N344I et N344I-
V260D (7-10). B. Schéma de l’interaction des domaines de Maf1. Les valeurs détaillées des activités 
β-galactosidase sont présentées dans la Table S9. 
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Figure 6. La régulation de la transcription par la Pol III est corrélée avec la croissance des 
souches mutantes sur un milieu contenant une source de carbone non fermentable. Les 
mutations du domaine BC en présence d’un domaine A sauvage ont été introduites par mutagenèse 
dirigée. A. C. Les cellules ont été récoltées en phase exponentielle de croissance après culture dans un 
milieu contenant du glucose (YPD) à 30°C puis transférées dans un milieu contenant du glycérol 
(YPGly) et incubées à 37°C pendant 1,5 h. L’ARN total isolé des cellules a été testé par Northern blot 
avec des sondes codant pour les précurseurs des ARNtLeu and ARNtPhe. B. D. Des dilutions sériées (par 
10) de cellules récoltées en phase exponentielle de croissance ont été disposées sur des milieux gélifiés 
contenant du glucose (YPD) à 30°C ou du glycérol (YPGly) à 37°C et incubées pendant 2-3 jours. La 
double mutation V260D-N344I inhibe la régulation de la synthèse d’ARNt et la croissance sur un 
milieu contenant du glycérol. Au contraire, les mutations D250E (A) V260D and N344I (C) n’ont aucun 
effet. 
 
• L’interaction des domaines A et BC permet la déphosphorylation de 
Maf1 lors du transfert des cellules dans un milieu contenant une source de 
carbone non fermentable. 
 
La phosphorylation de Maf1 est observée lorsqu’il n’y a pas de répression de la 
transcription par la Pol III lorsque les cellules sont cultivées sur un milieu 
contenant du glucose (Towpik et al., 2008). Le transfert des cellules dans un milieu 
contenant une source de carbone non fermentable induit une déphosphorylation de 
Maf1, son importation dans le noyau et l’inhibition de la synthèse d’ARNt (Ciesla et 
al., 2007). Comme nous avons montré que l’interaction entre les domaines A et BC 
est cruciale pour la régulation de la Pol III, nous avons cherché à étudier les 
relations entre cette interaction et la régulation de Maf1 par la phosphorylation. 
Nous avons cherché à identifier si une altération de l’interaction des domaines de 
Maf1, dans les mutants précédemment identifiés, pourrait modifier la 
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phosphorylation de Maf1. Pour cela, les différentes formes phosphorylées de Maf1 
ont été, résolues par électrophorèse en condition dénaturante (SDS-PAGE) et 
identifiées par immunodétection, ceci à différents temps après le transfert des 
cellules d’un milieu contenant du glucose dans un milieu contenant du glycérol 
(Figure 7A). 
Comme il est décrit dans la littérature, la protéine Maf1 sauvage est rapidement 
déphosphorylée lors de ce changement de milieu. De manière remarquable la 
mutation K35E du domaine A, qui altère l’interaction avec le domaine BC, modifie 
aussi la déphosphorylation de Maf1. La restauration de l’interaction à un niveau 
sauvage grâce aux mutations secondaires suppresseurs D250E et V260D-N344I 
rétablit aussi la déphosphorylation rapide de Maf1 lors du transfert des cellules 
d’un milieu contenant du glucose vers un milieu contenant du glycérol. La 
déphosphorylation de Maf1 dans les mutants suppresseurs serait seulement un 
peu plus lente que dans une souche sauvage (Tables supplémentaires S6-7). 
 
 
Figure 7. Les mutations de Maf1 affectant la répression de la transcription par la Pol III 
Mutations ont un effet sur la cinétique de déphosphorylation de Maf1 lors d’un transfert des 
cellules d’un milieu contenant du glucose dans un milieu contenant du glycérol. A. Les souches 
mutantes maf1-K35E, maf1-K35E-D250E et maf1-K35E-V260D-N344I et la souche isogénique 
YPH500 maf1-∆ transformée par le plasmide pRS315-MAF1 (WT) ont été cultivées dans un milieu 
contenant du glucose jusqu’en phase de croissance exponentielle (Exp) puis transférées dans un 
milieu contenant du glycérol, incubées à 37°C et récoltées aux temps indiqués. Les extraits buts de 
levure ont été analysés par SDS-PAGE avec un ratio acrylamide:bisacrylamide modifié et révélé par 
immunodétection en utilisant des anticorps anti-Maf1. Les bandes ayant une migration ralentie 
correspondent aux formes phosphorylées de Maf1. B. Les mutants maf1-D250E, maf1-V260D et maf1-
N344I ont été créés par mutagenèse dirigée. Les cellules de levure ont été soumises aux même 
analyses que précédemment. La double mutation V260D-N344I inhibe la déphosphorylation de Maf1 
lors du transfert des cellules sur un milieu contenant du glycérol. Au contraire, les mutations D250E 
V260D and N344I n’ont aucun effet. Les valeurs sous chaque piste indiquent le ratio entre les formes 
phosphorylées et déphosphorylées de Maf1 normalisées pour la phase exponentielle (Exp). Les 
quantifications sont disponibles dans les Tables S6-S7. 
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De manière intéressante, la mutation double V260D-N344I du domaine BC en 
présence d’un domaine A sauvage empêche l’interaction de ces domaines (Figure 5) 
et altère la déphosphorylation de Maf1 (Figure. 7B).  
En final, ces résultats suggèrent que l'interaction entre les domaines A et BC facilite 
grandement la déphosphorylation de Maf1. 
 
• DISCUSSION 
 
• L’interaction entre les domaines A et BC est importante pour la 
fonction de Maf1.  
 
La famille des protéines Maf1 des Eucaryotes présente des caractéristiques de 
séquence en acides aminés qui sont conservées aux cours de l’évolution avec deux 
régions aisément reconnaissable : les domaines A et BC. Cette étude compare pour 
la première fois la structure de Maf1 à l’inhibition de la transcription par la Pol III 
chez S. cerevisiae. Nous montrons que l’interaction entre les deux domaines de 
Maf1 est requise pour son activité dans la répression de la transcription par la 
Pol III. 
Une analyse bioinformatique utilisant un serveur de prédiction de structure de 
protéine (PSIPRED v 2.6 ; Jones, 1999 ; Bryson et al., 2005) nous a permis de faire 
une analyse fine de nos résultats obtenus par la technique du double hybride. Chez 
l’homme et la levure S. cerevisiae, ce serveur prédit que le domaine A pourrait être 
constitué de deux hélices α (chez S. cerevisiae: aa 7-16 et aa 40-56) séparés par 
deux feuillets β (aa 24-27 et 29-35 ) tandis que le domaine BC serait constitué de 
cinq hélices α et de quatre feuillets β (Figure 8). Aucune structure secondaire n’est 
prédite entre les domaines A et BC.  
La mutation K35E est localisée à la fin du second feuillet β du domaine A. Les 
acides aminés 1-34 du domaine A ont été identifiés, lors de ce travail, comme le 
domaine minimal encore capable de se lier au domaine BC. Nous faisons 
l’hypothèse que l’interaction entre le domaine A et BC requiert la première hélice α 
les deux feuillets β adjacents. 
L’Analyse de Cluster Hydrophobe (HCA), un outil utilisant une représentation en 
hélice en deux dimensions de la séquence d’une protéine pour identifier des régions 
hydrophobes, permet d’identifier aussi des structures secondaires (Callebaut et al., 
1997). L’analyse HCA révèle la présence de deux régions riches en résidus 
hydrophobes qui correspondent aux domaines A et BC des protéines Maf1 de H. 
sapiens et S. cerevisiae (Figure 9). Une région pauvre en résidus hydrophobes se 
trouve entre ces domaines et correspond au « linker » qui peut être dégradé par  
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Figure 8. Prédiction de structure de la protéine Maf1. Le serveur de prédiction de structure de 
protéine PSIPRED v 2.6 a été utilisé pour identifier la structure secondaire des protéines Maf1 de S. 
cerevisiae et H. sapiens. Seuls les domaines A et BC sont présentés. Les tubes verts (ou lettre H), les 
flèches jaunes (ou lettre E) ou les lignes noires (ou lettre C) représentent respectivement les hélices α, 
les feuillets β et les boucles. Les positions des mutations K35E, D250E, V260D et N344I dans la 
protéine Maf1 de S. cerevisiae sont indiquées par des croix rouges. Les mutations correspondantes 
chez la protéine Maf1 de H. sapiens sont aussi indiquées.  
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protéolyse ménagée (voir plus haut, expérience réalisée dans le laboratoire de 
Christoph Müller). 
Nous avons montré lors de ce travail que l’interaction entre les domaines A et 
BC facilite la déphosphorylation de Maf1 qui est nécessaire pour la répression de 
l’activité de la Pol III. Nous faisons aussi l’hypothèse que l’interaction entre ces 
domaines est influencée par l’état de phosphorylation de Maf1. Ainsi les différentes 
formes de Maf1 qui sont observées dans une électrophorèse en condition 
dénaturante et qui sont interprétées comme représentant différents niveaux de 
phosphorylation pourraient être dues, en fait, à différent états conformationnels 
dépendant de l’interaction entre les domaines A et BC. Il faut noter que les 
mutations S90A, S101A et S177A, S178A dans le « linker » changent profondément 
la proportion de formes lentes et rapides dans ce type d’électrophorèse sans 
changer notablement le niveau de phosphorylation de Maf1 (Lee et al., 2009). 
Nous proposons que le « linker » non structuré pourrait être phosphorylé et que 
son niveau de phosphorylation pourrait moduler l’état conformationnel de Maf1. 
Nous avons utilisé le serveur NetPhos 2.0 pour étudier cette question (Blom, 1999) 
et prédire les sites de phosphorylation chez quatre orthologues de Maf1 contenant 
des « linkers » de taille différente. Les sites de phosphorylation prédits sont plus 
fréquemment trouvés dans les longs « linkers » entre les domaines A et BC  
S. cerevisiae et C. glabrata. Ces sites sont plus uniformément distribués le long de 
la séquence de Maf1 chez C. elegans et H. sapiens, mais ils sont un peu plus 
présents dans leurs « linkers » (Figure 10). Nous faisons l’hypothèse que la 
phosphorylation et la déphosphorylation des résidus du « linker » modifie la 
conformation de la protéine, change la distance entre les domaines A et BC et donc 
module l’activité de répression par Maf1 de la transcription par la Pol III (Figure 11). 
L’interaction des domaines A et BC, régulée par la phosphorylation, pourrait 
aussi affecter l’importation de Maf1 dans le noyau et l’interaction avec la Pol III. 
Cette supposition est soutenue par des données publiées qui montre que la 
phosphorylation de six résidus du « linker » par la kinase PKA inhibe l’import 
nucléaire de Maf1 et la répression de la transcription par la Pol III (Moir et al., 
2006). 
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Figure 9. Analyse de cluster hydrophobe (HCA) dans la séquence de Maf1 de H. sapiens et S. cerevisiae. Représentation schématique de structure 
secondaire de Maf1 : une étoile rouge indique une proline, un losange une glycine, un carré avec ou sans point respectivement une serine et une thréonine. 
Les résidus acides (E, Q, N) sont en rouge, les résidus basiques (K, R) sont en bleu. Les clusters d’acides aminés hydrophobes sont en vert et entourés. Un 
cluster vertical correspond à un feuillet β tandis qu’un cluster horizontal est associé avec une structure en hélice α (Callebaut et al., 1997). Les localisations 
des domaines A et BC sont indiquées par des flèches noires.  
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Figure 10. Prédiction des sites de phosphorylation de Maf1. Les séquences protéiques ont été 
analysées avec le serveur NetPhos 2.0. Les diagrammes représentent la probabilité de phosphoryaltion 
dans une échelle [0,000-1,000]. La figure présente les localisations des sérines (bleu), thréonine (vert) 
et tyrosine (rouge) prédites pour être phosphorylées. Les sites de phosphorylation sont comparés dans 
des séquences de Maf1 avec un long (S. cerevisiae et C. glabrata) et court (C. elegans and H. sapiens) 
« linker » entre les domaines A et BC. Les pourcentages des sites de phosphorylation localisés dans le 
« linker » sont indiqués sur le côté droit. 
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Figure 11. Localisation des résidus potentiellement phosphorylable dans la protéine Maf1 chez S. cerevisiae. La figure présente les localisations des 
sérines (bleu), thréonine (vert) et tyrosine (rouge) prédites pour être phosphorylées. Les résidus potentiellement phosphorylables (entourés par un cercle 
orange) sont représentés sur une représentation obtenue par analyse des clusters hydrophobes (HCA) (Callebaut et al., 1997). Une représentation schématique 
des domaines de Maf1 est présentée en bas. Les pourcentages de résidus potentiellement phosphorylables dans chaque domaine A, « linker », BC et région 
acide sont indiqués. 
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• Structure cristallographique de la protéine Maf1.  
 
Lors de la rédaction de ce rapport de thèse, les premières données 
cristallographiques sur la structure tridimensionnelle de Maf1 humaine ont été 
exposées lors du congrès scientifique biennal « The 7th International Biennial 
Conference on RNA Polymerases I & III. The Odd Pols '10 Meeting » en juin 2010 
(Rieke Ringel du laboratoire de Patrick Cramer, Gene Center, Munich). Ces données 
coïncident sur bien des points avec nos données et celles qui ont été obtenues par 
le laboratoire de Christoph Müller et rapportent que la protéine Maf1 est composée 
de deux domaines structurés A et BC séparés par un « linker » non structuré. 
Comme le laboratoire de Christoph Müller, Rieke Ringel a été en mesure de 
protéolyser de façon ménagée la protéine Maf1 humaine et d’isoler deux fragments 
correspondants aux domaines A et BC (données publiées très récemment le 1er 
octobre 2010 par Vannini et al.). La protéine humaine a été surproduite sans sa 
partie C-terminale acide et sans le « linker » entre les domaines A et BC. Tous les 
acides aminés du « linker » et même certains résidus de la partie C-terminale du 
domaine A ont été enlevés. La structure cristallographique de Maf1, définie avec 
une précision de 1,5 ångström, a été obtenue après deux ans et demi d’effort à 
temps plein et après de nombreuses tentatives. 
Maf1 est une protéine globulaire constituée d’un coeur hydrophobe de feuillets β 
entourés par des hélices α (Figure 12 aimablement donnée avant publication par 
Rieke Ringel). Le domaine A est constitué principalement d’un feuillet β (localisé 
dans le milieu de la structure) et d’une hélice α (située à l’extérieur de la structure). 
Cette nouvelle structure n’a pas d’homologues structuraux dans les bases de 
données et il n’est donc pas possible de prédire de fonction à un domaine 
particulier de Maf1 (Vannini et al., 2010). 
Comme les domaines A et BC de Maf1 sont fortement conservés entre H. sapiens 
et S. cerevisiae, il est raisonnable de situer les mutations identifiés chez la levure, 
lors de mon travail de thèse, sur la structure de la protéine Maf1 humaine. Ce 
positionnement permet d'apprécier spatiallement l’effet des mutations de Maf1 sur 
l’interaction entre les domaines A et BC. 
La position des mutations K35E, D250E, V260D et N344I chez la protéine Maf1 
de S. cerevisiae correspond respectivement aux positions des résidus K35, D109, 
S119 et S209 chez H. sapiens (Figure 12). La position de la mutation N344I n’est 
pas indiquée chez l’homme car le résidu S209 correspondant appartient à 
l’extrémité C-terminale acide qui a été exclue pour obtenir le cristal de Maf1. 
 - 147 - 
Néanmoins, le résidu S209 devrait être très proche de l’extrémité C-terminale du 
cristal (acide aminé 205)  
Il est intéressant de noter que la mutation K35E dans le domaine A qui altère la 
régulation de la transcription par la Pol III et les mutations suppresseurs D250E 
(D109) et V260D (S119) du domaine BC qui permettent de restaurer cette activité 
sont localisées à proximité (mais pas en contact). Ces localisations proches sont en 
bon accord avec l’impact des mutations sur l’interaction des domaines A et BC 
comme nous avons pu le voir lors de cette thèse par notre approche génétique et 
notre étude par la technique du double-hybride.  
Il faut, de plus, remarquer que la mutation V260D de la protéine Maf1 de  
S. cerevisiae (S119 chez l’homme) qui a un effet majeur sur l’interaction des 
domaines A et BC dans la technique du double-hybride est localisée le plus près du 
résidu K35. 
 
 
Figure 12. Structure tridimensionnelle de la protéine Maf1 de H. sapiens déterminée par 
cristallographie. La structure est présentée sous deux points de vue différents par une rotation de 
90°. La structure est définie avec une précision de 1,5 ångström. La position des résidus K35, D109 et 
S119 correspondant respectivement aux mutations K35E, D250E, et V260D, identifiées chez 
S. cerevisiae, a été indiquée en vert. La position de la mutation N344I correspondant à S209 chez 
l’homme n’est pas montrée car ce résidu est localisé dans l’extrémité C-teminale acide qui n’a pas été 
cristallisée. Le dernier résidu C-terminal est l’acide aminé 205 (Figure aimablement donnée avant 
publication par Rieke Ringel).  
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Enfin, la structure cristallographique de la protéine Maf1 humaine révèle que les 
deux séquences de localisation nucléaire (NLS) sont accessibles car localisées en 
surface. Le premier NLS fait partie du « linker » et le deuxième est a proximité 
(Vannini et al., 2010). Ainsi, les auteurs ont proposé que la phosphorylation du 
« linker » pourraient engendrer des changements structuraux de Maf1 qui 
masqueraient les séquences NLS et empêcheraient la localisation nucléaire de cette 
protéine. 
Nous faisons l’hypothèse que ces changements de conformation pourraient aussi 
affecter l’interaction entre les domaines A et BC indispensable à l’activité de 
répresseur de Maf1. 
 
• PERSPECTIVES 
L’identification de la structure cristallographique de Maf1 et des mécanismes 
moléculaires qui conduisent à la répression de la transcription par la Pol III vont 
étendre les possibilités des futures recherches. Il a été montré qu’une dérégulation 
de l’activité de la Pol III était liée à la transformation maligne (Marshall et al., 
2008a; Marshall et al., 2008b; Johnson et al., 2008). On peut donc imaginer que 
des agents thérapeutiques, structurellement similaires à Maf1, pourraient réprimer 
spécifiquement la transcription hyperactive de la Pol III dans les cellules tumorales 
et ainsi contrôler le développement anarchique de ces cellules.  
Des résultats récents de notre laboratoire montrent que Maf1 pourraient avoir 
un rôle aussi dans la maturation des ARNt (Karkusiewicz – données non publiées). 
Il serait intéressant d’identifier si cette fonction requiert les deux domaines A et BC 
de Maf1 ou si un des domaines est plus particulièrement impliqué. 
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